New in Cephalalgia Reports!
Educational interventions may improve headache outcomes, disability, quality of life, self-efficacy, medication use, and adherence.
•
Evidence is strongest for migraine and MOH but remains limited for other headache disorders and often comes from multicomponent interventions.
•
Migraine education should be concise, individualized, reinforced over time, and focused on diagnosis, lifestyle, medication, complication recognition, and follow-up according to individual patient needs.
journals.sagepub.com/doi/10.1177/25158163261505486
#migraine #headache #brain #pain #neurology #neuroscience
Cephalalgia (journal)
Cephalalgia: An International Journal of Headache is a peer-reviewed medical journal covering research on headaches. It is published by SAGE Publications on behalf of the International Headache Society; it was previously published by Blackwell Publishing. The journal was established in 1981 and currently has 16 issues per year. The editor-in-chief is Arne May. More on Wikipedia
-
Cephalalgia
@JCephalalgia
-
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine is chronic. Its frequency varies. This latest correspondence argues that it may be time to reconsider the terms “episodic” and “chronic” migraine and adopt terminology that better reflects migraine as a spectrum disorder.
What do you think?
What terms do you suggest?
journals.sagepub.com/doi/10.1177/03331024261507500
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A definition of restlessness that includes both its observable and its subjective dimensions would bring us closer to capturing the full clinical phenotype of cluster headache and, ultimately, to shortening the diagnostic delay for patients who do not fit the textbook picture.
journals.sagepub.com/doi/10.1177/03331024261506164
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
•
Long-term treatment of atogepant for the preventive treatment of migraine was safe and well tolerated. Overall safety results across 156 weeks were consistent with the known safety profile of atogepant; no new safety signals were observed.
•
Efficacy and functional outcomes showed improvement from lead-in study baseline at weeks 13–16 and were consistent through 156 weeks.
journals.sagepub.com/doi/10.1177/03331024261500983
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In this real-world case series, gepants were associated with clinically meaningful reductions in attack frequency in patients with active cluster headache bouts, with good short-term tolerability.
journals.sagepub.com/doi/10.1177/03331024261495544
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Atogepant showed rapid reductions in headache burden within one week in episodic cluster headache. Improvements across outcomes support its potential as an early preventive option in real-world practice.
journals.sagepub.com/doi/10.1177/03331024261495542
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Management must move beyond reducing attack frequency to standardizing measures that capture and treat the full spectrum of pain-free disability.
journals.sagepub.com/doi/10.1177/03331024261502429
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
If future trials confirm efficacy, gepants could offer a fast-acting, mechanism-based alternative, with a potentially more favourable side-effect profile than current treatment options.
journals.sagepub.com/doi/10.1177/03331024261495532
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Rimegepant provides 2-hour pain freedom in nearly half of treated migraine attacks, with a consistent response across repeated attacks in a meaningful proportion of individuals.
journals.sagepub.com/doi/10.1177/03331024261484897
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Post-hoc analyses in 234 women with suspected/confirmed hypertensive disorders of pregnancy (HDP) showed no association between migraine and sFlt-1, PlGF, or their ratio within HDP groups, yet differences were seen in the overall population
journals.sagepub.com/doi/10.1177/03331024261492308
#migraine #headache #brain #pain #neurology #neuroscience
@L_AlHassany -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Across all countries, substantial humanistic and economic burden was reported in individuals with migraine and comorbid depression compared with individuals with migraine alone, emphasizing the need for comprehensive management and preventive strategies to cohesively address both conditions
journals.sagepub.com/doi/10.1177/03331024261477399
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A 10-year study developed and externally validated the Migraine Risk Stratification Score (MRSS) to stratify cryptogenic ischemic stroke (CIS) risk in patients with migraine and right-to-left shunt, with particular value for identifying individuals at low risk.
journals.sagepub.com/doi/10.1177/03331024261499744
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
🧠 How much can we learn about a headache simply by asking the right questions?
When it comes to headache disorders, a good clinical history is often our most powerful diagnostic tool.
But effective history-taking is more than ticking boxes. It requires active listening, empathy, structured questioning, and clinical reasoning.
📢 A new article published in Cephalalgia Reports by the International Headache Society Education Committee presents a practical approach to optimising headache history-taking:
1️⃣ Listen and connect: Build rapport, ask open-ended questions, and understand the patient's experience.
2️⃣ Characterise the headache: Explore the onset, timing, pain characteristics, associated symptoms, triggers, and impact on daily life.
3️⃣ Check for red flags: Identify warning signs of secondary headaches using tools such as SNNOOP10 and careful assessment of temporal patterns.
4️⃣ Explain and plan: Communicate the diagnosis, address patient concerns, and develop a shared management plan.
💡 The key message?
Headache diagnosis is not just about recognising symptoms. It is about understanding the person experiencing them.
And while digital tools and AI may support clinical assessment, they cannot replace the art of listening.
📖 Read the full paper:
Souza MNP, et al. Optimizing headache history-taking: A structured approach from the International Headache Society Education Committee. Cephalalgia Reports. 2026;9.
🔗 doi.org/10.1177/25158163261486759
💬 For clinicians: What is the one question you never forget to ask when taking a headache history?
#cephalalgiareports #headachemedicine #migraine #neurology #headacheeducation #internationalheadachesociety #medicaleducation -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The evidence cited in the letter supports giving UdH greater attention in future population studies and burden estimates. At the same time, its clinical course and the benefits of any specific intervention require further study.
The authors therefore regard UdH as an important research and public health consideration, without assuming that every child with brief or mild
headache requires treatment.
journals.sagepub.com/doi/10.1177/03331024261501141
#migraine #headache #brain #pain #neurology #neuroscience
@deryauluduz -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Some other headache was unaccounted for in these studies; moreover, it was common: the Turkish study, with 7,088 participants, estimated its 1-year prevalence as 29.2%.6 The study authors labelled it “undifferentiated headache” (UdH) (in terminological alignment with A3.6 Undifferentiated
trigeminal autonomic cephalalgia in ICHD-3).
journals.sagepub.com/doi/10.1177/03331024261501136
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The authors encourage colleagues within the international orofacial pain
and oral medicine communities, to evaluate our proposed criteria through independent validation studies and multicenter collaborative research.
journals.sagepub.com/doi/10.1177/03331024261493168
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This Letter discusses how discordant negative-control outcomes should be interpreted when assessing residual bias in the cerebrovascular safety evaluation of CGRP monoclonal antibodies.
journals.sagepub.com/doi/10.1177/03331024261493119
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Both negative-control findings should inform interpretation, without treating the fracture result as confirmation of exchangeability or
the UTI result as a quantitative measure of bias in the primary outcome.
journals.sagepub.com/doi/10.1177/03331024261493112
#migraine #headache #brain #pain #neurology #neuroscience
@BradleyOngMD -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
~4 million Australians live with migraine.
Yet our new paper found just ONE NHMRC/MRFF-funded headache clinical trial from 2013–2025, and NONE for migraine or tension-type headache.
We need stronger investment and research capacity.
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Headache disorders are a leading cause of disability, yet publicly funded headache clinical trials in Australia are remarkably scarce. This new paper highlights the gap and the opportunity for change.
Article highlights
•
No funded clinical trials were identified for migraine or tension-type headache, despite their substantial burden.
•
A review of NHMRC and MRFF funding in Australia identified only one funded headache disorder clinical trial since 2013, focused on cluster headache.
•
Increased investment in headache clinical trials, workforce development, and national research infrastructure could help accelerate evidence generation and improve patient outcomes.
journals.sagepub.com/doi/10.1177/25158163261501562
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia reposted
Sage Journals
@SageJournals
Cephalalgia is excited to announce the Jes Olesen Awards winners at the European Headache Congress!
Stay tuned to discover the winning papers: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
@JCephalalgia @ihs_official -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Headache disorders are a leading cause of disability, yet publicly funded headache clinical trials in Australia are remarkably scarce. This new paper highlights the gap and the opportunity for change.
Article highlights
•
No funded clinical trials were identified for migraine or tension-type headache, despite their substantial burden.
•
A review of NHMRC and MRFF funding in Australia identified only one funded headache disorder clinical trial since 2013, focused on cluster headache.
•
Increased investment in headache clinical trials, workforce development, and national research infrastructure could help accelerate evidence generation and improve patient outcomes.
journals.sagepub.com/doi/10.1177/25158163261501562
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠🏆
Submissions are now open!
Cephalalgia invites researchers worldwide to submit their original research for the Jes Olesen Awards, recognising excellence and innovation in headache medicine.
🏆 Two prestigious awards:
🔬 Jes Olesen Basic Science Award
🩺 Jes Olesen Clinical Science Award
Each award includes:
💶 €10,000 prize
🌍 Recognition through Cephalalgia and IHS platforms
🎤 Opportunity to present at a major scientific meeting
✅ Eligibility:
• Original research papers only
• First author must be under 45 years of age at submission
• One submission per participant
📅 Submission deadline: 28 February 2027
📄 All submissions will undergo Cephalalgia's standard peer-review process, with winners selected from accepted papers by an expert panel.
The awards are generously funded by Professor Jes Olesen through JO Health to support and inspire the next generation of headache researchers.
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
More details: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Don't miss this opportunity to have your research recognised!
#jesolesenawards #cephalalgia #ihs #headacheresearch #headachemedicine #callforpapers #headache -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Can rheumatoid meningitis mask itself as a simple worsening of pre-existing migraine with aura? Yes, even without focal signs! Read how calculating the serum anti-CCP antibody (ACPA) index via the Reiber equation cracked this diagnostic puzzle.
journals.sagepub.com/doi/10.1177/25158163261503143
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
にゅ〜ろろぐ🧠|頭痛専門医|脳神経内科医🔨
@NeurologStrHd
メマンチンが有効だった慢性群発頭痛か〜🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A 69-year-old man with chronic cluster headache enjoyed a notable reduction in attack frequency with memantine 20 mg twice daily. Off-label use of memantine in cluster headache should be considered in select patients.
journals.sagepub.com/doi/10.1177/25158163261500757
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
前兆のある片頭痛に対する、
抗てんかん発作薬ラモトリギンの効果?
やや重症な集団ではありますが、効果は極めて限定的。
前兆の改善報告もなし。
副作用による中止も23.1%。
結構、厳しい結果ですね。
最近、ペランパネルも有効性が示せなかった研究を紹介しました。
片頭痛にはCSDという異常な神経活動が関わります。
ですので神経の興奮性という共通点から、
抗てんかん発作薬は特に前兆に効果が期待できそうに思えます。
しかしなかなか厳しい結果が多く、意外です🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Lamotrigine should be considered with caution as a preventive treatment for migraine with aura.
Lamotrigine showed minimal effectiveness for preventing migraine with aura, with only one responder out of 52 patients.
•
No improvements in aura symptoms were reported across the cohort.
•
Nearly one quarter discontinued treatment due to adverse effects.
journals.sagepub.com/doi/10.1177/25158163261486689
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A letter to the editor from Uzun and Sahin responding to the recent case series by Abdalla et al. on lamotrigine in migraine with aura.
journals.sagepub.com/doi/10.1177/25158163261504730
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A first-ever migraine aura was followed by a small cerebellar ischemic lesion in a patient with a patent foramen ovale, supporting a possible link between paradoxical microembolism, cortical spreading depression, and focal ischemia.
journals.sagepub.com/doi/10.1177/25158163261500746
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A 69-year-old man with chronic cluster headache enjoyed a notable reduction in attack frequency with memantine 20 mg twice daily. Off-label use of memantine in cluster headache should be considered in select patients.
journals.sagepub.com/doi/10.1177/25158163261500757
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In 1M+ headache-diary days, weather was a real but tiny correlate of headache reports — no reproducible "weather-sensitive" subgroup could be identified, no match to patients' own triggers, and near-chance day-level prediction.
journals.sagepub.com/doi/10.1177/25158163261498893
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The first study in the world comparing pharmacopuncture, a type of acupuncture technique, to standard oral medication (propranolol) as prophylaxis treatment for migraine.
.............
GB20 pharmacopuncture with 2% lidocaine produced reductions in migraine frequency, disability and bothersome symptoms in the same direction as propranolol, without evidence of a statistically significant between-group difference.
•
GB20 pharmacopuncture with 2% lidocaine warrants further evaluation as a possible option for patients intolerant of or contraindicated for propranolol prophylaxis.
journals.sagepub.com/doi/10.1177/25158163261496909
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This paper compared the ICHD-3 and DC/TMD diagnostic systems for headache attributed to temporomandibular disorder in the OPPERA-II cohort and found that the two approaches identify overlapping but clinically distinct headache presentations.
journals.sagepub.com/doi/10.1177/25158163261497660
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Adjunctive masseter botox may improve outcomes in patients with chronic migraine and muscular temporomandibular disorder.
journals.sagepub.com/doi/10.1177/25158163261498886
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In patients with refractory migraine, evolving systemic features may provide an important clue to an underlying neuroendocrine disorder.
journals.sagepub.com/doi/10.1177/25158163261496890
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This systematic review examined EEG findings in migraine with brainstem aura. EEG was usually normal, while generalized rhythmic delta activity was the most frequently reported abnormal pattern in patients with decreased level of consciousness.
journals.sagepub.com/doi/10.1177/25158163261493456
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Secondary headaches can signal serious disease. The authors reviewed warning signs (“red flags”) and organised them into a structured framework (DIPIH-T) to help clinicians decide when further testing is needed.
journals.sagepub.com/doi/10.1177/25158163261488715
#migraine #headache #brain #pain #neurology #neuroscience
@HeikoPohl1 -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Secondary headaches can signal serious disease. The authors reviewed warning signs (“red flags”) and organised them into a structured framework (DIPIH-T) to help clinicians decide when further testing is needed.
.......
•
Secondary headaches often present with symptoms that are uncommon in primary headaches (red flags) and should prompt further diagnostic evaluation.
•
Red-flag information can be organized into different domains reflecting underlying pathological processes.
•
The proposed DIPIH-T framework groups warning signs into neurological dysfunction, inflammation/infection, precipitating factors, intracranial pressure abnormalities, hormonal dysfunction, and temporal features.
•
This structured approach may help clinicians recognize potentially dangerous headaches and guide decisions about further investigations.
journals.sagepub.com/doi/10.1177/25158163261488715
#migraine #headache #brain #pain #neurology #neuroscience
@HeikoPohl1 -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Masterclass in Headache
No treatment for new daily persisten headache (NDPH) has been well established. Although NDPH is rare in both general and clinic-based populations, and more frequent in adolescents than in adults,
it is usually disabling and highly refractory.
Link to the 'Masterclass in Headache' paper:
journals.sagepub.com/doi/10.1177/25158163261503151
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The purpose of this letter to the editor was to draw attention to the fact that Peru has two established headache organizations, rather than to explain their full activities.
journals.sagepub.com/doi/epub/10.1177/25158163261491881
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
These updates complement the valuable regional perspective provided by Velez-Jimenez et al. and offer international readers a more contemporary and nuanced view of the progress and remaining challenges in headache care in Peru.
journals.sagepub.com/doi/10.1177/25158163261491909
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The clinical significance of pain behaviors in chronic headache patients is unclear. Headache specialists place less weight on these compared to other neurologists who may withhold treatment if headache behaviors are not displayed.
Highlights
•
Online survey of general neurologists and headache specialists about whether pain behaviors in patients with chronic headache influence clinical management.
•
Although the clinical significance of these behaviors is unclear, headache specialists appeared to place less weight on them.
•
Practical implication: clinicians should not dismiss reports of chronic headache, even when observed pain behaviors are absent.
journals.sagepub.com/doi/10.1177/25158163261485447
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A structured, patient-centred headache history improves diagnostic accuracy and safety. This framework integrates ICHD-3–based diagnosis with assessment of red flags, MOH risk, and disability measures to guide practical, real-world care.
journals.sagepub.com/doi/10.1177/25158163261486759
#migraine #headache #brain #pain #neurology #neuroscience
@MarcioNattan -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Alterations in the interstitial microenvironment across headache phases and clinical phenotypes in migraine: A multimodal diffusion MRI study”, which has been selected as the Editor’s Choice for the October issue of Cephalalgia.
.................
Migraine-related alterations in the interstitial microenvironment vary with headache phase and disease burden
•
Individuals with migraine experiencing headache and with higher disease burden showed reduced extracellular volume fraction and increased intracellular volume fraction, suggesting a microenvironment that may influence interstitial fluid dynamics and glymphatic activity.
•
Observed alterations involved major white matter tracts implicated in multisensory processing and migraine pathophysiology.
•
Diffusion-derived alterations vary with headache phase and disease burden rather than representing a static trait.
journals.sagepub.com/doi/10.1177/03331024261470368
#migraine #headache #brain #pain #neurology #neuroscience
@_RobertaMessina -
Cephalalgia
@JCephalalgia
🏆 Jes Olesen Awards – Winners Announcement & Award Lectures!
The wait is almost over!
Join us at the European Headache Congress (EHC) for the announcement of the inaugural Jes Olesen Award winners and their award lectures!
Celebrating excellence in Basic Science and Clinical Science research, these prestigious awards recognise outstanding contributions to the advancement of headache medicine.
📅 11 December 2026
🕔 17:45–18:45, Berlin
📍 Plenary Hall | EHC
Each award carries a €10,000 prize, generously funded by Professor Jes Olesen through JO Health.
We look forward to celebrating the winners and hearing about their exceptional research!
#jesolesenawards #cephalalgia #ehc2026 #headacheresearch #headachemedicine -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
~4 million Australians live with migraine.
Yet our new paper found just ONE NHMRC/MRFF-funded headache clinical trial from 2013–2025, and NONE for migraine or tension-type headache.
We need stronger investment and research capacity.
doi.org/10.1177/25158163261501562
#headache #migraine -
Cephalalgia reposted
EMHA- European Migraine and Headache Alliance
@EMHAlliance
Proud to endorse a new letter in @JCephalalgia on tension-type headache, co-authored by Elena Ruiz de la Torre (EMHA) with Al.Ce.
“Tension” implies stress or muscle strain, not sensitisation, fuelling stigma and self-blame in many languages. journals.sagepub.com/doi/10.1177/03331024261476229
International Headache Society
@ihs_official
New in Cephalalgia!
In TTH, tension is not stress or muscle tension. A single word shapes how doctors talk about the condition, how patients understand their own bodies, and how easily they fall into the hands of unproven or costly treatments. Time to change!
journals.sagepub.com/doi/10.1177/03331024261476229
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
群発頭痛を含む頭痛グループ「TACs」
その外科治療に関するレビューが出てます📖
中でも特に面白いと思うのは、
超短時間のTACs 「SUNCT/SUNA」で、
MVDの効果が結構あること。
MVDは開頭して三叉神経を物理的に除圧する主に三叉神経痛の手術🧠
群発頭痛の仲間に有効とは不思議です🤔
⬇️
実は、
・SUNCT/SUNAはラモトリギンが有効
・三叉神経痛はカルバマゼピンが第一選択
共に、抗てんかん発作薬が有効な点も共通しています。
更に言うとNaチャネルブロッカーですね💊
「SUNA/SUNCTは群発頭痛よりもむしろ、
三叉神経痛に似た病態なのでしょうか?」
示唆に富んでいて興味深いです🤔
📚
Kumar et al. Cephalalgia Reports, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Trigeminal autonomic cephalalgias (TACs) are severe headaches that sometimes do not respond to medication. This study reviewed surgical options and found that microvascular decompression can provide lasting relief, especially when imaging shows nerve compression.
journals.sagepub.com/doi/10.1177/25158163261478501
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
片頭痛患者さんへの有酸素運動の効果🏃♂️
興味深いことに、前向き研究です!
睡眠の質やQOLが対照群より有意に改善
頭痛強度も運動群で改善したものの、
群間差は有意ではありませんでした。
片頭痛と運動の観察研究では、
「運動できるくらい軽症なだけでは?」
という交絡の問題がついて回ります🤔
今回はランダム化比較試験(RCT)なので、
その交絡は抜きで考えられますね😀
📚Selvakumar et al. Cephalalgia Reports, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Aerobic training increased resting-state alpha wave activity than Biofeedback and Placebo. Sleep quality and quality of life improved significantly, with large effect sizes. Pain reduction did not differ significantly between groups.
journals.sagepub.com/doi/10.1177/25158163261481054
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sage Journals
@SageJournals
Call for papers for the Jes Olesen Awards for the Advancement of Headache Medicine: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Submission Closes: February 28, 2027 @JCephalalgia -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
緊張型頭痛の本質は「緊張」ではない。
なのに、この紛らわしい名前のせいで、
・精神の緊張→ストレスのせい?
・筋肉の緊張→肩こりや姿勢のせい?
というイメージが付きすぎてしまいます😅
医師ですら誤解していることがあります。
結果、「緊張をほぐす」に主眼が置かれ、
非科学的な高額施術に誘導されたり、
適切な頭痛治療につながりにくくなる懸念があります😣
「これ名前変えた方がいいんじゃない?」
っていう提言が出ていました。
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In TTH, tension is not stress or muscle tension. A single word shapes how doctors talk about the condition, how patients understand their own bodies, and how easily they fall into the hands of unproven or costly treatments. Time to change!
journals.sagepub.com/doi/10.1177/03331024261476229
#migraine #headache #brain #pain #neurology #neuroscience
@cherubinodilorenzo -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The chronicization process in migraine patients involves changes in the structure, function, iron content, and clearance function of multiple nuclei.
•
Migraine was associated with subcortical dysfunction, including selective subcortical functional and glymphatic changes.
•
These abnormalities provide new insight into chronic migraine pathophysiology.
journals.sagepub.com/doi/10.1177/03331024261485487
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
3,000 migraine papers. 1 in 5 open with the same tired 'common, prevalent, disabling' line. This Cephalalgia letter says: it's not plagiarism, it's just boring, and asks authors (and reviewers) to try harder.
journals.sagepub.com/doi/10.1177/03331024261489743
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
From Aristotle’s metaphysics to IHS higher standards: shifting migraine prevention from relative response to residual disease control, requiring real-world evidence, education, and routine clinical implementation.
journals.sagepub.com/doi/10.1177/03331024261489742
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Al-Sayegh et al. reported that CGRP-targeted therapies consistently reduced depressive and anxiety symptoms in migraine patients across 12 studies (n=2,796), likely secondary to migraine control rather than direct psychotropic effects.
....
Placebo-controlled evidence did not confirm a direct psychotropic effect, suggesting improvements may be mediated through effective migraine control.
•
The predominance of open-label designs underscores the need for randomised controlled trials with prespecified psychiatric endpoints.
journals.sagepub.com/doi/10.1177/03331024261484898
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In TTH, tension is not stress or muscle tension. A single word shapes how doctors talk about the condition, how patients understand their own bodies, and how easily they fall into the hands of unproven or costly treatments. Time to change!
journals.sagepub.com/doi/10.1177/03331024261476229
#migraine #headache #brain #pain #neurology #neuroscience
@cherubinodilorenzo -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Developed and externally validated the Migraine Analgesic Usage (MAU) Index, a simple triage score using acute medication days and Migraine Treatment Optimization Questionnaire 6-item version (MTOQ-6) to identify high multidimensional migraine burden. It supports Green/Yellow/Red clinical prioritisation.
journals.sagepub.com/doi/10.1177/03331024261478621
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Escalation to eptinezumab 300 mg was associated with improved population-averaged outcomes in this selected cohort of difficult-to-treat partial responders to 100 mg, supporting, as such, dose escalation over switching therapy.
•
Escalation converted partial 100 mg responders: 57.9% and 64.9% achieved ≥ 50% MHD reduction after first and second 300 mg cycles.
•
After two 300 mg cycles, MHD decreased from 17 to 5, and MIDAS scores dropped from 93 to 39.
•
Greater 100 mg MHD reduction and no prior erenumab exposure independently predicted ≥ 50% response, supporting escalation before switching treatment.
journals.sagepub.com/doi/10.1177/03331024261498883
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine-related alterations in the interstitial microenvironment vary with headache phase and disease burden
•
Individuals with migraine experiencing headache and with higher disease burden showed reduced extracellular volume fraction and increased intracellular volume fraction, suggesting a microenvironment that may influence interstitial fluid dynamics and glymphatic activity.
•
Observed alterations involved major white matter tracts implicated in multisensory processing and migraine pathophysiology.
•
Diffusion-derived alterations vary with headache phase and disease burden rather than representing a static trait.
journals.sagepub.com/doi/10.1177/03331024261470368
#migraine #headache #brain #pain #neurology #neuroscience
@_RobertaMessina -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A structured two-tier headache curriculum defines core competencies for general neurologists and advanced skills for specialists—aligning education with ICHD-3, modern therapeutics, and multidisciplinary care to improve headache diagnosis.
journals.sagepub.com/doi/10.1177/03331024261485181
@amrhasanneuro
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Comment from the authors:
"We therefore view the contribution by Wasserman and
colleagues not as an alternative to our proposal, but as an important extension that illustrates the breadth of hypotheses
that can be systematically explored within a shared descriptive framework"
journals.sagepub.com/doi/10.1177/03331024261479677
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Musella et al. propose a multidimensional Oral Dysaesthetic and Perceptual Disorder (ODPD) framework for burning mouth syndrome and call for psychiatric input. This reply: the perceptual dimension is exactly where that input is needed — psychoanalytic, interoceptive & Complex Regional Pain Syndrome (CRPS) accounts converge.
journals.sagepub.com/doi/10.1177/03331024261479682
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Headache medicine is full of questions. Are we always asking the right ones?
How do we recognise the less obvious presentations? Navigate diagnostic pitfalls? Make better treatment decisions?
A new educational initiative is coming to Cephalalgia Reports: Masterclass in Headache — a series featuring contributions from leading experts in the field, bringing practical, evidence-informed insights to clinicians who want to improve the way they diagnose and manage headache disorders.
Our introductory editorial has just been published. This is only the beginning.
📖 Read the editorial:
journals.sagepub.com/doi/10.1177/25158163261497651
More knowledge. More practical insights. Better headache care.
#headache #migraine #ihs #cephalalgiareports #masterclassinheadache
@Simona_Sacco_
@MarcioNattan -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The Arabic Migraine Attacks–Subjective Cognitive Impairments (Mig-SCog) demonstrated good internal consistency and acceptable construct validity in Arabic-speaking individuals with migraine. Its correlations with HIT-6, MoCA, and monthly migraine days support its utility as a screening tool.
journals.sagepub.com/doi/10.1177/25158163261486045
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In adults with episodic migraine, higher retrospective premonitory symptom burden was associated with greater cephalic and extracephalic allodynia, but not clinically meaningful HIT-6 change.
journals.sagepub.com/doi/10.1177/25158163261484899
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Lamotrigine should be considered with caution as a preventive treatment for migraine with aura.
Lamotrigine showed minimal effectiveness for preventing migraine with aura, with only one responder out of 52 patients.
•
No improvements in aura symptoms were reported across the cohort.
•
Nearly one quarter discontinued treatment due to adverse effects.
journals.sagepub.com/doi/10.1177/25158163261486689
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
CGRPは血管拡張作用があります💉
よって片頭痛予防の抗CGRP薬は、
「血圧が上がるのでは?」🤷
と懸念されていました。
約1.9万人を対象としたメタアナリシス
→抗CGRPでの明らかな血圧上昇は見られなかったそうです。
少なくとも短期的には、大きな影響はなさそうですね🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Meta-analysis of FDA trial data shows anti-CGRP therapies are not associated with clinically significant increases in blood pressure, supporting their cardiovascular safety in migraine treatment.
journals.sagepub.com/doi/10.1177/25158163261478222
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Trigeminal autonomic cephalalgias (TACs) are severe headaches that sometimes do not respond to medication. This study reviewed surgical options and found that microvascular decompression can provide lasting relief, especially when imaging shows nerve compression.
journals.sagepub.com/doi/10.1177/25158163261478501
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Aerobic training increased resting-state alpha wave activity than Biofeedback and Placebo. Sleep quality and quality of life improved significantly, with large effect sizes. Pain reduction did not differ significantly between groups.
journals.sagepub.com/doi/10.1177/25158163261481054
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Atraumatic-first lumbar puncture was associated with a low post-dural puncture headache (PDPH) incidence of 4.1% in 344 neurological outpatients undergoing diagnostic LP at a tertiary neurological outpatient clinic. Younger age, but not sex, BMI or puncture attempts, predicted PDPH. Findings support routine atraumatic-first LP.
journals.sagepub.com/doi/10.1177/25158163261480327
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
Do anti-CGRP migraine medications increase blood pressure?
We analysed FDA data from 20 RCTs and 18,886 participants.
Reassuringly, neither anti-CGRP monoclonal antibodies nor gepants were associated with significant increases in BP vs placebo.
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Meta-analysis of FDA trial data shows anti-CGRP therapies are not associated with clinically significant increases in blood pressure, supporting their cardiovascular safety in migraine treatment.
journals.sagepub.com/doi/10.1177/25158163261478222
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
An interesting case presented with both intracranial hyper and hypotension, associated with cerebellar tonsillar displacement as a navigator.
Tonsillar displacement can be associated with both intracranial hypertension and hypotension. This phenomenon should be understood as a dynamic process instead of a fixed or unidirectional force.
•
It is crucial to understand the pathophysiology of CSF dynamics and to recognize the imaging findings.
•
Careful clinical and imaging surveillance are essential for managing patients with conditions related to intracranial pressure.
journals.sagepub.com/doi/10.1177/25158163261478626
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Meta-analysis of FDA trial data shows anti-CGRP therapies are not associated with clinically significant increases in blood pressure, supporting their cardiovascular safety in migraine treatment.
journals.sagepub.com/doi/10.1177/25158163261478222
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Protocol for a systematic review/meta-analysis assessing whether migraine—especially with aura—is associated with increased white matter hyperintensity burden on MRI, addressing conflicting evidence using rigorous, population-based methods.
journals.sagepub.com/doi/10.1177/25158163261472105
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Can pitolisant, a selective H3 receptor inverse agonist, trigger migraine-like attacks in women with migraine without aura?
This randomized, double-blind, placebo-controlled crossover study in 14 women will provide novel insights into the involvement of the H3 receptor in migraine pathophysiology and clarify whether selective modulation of this receptor is sufficient to provoke migraine-like attacks.
journals.sagepub.com/doi/10.1177/25158163261474461
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Migraine-related healthcare interaction status was associated with substance-use indicators among U.S. college students engaged in care.
•
No treatment after appointment/discussion or being told no treatment was necessary showed elevated substance-use odds.
•
Depression, anxiety, or PTSD explained only a modest portion of selected associations.
•
Findings are hypothesis-generating, not evidence of treatment adequacy or mechanistic mediation.
journals.sagepub.com/doi/10.1177/25158163261474168
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A systematic review of 17 studies with 1857 pediatric patients with status migrainosus highlights literature gaps and brings attention to an under-recognized condition.
.............................
Status migrainosus in pediatric populations is under-recognized, mostly affecting adolescent girls.
•
Evidence on pediatric status migrainosus is limited to observational, non-comparative, predominantly retrospective studies; no randomized trials were identified.
•
Stress, chronic migraine, and psychiatric comorbidities are reported associated factors.
•
Nerve blocks showed a trend toward short-term pain control in observational, non-randomized studies.
•
Pediatric-focused, standardized, acute management protocols from clinical trials are urgently needed.
journals.sagepub.com/doi/10.1177/25158163261469216
#migraine #headache #brain #pain #neurology #neuroscience
@MoIbr_X -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This paper reports that intravenous dihydroergotamine (DHE) given as a five-day infusion is an effective, well tolerated approach to the management of intractable primary headache disorders.
journals.sagepub.com/doi/10.1177/25158163261470348
#migraine #headache #brain #pain #neurology #neuroscience
@Atirahcus -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
New research is testing whether blocking 10 nerves of the scalp instead of 2 stops migraine faster and prevents them for longer. It could change how episodic migraine is treated.
journals.sagepub.com/doi/10.1177/25158163261471133
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The findings of this study highlight the need for consensus-based guidelines, specialized physiotherapy training, and stronger multidisciplinary collaboration in headache care.
......................
Exercises and manual therapy were the most frequently advised physiotherapy modalities, with neck pain and musculoskeletal findings being the main drivers for referral.
•
Referral patterns differed by country income level, with high-income countries more often using defined criteria than lower-to-upper-middle-income countries.
•
These findings highlight the need for consensus-based guidelines, specialized physiotherapy training, and stronger multidisciplinary collaboration in headache care.
journals.sagepub.com/doi/10.1177/25158163261469410
#migraine #headache #brain #pain #neurology #neuroscience
@dilara_onan -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠🏆
Submissions are now open!
Cephalalgia invites researchers worldwide to submit their original research for the Jes Olesen Awards, recognising excellence and innovation in headache medicine.
🏆 Two prestigious awards:
🔬 Jes Olesen Basic Science Award
🩺 Jes Olesen Clinical Science Award
Each award includes:
💶 €10,000 prize
🌍 Recognition through Cephalalgia and IHS platforms
🎤 Opportunity to present at a major scientific meeting
✅ Eligibility:
• Original research papers only
• First author must be under 45 years of age at submission
• One submission per participant
📅 Submission deadline: 28 February 2027
📄 All submissions will undergo Cephalalgia's standard peer-review process, with winners selected from accepted papers by an expert panel.
The awards are generously funded by Professor Jes Olesen through JO Health to support and inspire the next generation of headache researchers.
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
More details: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Don't miss this opportunity to have your research recognised!
#jesolesenawards #cephalalgia #ihs #headacheresearch #headachemedicine #callforpapers #headache -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
「頭痛薬の飲みすぎによる頭痛」
の脳内ネットワーク🧠
FDG-PET/MRIで検討されています。
個人的に興味深いのは、
治療成績不良群における、
「側坐核・視床・眼窩前頭皮質の代謝亢進」
いわゆる報酬系にも関わる領域ですよね?
疼痛だけでなく依存との両面で興味深い。
fMRIのちゃんとした研究もあるのでしょうか🤔
📚Liu et al. Cephalalgia, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
FDG-PET/MRI revealed distinct reward- and cerebellar-network alterations in chronic migraine with medication overuse patients with poor 1-year outcomes. Network-level metabolic covariance was closely linked to dependence severity.
.............
Patients with poor outcomes showed hypermetabolism in reward-related regions and the cerebellum when compared with healthy controls (HC), and in the cerebellum when compared with good-outcome patients.
•
Cerebellar metabolic covariance with the putamen and occipital cortex was associated with dependence severity and long-term outcomes.
•
Findings support early, comprehensive interventions targeting both headache burden and maladaptive neurobehavioral processes in Chronic migraine with medication overuse (CMwMO).
journals.sagepub.com/doi/10.1177/03331024261476230
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
"Reply to Letter to the Editor. The authors provided responses to clarify the methodological considerations and clinical framework
underlying our case series and satisfactorily address the points raised by Viceconti et al."
journals.sagepub.com/doi/10.1177/25158163261477300
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Letter to the Editor highlighting methodological and clinical concerns in a study on individualized physiotherapy for migraine: unclear diagnosis, incomplete outcomes, missing medication data, and potential interpretation bias.
journals.sagepub.com/doi/10.1177/25158163261477293
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The available literature consistently suggests that gender-affirming hormone therapy can trigger or exacerbate migraine through hormonal pathways. The authors propose that Migraine Triggered or exacerbated by gender-affirming hormone therapy could be included in the ICHD-4.
journals.sagepub.com/doi/10.1177/25158163261472312
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
片頭痛は家庭のあり方にも影響を及ぼす🤕
片頭痛が重症になるほど、家事負担をパートナーが担う傾向もありそう。
片頭痛を早い段階から治療することは、
自分のためはもちろん、
家族のためにも良いかもしれませんね🤔
📚Zlotnik et al. Cephalalgia, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In a population-based cohort of 675 adults with migraine and 232 controls, domestic labor patterns differed by sex.
•
Females with migraine reported greater involvement in female-dominated household tasks, whereas males showed increased participation in distinct domains.
•
Migraine severity correlated with task-specific partner reliance, particularly among females.
•
·Domestic labor emerges as an overlooked dimension of migraine-related disability.
journals.sagepub.com/doi/10.1177/03331024261464573
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🏆 Jes Olesen Awards – Winners Announcement & Award Lectures!
The wait is almost over!
Join us at the European Headache Congress (EHC) for the announcement of the inaugural Jes Olesen Award winners and their award lectures!
Celebrating excellence in Basic Science and Clinical Science research, these prestigious awards recognise outstanding contributions to the advancement of headache medicine.
📅 11 December 2026
🕔 17:45–18:45, Berlin
📍 Plenary Hall | EHC
Each award carries a €10,000 prize, generously funded by Professor Jes Olesen through JO Health.
We look forward to celebrating the winners and hearing about their exceptional research!
#jesolesenawards #cephalalgia #ehc2026 #headacheresearch #headachemedicine -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In Visual Snow Syndrome, persistent visual symptoms occur despite normal cerebral imaging. This EEG- based study reveals altered interaction between cardiac-related brain activity and visual prediction-error responses.
journals.sagepub.com/doi/10.1177/03331024261480300
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
App-based self-administered biofeedback therapy was associated with a reduction in migraine frequency in adults with episodic migraine. Higher adherence was associated with a greater reduction in migraine days
journals.sagepub.com/doi/10.1177/03331024261480724
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Headache is common in patients with joint hypermobility but often overlooked. This review highlights links with migraine and secondary causes such as intracranial hypotension and craniocervical instability.
..................
Joint hypermobility is frequently underrecognized in patients with headache.
•
Migraine is the predominant primary headache phenotype, but secondary headache disorders should be systematically considered.
•
Headache assessment should incorporate musculoskeletal, autonomic, and systemic evaluation.
•
Management should be individualized, integrating standard headache care with management of hypermobility-related comorbidities and secondary headache disorders.
journals.sagepub.com/doi/10.1177/03331024261477381
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Which receptor lets Substance P and PACAP activate dural mast cells in migraine? Not NK1R or PAC1, both essentially absent. Only MRGPRX2 is expressed, pointing to a single convergent target for future headache therapies.
journals.sagepub.com/doi/10.1177/03331024261480167
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
FDG-PET/MRI revealed distinct reward- and cerebellar-network alterations in chronic migraine with medication overuse patients with poor 1-year outcomes. Network-level metabolic covariance was closely linked to dependence severity.
.............
Patients with poor outcomes showed hypermetabolism in reward-related regions and the cerebellum when compared with healthy controls (HC), and in the cerebellum when compared with good-outcome patients.
•
Cerebellar metabolic covariance with the putamen and occipital cortex was associated with dependence severity and long-term outcomes.
•
Findings support early, comprehensive interventions targeting both headache burden and maladaptive neurobehavioral processes in Chronic migraine with medication overuse (CMwMO).
journals.sagepub.com/doi/10.1177/03331024261476230
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We’re delighted to share that the paper “EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication”, has been selected as essential reading by our Editor-in-Chief, Prof. Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
............................
This new scoring system highlighted the importance of treatment reliability, pain intensity, and frequency in categorizing patients into a simple migraine severity grouping. The European Migraine and Headache Alliance–Migraine Scoring System (EMHA-MSS) could facilitate tailored management and longitudinal monitoring, potentially improving alignment with sufferers’ perceptions and enhancing patient-physician communication and understanding.
journals.sagepub.com/doi/10.1177/03331024261471185
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
According to this systematic review, current evidence on blood PACAP-38 levels in migraine remains inconsistent and inconclusive. At present, circulating PACAP-38 cannot be considered a reliable clinical biomarker for migraine.
journals.sagepub.com/doi/10.1177/03331024261468031
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Migraine attack prediction using wearable biosensor data” which has been selected as the Editor’s Choice for the September issue of Cephalalgia.
.........................
This study supports the feasibility of migraine attack prediction using continuous physiological data from a wrist-worn biosensor analysed with personalised machine learning approaches.
journals.sagepub.com/doi/10.1177/03331024261492220
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@HenrikSchytz -
Cephalalgia
@JCephalalgia
Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
journals.sagepub.com/doi/10.1177/03331024261474833
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A randomized, placebo-controlled trial prospectively stratified by baseline severity and treatment timing would be better positioned to determine whether earlier rimegepant administration truly improves acute vestibular outcomes.
journals.sagepub.com/doi/10.1177/03331024261474832
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In a population-based cohort of 675 adults with migraine and 232 controls, domestic labor patterns differed by sex.
•
Females with migraine reported greater involvement in female-dominated household tasks, whereas males showed increased participation in distinct domains.
•
Migraine severity correlated with task-specific partner reliance, particularly among females.
•
·Domestic labor emerges as an overlooked dimension of migraine-related disability.
journals.sagepub.com/doi/10.1177/03331024261464573
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The EMHA-MSS is a novel scale to evaluate the severity of migraine reported by patients.
•
This new scoring system classifies patients with migraine based on the frequency of migraine, treatment effectiveness, pain intensity, and attack intensity.
•
The scores obtained in the EMHA-MSS may be used to foster patient-clinician conversations and shared understanding.
journals.sagepub.com/doi/10.1177/03331024261471185
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Reply to: Tariq N, Awais Amir, M. Letter to Editor: Methodological considerations regarding smoking, psychological distress, and medication-overuse headache
journals.sagepub.com/doi/10.1177/03331024261471846
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This letter critiques three methodological limitations in Hussein et al.'s cross-sectional study on smoking and medication-overuse headache: causal ambiguity, unvalidated instruments, and regression circularity.
journals.sagepub.com/doi/10.1177/03331024261471862
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Low unprompted recognition of prodromal symptoms suggests subjective awareness is unreliable, highlighting the need for objective prodrome detection.
•
Selected personalised machine learning configurations using wearable physiological signals achieved good or excellent migraine prediction in approximately two-thirds of participants.
•
Generalised model transferability was limited, with above-chance prediction in only one-third of participants, supporting the need for individual calibration.
journals.sagepub.com/doi/10.1177/03331024261492220
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from across the globe, highlighting regional challenges, healthcare disparities, and opportunities to advance migraine care.
In this interview, Ildefonso Rodríguez-Leyva discusses migraine care in Latin America, drawing on insights from the Latin American Headache Association (ASOLAC). The discussion explores barriers to accessing effective migraine treatments despite broad healthcare coverage and highlights priorities for improving headache care across the region.
Key takeaway:
💬 "The paradox: High healthcare coverage does not mean high healthcare access. That's the paradox at the heart of migraine care in Latin America and it's costing millions of people effective treatment for one of the world's most disabling conditions."
— Ildefonso Rodríguez-Leyva
🎥 Watch the author interview: www.youtube.com/watch?v=hkzEKVwS7ao
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163261456215
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #latinamerica #asolac #globalhealth #healthequity #headachecare #healthcareaccess -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from across the globe, highlighting regional advances, ongoing challenges, and opportunities to improve migraine care.
In this interview, Sucharita Ray discusses migraine care in India and Sri Lanka, exploring current practice standards, recent progress in healthcare access, and the opportunities and challenges that lie ahead for migraine management in South Asia.
Key takeaway:
💬 "From National Health Insurance to Universal Health policy, migraine care in India and Sri Lanka has soared to newer heights. But challenges remain amid opportunities in the vast landscape of South Asian healthcare."
— Sucharita Ray
🎥 Watch the author interview: www.youtube.com/watch?v=EiZVRXFj36c
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163261456124
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #india #srilanka #southasia #globalhealth #healthequity #headachecare -
Cephalalgia
@JCephalalgia
Please watch a great new @JCephalalgia Editor's @Simina_Sacco_ Choice Article, Video Interview with the Author, Dr. Joseph Lloyd!
Increased markers of heavy metal exposure and DNA methylation in #cluster headache. Lloyd J, Wellfelt K, Jennysdotter Olofsgård F, et al. Cephalalgia 2026;46(8). doi:10.1177/03331024261480707 @IHS_Official @NinaRiggins
www.youtube.com/watch?v=xo5gIo79PXg -
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona_Sacco_ Editor’s Recognition #essential Reading Article! Please watch a great interview with Authors Dr. Aynur Ozge and Dr. Vanda Faria #migraine and headache in children and adolescents: A 2026 evidence-based factsheet. Uludüz D, Abu-Arafeh I, Orr SL, et al. Cephalalgia 2026;46(8). doi:10.1177/03331024261463173 @IHS_Official @NinaRiggins
www.youtube.com/watch?v=DfiOgDQpx20 -
Cephalalgia reposted
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
Roundtable discussion on Optimal #migraine Control @Bohemian_Wu @faradoost @ihs_official 👏 @AANmember @ahsheadache @miles4migraine @AHDAorg @WNGtweets 🧠
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona_Sacco_ Editor's Recognition Roundtable discussion with authors of real-world studies on optimal #migraine control, published in Cephalalgia in June 2026 hosted by @NinaRiggins
Participants: Drs. Edoardo Caronna, Spain, Keisuke Suzuki, Japan, Claudia Altamura, Italy, and Andreas A Argyriou, Greece @IHS_Official
www.youtube.com/watch?v=zda0wxyR3_E -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together high-quality articles from different regions of the world, highlighting local challenges, advances, and opportunities to improve migraine care.
In this interview, Avidesh Panday discusses the article Management of Migraine in the Caribbean, exploring the current state of migraine care in the region, barriers to diagnosis and treatment, and the importance of education, advocacy, and professional collaboration.
Key takeaway:
💬 "Migraine care in the Caribbean can be improved through the formation of a unified and dedicated Headache Society aimed at improving health provider education as well as patient advocacy and education."
— Avidesh Panday
🎥 Watch the author interview: www.youtube.com/watch?v=fqVxzr7aeX8
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251415565
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #caribbean #globalhealth #healthequity #medicaleducation #headachecare -
Cephalalgia
@JCephalalgia
We’re delighted to share that the paper “Migraine and headache in children and adolescents: A 2026 evidence-based factsheet”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
.......
Pediatric headache is a growing global public health challenge. This factsheet reveals that 60% of children and adolescents worldwide experience headaches, and migraine is already among the leading causes of disability.
journals.sagepub.com/doi/10.1177/03331024261463173
#migraine #headache #brain #pain #neurology #neuroscience
@deryauluduz
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together perspectives from across the globe, highlighting regional challenges, innovations, and opportunities to improve migraine care and reduce health inequalities.
In this interview, Oxana Grosu discusses the current state of migraine care in the Eastern Europe region, highlighting barriers to care, gaps in access to evidence-based treatments, and the importance of education and regional collaboration in advancing headache care.
Key takeaway:
💬 "Migraine is not just a clinical condition, it is a health system challenge. By strengthening education, improving access to evidence-based treatments, and fostering regional collaboration, we can reduce inequalities and advance equitable migraine care across Eastern Europe."
— Oxana Grosu
🎥 Watch the author interview: www.youtube.com/watch?v=exmBU5ctj2U
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251414020
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #easterneurope #globalhealth #healthequity #medicaleducation #headachecare -
Cephalalgia reposted
Doç. Dr. Ferhat Arslan
@Ferhatarslandr
Muhteremler dikkat ediniz. Nörologlar dediğime gelecekler. Bu ağır metal olayı ve klinikteki ağırlığı gün geçtikçe artacak. Sadece başağrısı meselesi değil birçok nörolojik hastalıkta altda yatan neden bunlardır.
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Increased markers of heavy metal exposure and DNA methylation in cluster headache”, which has been selected as the Editor’s Choice for the August issue of Cephalalgia.
.......................................
This study shows that there is indirect evidence indicating heavy metal exposure in relation to cluster headache, as well as a tendency for alterations in global DNA methylation. These results support the hypothesis that heavy metal exposure from smoking contributes towards the pathophysiology of cluster headache.
journals.sagepub.com/doi/10.1177/03331024261480707
#clusterheadache #headache #brain #pain #neurology #neuroscience
@carminebelinlab -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Increased markers of heavy metal exposure and DNA methylation in cluster headache”, which has been selected as the Editor’s Choice for the August issue of Cephalalgia.
.......................................
This study shows that there is indirect evidence indicating heavy metal exposure in relation to cluster headache, as well as a tendency for alterations in global DNA methylation. These results support the hypothesis that heavy metal exposure from smoking contributes towards the pathophysiology of cluster headache.
journals.sagepub.com/doi/10.1177/03331024261480707
#clusterheadache #headache #brain #pain #neurology #neuroscience
@carminebelinlab -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from around the globe, highlighting regional challenges, innovations, and opportunities to improve migraine care.
In this interview, Mona Nada discusses migraine care in the Middle East and North Africa (MENA) region, with a particular focus on North Africa. The discussion explores current challenges in headache care, barriers to accessing evidence-based treatments, and the importance of education, collaboration, and sustainable healthcare development across the region.
Key takeaway:
💬 "Migraine care in North Africa needs to move from recognition to action. By strengthening education, expanding access to evidence-based care, and fostering regional collaboration, we can build more equitable and sustainable headache care for our communities."
— Mona Nada
🎥 Watch the author interview: www.youtube.com/watch?v=iKXl9amw8hA
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251403011
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #mena #northafrica #globalhealth #healthequity #medicaleducation #headachecare -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study shows that there is indirect evidence indicating heavy metal exposure in relation to cluster headache, as well as a tendency for alterations in global DNA methylation. These results support the hypothesis that heavy metal exposure from smoking contributes towards the pathophysiology of cluster headache.
journals.sagepub.com/doi/10.1177/03331024261480707
#clusterheadache #headache #brain #pain #neurology #neuroscience
@carminebelinlab -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together perspectives from around the globe, highlighting regional challenges, innovations, and opportunities to improve migraine care.
In this interview, Freda Dodd-Glover discusses migraine care in the Sub-Saharan Africa region, highlighting the importance of education, strengthening primary healthcare systems, expanding access to evidence-based treatments, and fostering locally led research to improve outcomes for people living with migraine.
Key takeaway:
💬 "The future of migraine care in Africa begins with education, strengthened primary healthcare, equitable access to evidence-based treatments, locally led research, and digital innovation powered by partnerships that ensure no person with migraine is left behind."
— Freda Dodd-Glover
🎥 Watch the author interview: www.youtube.com/watch?v=goki0oCW3og
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251402983
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together insights from different regions to explore the real-world challenges and opportunities in migraine diagnosis, treatment, and care delivery.
In this interview, the author discusses findings from an Australian hospital headache clinic, highlighting the substantial delays that many people with migraine continue to experience before receiving an accurate diagnosis and appropriate preventive treatment.
Key takeaway:
💬 "Despite significant advances in migraine therapies and science, patients with migraine still routinely face significant delays in reaching the diagnosis and being commenced on appropriate preventive therapies."
— Usman Ashraf
🎥 Watch the author interview: www.youtube.com/watch?v=UqhTwwHPoto
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251398869
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #australia #healthcareaccess #globalhealth #healthequity -
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona_Sacco_ Editor's Recognition Roundtable discussion with authors of real-world studies on optimal #migraine control, published in Cephalalgia in June 2026 hosted by @NinaRiggins
Participants: Drs. Edoardo Caronna, Spain, Keisuke Suzuki, Japan, Claudia Altamura, Italy, and Andreas A Argyriou, Greece @IHS_Official
www.youtube.com/watch?v=zda0wxyR3_E -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
🧠 This AI model distinguishes primary from secondary headaches in 1,219 patients (AUC=0.905). Trigger & symptom burden, not pain intensity, drive diagnosis. SHAP & LIME make every prediction explainable.
journals.sagepub.com/doi/10.1177/03331024261479693
#migraine #headache #brain #pain #neurology #neuroscience
@idrisdemirsoy -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection showcases innovative initiatives, regional experiences, and practical approaches to improving headache and migraine care across diverse healthcare settings worldwide.
In this interview, the authors discuss the Regional Outreach Programme of the International Headache Society in Sub-Saharan Africa, highlighting how education, collaboration, and local partnerships are helping to strengthen headache care capacity and improve access to training and expertise across the region.
Key takeaway:
💬 "Sustainable healthcare starts with shared knowledge. Through strategic education initiatives and collaborative regional partnerships, we are equipping local healthcare communities in Sub-Saharan Africa to transform headache management from the ground up."
— Daniele Martinelli
🎥 Watch the author interview: www.youtube.com/watch?v=duMfC6pPO60
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251396915
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #headachemedicine #migraineresearch #subsaharanafrica #globalneurology #healthequity #medicaleducation -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
•
Photophobia during a migraine attack is not directly correlated with variations in retinal or cortical electrophysiological responses.
•
During a migraine attack, activity in photoreceptors sensitive to the short-wavelength light spectrum can vary.
•
During a migraine attack, photophobia is associated with increased phase (e.g., latency) of cortical responses, suggesting cortico-subcortical integration mechanisms involving thalamo-trigeminovascular convergence onto the sensory cortices.
journals.sagepub.com/doi/10.1177/03331024261476232
#migraine #headache #brain #pain #neurology #neuroscience
@F_Casillo -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Author Interview Series
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together expert perspectives from across the globe, highlighting regional challenges, advances, and opportunities to improve migraine care.
In this interview, the authors discuss the current state of migraine care in Kuwait and the Gulf region, including progress made in recent years and the ongoing need for improved education, awareness, and evidence-based management.
Key takeaway:
💬 "Migraine care in Kuwait and the Gulf region has improved over the past years but still needs to be optimized. Primary care physicians need to be educated and migraine management guidelines are crucial."
— Jasem Al-Hashel
🎥 Watch the author interview: youtu.be/DLmi1IqJZ2M
📄 Read the paper: journals.sagepub.com/doi/full/10.1177/25158163251374141
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #kuwait #gulfregion #healthequity -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
There are no data available on fremanezumab as a migraine preventive treatment in a Chinese population.
This Phase 3, double-blind trial with an open-label extension demonstrates the robust efficacy and safety of fremanezumab, compared with placebo, in Chinese adults living with migraine.
journals.sagepub.com/doi/10.1177/03331024261462833
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Guest Editor Interview
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). The collection brings together high-quality articles from across the globe, exploring how migraine services are organised and delivered in different countries and regions, and highlighting opportunities to improve care worldwide.
In this interview, guest editor Francesca Puledda discusses the value of learning from diverse healthcare systems and sharing experiences across regions to better understand the challenges and strengths of migraine care globally.
Key takeaway:
💬 "The collection brings together contributions from around the world, exploring how migraine services are organised and delivered across different countries and regions. By highlighting local healthcare systems, barriers to care, health inequities, and different approaches, these conversations provide valuable insights into both the strengths and the challenges of migraine care worldwide."
— Francesca Puledda
🎥 Watch the interview: www.youtube.com/watch?v=RcbXYFbgxVA
📄 Explore the topical collection: journals.sagepub.com/doi/full/10.1177/25158163251339440
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #healthequity #ihsheadache -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Cerebrospinal fluid (CSF) in 36 Visual Snow Syndrome (VSS) patients showed no meaningful differences vs matched controls. Routine lumbar puncture and autoimmun antibody screening may not be routinely indicated in patients with typical VSS and no clinical red flags.
journals.sagepub.com/doi/10.1177/03331024261469080
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Pediatric headache is a growing global public health challenge. This factsheet reveals that 60% of children and adolescents worldwide experience headaches, and migraine is already among the leading causes of disability.
doi.org/10.1177/03331024261463173
#migraine #headache #brain #pain #neurology #neuroscience
@deryauluduz -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Guest Editor Interview
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). Through contributions from experts across different regions, the collection highlights how migraine care is shaped by local healthcare systems, resources, and cultural contexts, while identifying opportunities to improve care globally.
In this interview, guest editor Tesha Monteith discusses the importance of sharing regional experiences and fostering international collaboration to advance equitable migraine care worldwide.
Key takeaway:
💬 "Migraine is universal, but its care is shaped by regional realities. Sharing experiences across regions fosters collaboration and advances equitable migraine care worldwide."
— Tesha Monteith
🎥 Watch the interview: www.youtube.com/watch?v=vbItbLHEMS0
📄 Explore the topical collection: journals.sagepub.com/doi/full/10.1177/25158163251339440
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #healthequity #ihsheadache -
Cephalalgia
@JCephalalgia
🌍 Migraine Care Around the World | Guest Editor Interview
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). This collection brings together perspectives from around the globe to explore how migraine is understood, diagnosed, and treated across diverse healthcare systems, while highlighting opportunities to advance equitable care worldwide.
In this special interview, the guest editors discuss the vision behind the collection and why sharing experiences from different countries and regions is essential for improving migraine care globally.
Key takeaway:
💬 "Migraine Care Around the World is more than a collection of articles. It is a global portrait of how migraine is understood, treated, and too often neglected across different health systems and cultures. By bringing these realities together, we hope to make inequalities visible, share solutions, and inspire a more equitable future in which every person with migraine, wherever they live, has access to informed and effective care."
— Mario Peres
🎥 Watch the interview: www.youtube.com/watch?v=wvWtglAA6QM
📄 Explore the topical collection: journals.sagepub.com/doi/full/10.1177/25158163251339440
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #globalhealth #migraineresearch #headachemedicine #healthequity -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Cephalalgia Reports lets the headache community see the whole of its shared problem. What remains is to move from describing it to acting on it, so that where someone happens to live no longer decides whether their migraine is recognized.
journals.sagepub.com/doi/10.1177/03331024261474132
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
"Headache Classification - A view from the clinic- what needs to be changed?" presented by Dr. Fayyaz Ahmed at the Migraine Trust International Symposium #mtis. @IHSHeadache @IHS_Official @JCephalalgia
-
Cephalalgia
@JCephalalgia
@DrMarioPeres @IHS_Official @IHSHeadache at the #mtis "Headache Classification – Cultural Nuances and Pitfalls" @JCephalalgia
-
Cephalalgia
@JCephalalgia
@IHSHeadache @PeterGoadsby "ICHD-4: what are we working on" #mtis Migraine Trust International Symposium in Glasgow. @JCephalalgia @IHS_Official
-
Cephalalgia
@JCephalalgia
"Why Earlier Optimisation Matters in #migraine Prevention: Insights from Real-World Evidence" Dr. Anna Andreou #mtis presented real world evidence studies using CGRP mAbs @IHSHeadache @IHS_Official @JCephalalgia
-
Cephalalgia
@JCephalalgia
Discover Migraine Care Around the World | Topical Collection & Author Interview Series
🌍 Migraine Care Around the World
How is migraine care delivered across different countries, healthcare systems, and cultures? What challenges remain, and what solutions are emerging to improve care for people living with migraine worldwide?
Migraine Care Around the World is a special Topical Collection in Cephalalgia Reports, one of the official journals of the International Headache Society (IHS). This collection brings together high-quality articles from experts across the globe, exploring regional perspectives on migraine care, health system challenges, inequalities in access, education, advocacy, and innovative approaches to improving patient outcomes.
To complement the collection, we have launched a series of exclusive author and guest editor interviews, providing insights from contributors representing:
📍 Caribbean
📍 Sub-Saharan Africa
📍 North Africa and the MENA region
📍 Eastern Europe
📍 India and Sri Lanka
📍 Kuwait and the Gulf Region
📍 Latin America
📍 Australia
These conversations highlight the realities of migraine care in different regions while sharing lessons that can help advance equitable and effective headache care worldwide.
🎥 Watch the interviews: ihs-headache.org/en/resources/cephalalgia/topical-collect…
📄 Explore the topical collection: journals.sagepub.com/topic/collections-rep/rep-1-migraine…
#migrainecarearoundtheworld #migraine #headachedisorders #cephalalgiareports #internationalheadachesociety #neurology #headachemedicine #migraineresearch #globalhealth #healthequity #medicaleducation #headachecare #ihsheadache #migraineadvocacy
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
@JCephalalgia Fantastic @Simona_Sacco_ Editor's Choice Article #prediction of #migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study. Abildsnes HK, Danelakis A, Giri S, et al. Cephalalgia. 2026;46(7). doi:10.1177/03331024261467723 Video Program Interview with great Author Dr. Abildsnes by @NinaRiggins @IHS_Official
www.youtube.com/watch?v=yjVoyyQMPmw -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In a study by Petersen et al., preventive treatment patterns in cluster headache were explored. Treatment was limited by insufficient efficacy and tolerability, but verapamil was effective long term in intial responders.
journals.sagepub.com/doi/10.1177/03331024261456265
#clusterheadache #headache #brain #pain #neurology #neuroscience
@AnjaSofiePeter4
@rj_rigmor -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Cervical strengthening and stabilization may be a helpful adjunct for select patients with migraine, especially those with neck pain. Evidence is promising, but stronger trials are needed to clarify dosing, safety, and ideal candidates
journals.sagepub.com/doi/10.1177/03331024261471179
#migraine #headache #brain #pain #neurology #neuroscience
@LisBteamdizzy -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study suggests a potential mismatch between perceived urgency and actual risk, highlighting the need to consider sex-specific factors in emergency headache care.
journals.sagepub.com/doi/10.1177/03331024261462493
#migraine #headache #brain #pain #neurology #neuroscience
@Raffaelli_B -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The authors thank Suga et al. for their constructive comments, support expanding BMS criteria to include dysaesthetic pain, and clarify that ODPD is a complementary phenotyping framework to improve classification, research, and patient care.
journals.sagepub.com/doi/10.1177/03331024261470425
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study reveals significant alterations in the periaqueductal grey matter in chronic migraine patients compared to controls, highlighting its potential as a reliable ultrasound marker.
journals.sagepub.com/doi/10.1177/03331024261467732
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
New study investigates endocannabinoids in migraine and reveals a significant link between CSF levels of the endocannabinoid 2-AG and depression, offering new insights into the neurochemical basis of comorbid migraine and depression.
journals.sagepub.com/doi/10.1177/03331024261451250
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The triglyceride-glucose (TyG) index was associated with 50% response status after adjustment.
•
The TG/HDL-C ratio, TyG-BMI, and metabolic score for IR (METS-IR) were not significant in the final adjusted model.
•
Further validation is needed to assess the prognostic relevance of these indices in MOH.
journals.sagepub.com/doi/10.1177/03331024261464213
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This letter discusses that diagnostic criteria for burning mouth syndrome should balance accuracy with clinical inclusiveness. Also, the authors caution against making bilaterality and a ≥6-hour daily duration mandatory without broader external validation.
journals.sagepub.com/doi/10.1177/03331024261467715
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
「あなたはどの片頭痛予防薬が効くか?」
機械学習で予測する研究🤖
今はまだ、より大規模なデータに期待!
という感じの内容でしたが、とても面白い試みですね🤔
この前Headacheの論文を紹介しましたが、
AI×頭痛の研究がどんどんきてますね!
📚
Abildsnes et al. Cephalalgia. 2026
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study” which has been selected as the Editor’s Choice for the July issue of Cephalalgia.
..................................
Article highlights
•
Machine learning models can predict treatment response to migraine preventives with modest accuracy.
•
Inclusion of genotype data in the models did not improve performance, however, this could be a result of the low sample size.
•
Predictions of triptan retention were unreliable.
journals.sagepub.com/doi/10.1177/03331024261467723
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
「頭痛を学ぶことはもはや治療?」🤔
最新のレビューがでました📚
・いつどのように薬を使う? ・使いすぎの基準は? ・睡眠や生活リズムをどう整える?
標準治療に「教育」を加えることで、 様々な指標で治療効果の上乗せがあるさう😳
ポイントは、単なる資料配布ではなく、 ・質問できること ・振り返れること ・周りを巻き込めること
SNSの参考にもなりそうな論文です😂
📚Garg et al. Cephalalgia Reports, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
•
Therapeutic patient education (TPE) is a structured programme empowering migraine patients toward self-management and behavioural change.
•
Evidence shows TPE with standard treatments outperforms standard treatments alone, with in-person group sessions proving superior to digital or written formats.
•
Effective delivery of TPE does not require headache experts; trained nurses, medical students and lay migraineurs can successfully facilitate it.
journals.sagepub.com/doi/10.1177/25158163261467653
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
CGRP monoclonal antibodies were associated with improvement in HIT-6 scores in adolescents with migraine.
•
Early clinically meaningful improvement was observed within about 3 months.
•
CGRP mAbs in adolescents with migraine may support participation in school and social activities during adolescence.
journals.sagepub.com/doi/10.1177/03331024261461634
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In vivo confocal microscopy reveals progressive corneal nerve degeneration and neuroinflammation in trigeminal neuralgia, highlighting its potential as a non-invasive biomarker for disease severity and progression.
journals.sagepub.com/doi/10.1177/03331024261466134
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Evidence suggests that candesartan should have a stronger place in migraine prevention. Its success highlights the need for regular guideline updates, standardized trial outcomes, and deeper research into repurposed treatments.
journals.sagepub.com/doi/10.1177/03331024261471180
#migraine #headache #brain #pain #neurology #neuroscience
@RaffaeleOrnello -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine is associated with significantly reduced thalamic glutathione (GSH) levels, resulting in decreased GSH/glutamate (Glu) ratios that indicate diminished antioxidant buffering capacity.
•
This metabolic alteration is present in both migraine with and without aura but not in tension-type headache, supporting distinct pathophysiological mechanisms.
•
Tissue-corrected thalamic metabolic profiling may help clarify migraine vulnerability and guide therapeutic strategies targeting oxidative stress.
journals.sagepub.com/doi/10.1177/03331024261462792
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
•
Migraine in children causes significant disability, yet preventive drug efficacy and safety remain a matter of debate.
•
Meta-analysis of 40 studies (2742 patients) found that 30% experienced adverse effects, mainly drowsiness, anorexia, fatigue and paraesthesia.
•
Safety data is crucial for clinicians to weigh risk/benefit, given the low efficacy of current prophylactic treatments.
journals.sagepub.com/doi/10.1177/03331024261441586
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Now available in Cephalalgia! 🧠
The abstracts from the 2026 China Headache Congress (Xi'an, China, 15–17 May 2026) have now been published in Cephalalgia.
Congratulations to all authors and presenters on their contributions to advancing headache research.
Read the published abstracts and stay up to date with the latest developments in the field.
journals.sagepub.com/doi/10.1177/03331024261461082
#cephalalgia #chinaheadachecongress #headacheresearch #migraine #neurology #headachemedicine #medicalresearch #ihs -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
Please watch a great Video Interview with @JCephalalgia @Simona_Sacco_ Editor's Choice Article Authors
with Dr Zhao Dong and Dr Longteng Ma #environmental and psychological risk factors for #migraine chronification.
Cephalalgia 2026;46(5). doi:10.1177/03331024261446614 -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Seung Ae Kim
👩🏫 Mentor: Teshamae Monteith
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Seung Ae will work closely with Teshamae, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Seung Ae and thanking Teshamae for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study” which has been selected as the Editor’s Choice for the July issue of Cephalalgia.
..................................
Article highlights
•
Machine learning models can predict treatment response to migraine preventives with modest accuracy.
•
Inclusion of genotype data in the models did not improve performance, however, this could be a result of the low sample size.
•
Predictions of triptan retention were unreliable.
journals.sagepub.com/doi/10.1177/03331024261467723
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This new study uses machine learning to predict individual responses to migraine drugs. Clinical data provided modest accuracy, while genetic data contributed little. Hormones, lipids and blood pressure look most informative.
journals.sagepub.com/doi/10.1177/03331024261467723
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
First real-world study of rimegepant as preventive treatment (n=150), including prior anti-CGRP mAb exposure. Effective at 3 months, well tolerated, and associated with improved mood symptoms, even in highly treatment-resistant patients
journals.sagepub.com/doi/10.1177/03331024261462836
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Seventy-six Special Interest Group-registered physiotherapists practicing as headache experts in 24 countries, provided insights into their approaches for cervicogenic headaches, migraine, tension-type headaches and temporomandibular disorders.
•
Regardless of headache type, education, manual therapy and exercise were used. There was little distinction reported regarding the approaches for the different headache types.
•
Self-referral was the most common pathway into physiotherapy.
journals.sagepub.com/doi/10.1177/25158163261469090
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Nevra Öksüz Gürlen
👨🏫 Mentor: Andrew Hershey
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Nevra will work closely with Andrew, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Nevra and thanking Andrew for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study looked at treatments used for new daily persistent headache in youth, finding that earlier treatment may improve outcomes, and transitional therapies benefit most patients but should be followed with preventive therapies.
journals.sagepub.com/doi/10.1177/03331024261426562
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Yan Zhou
👨🏫 Mentor: Gianluca Coppola
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Yan will work closely with Gianluca, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Yan and thanking Gianluca for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
•
Therapeutic patient education (TPE) is a structured programme empowering migraine patients toward self-management and behavioural change.
•
Evidence shows TPE with standard treatments outperforms standard treatments alone, with in-person group sessions proving superior to digital or written formats.
•
Effective delivery of TPE does not require headache experts; trained nurses, medical students and lay migraineurs can successfully facilitate it.
journals.sagepub.com/doi/10.1177/25158163261467653
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🚨 We’re looking for new Associate Editors!
Cephalalgia Reports, the official open-access journal of the International Headache Society (IHS), is inviting applications for Associate Editors to join its international Editorial Board.
This is an exciting opportunity to:
🧠 Help shape the future of headache and facial pain research
📚 Contribute to a rigorous and constructive peer-review process
🌍 Join a diverse, international editorial team
🤝 Work alongside leading researchers and clinicians from around the world
We particularly encourage applications from colleagues representing diverse geographical regions, disciplines, career stages, and backgrounds, reflecting the global headache community.
📅 Application deadline: 23 August 2026
🔗 Read the full call and application details here:
ihs-headache.org/en/news/call-for-associate-editors-for-c…
Please help us spread the word by sharing this opportunity with colleagues who may be interested.
#cephalalgiareports #internationalheadachesociety #headacheresearch #neurology #academicpublishing #peerreview #openaccess #research #editorialboard #facialpainThis media couldn't be displayed. See it on the original post. -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This Letter discusses how chronic idiopathic oral symptoms should be classified in future headache and orofacial pain taxonomies. It supports the proposal of oral dysaesthetic and perceptual disorder as a useful descriptive framework
journals.sagepub.com/doi/10.1177/03331024261464166
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Migraine affects approximately 9.3% of Latin Americans
•
Migraine remains underdiagnosed and undertreated across Latin America.
•
Specialist care is concentrated in urban areas, with rural waits up to five years.
•
Triptan and anti-CGRP access is limited mainly to the private sector in most countries.
•
Medical schools offer only 2–4 h of headache education on average.
•
Regional telemedicine and unified advocacy could bridge major care gaps.
journals.sagepub.com/doi/10.1177/25158163261456215
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Sophie M. Yener
👨🏫 Mentor: Erling Tronvik
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Sophie will work closely with Erling, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Sophie and thanking Erling for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Mohamed I. Mohamed
👩🏫 Mentor: Simona Sacco
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Mohamed will work closely with Simona, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Mohamed and thanking Simona for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Merve Ceren Akgör
👩🏫 Mentor: Francesca Puledda
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Merve Ceren will work closely with Francesca, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Merve Ceren and thanking Francesca for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
Please submit your applications for an Associate Editor at @CephReports
@Simona_Sacco_ @IHS_Official
ihs-headache.org/en/news/ -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Carlo Piero Lastarria Pérez
👩🏫 Mentor: Mi Ji Lee
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Carlo Piero will work closely with Mi Ji, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Carlo Piero and thanking Mi Ji for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Stefano Di Antonio
👨🏫 Mentor: Sait Ashina
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Stefano will work closely with Sait, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Stefano and thanking Sait for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce another mentor–mentee pair from the 2026–2027 Cephalalgia Reviewer Academy.
👨🎓 Fellow: Lukasz Kolakowski
👨🏫 Mentor: Kuan-Po Peng
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Lukasz will work closely with Kuan-Po, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Lukasz and thanking Kuan-Po for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
🌟 Mentor Spotlight | Cephalalgia Reviewer Academy 2026–2027
We are delighted to introduce one of our mentor–mentee pairs for the 2026–2027 Cephalalgia Reviewer Academy.
👩🎓 Fellow: Chisato Iba
👩🏫 Mentor: Patricia Pozo-Rosich
Through the Cephalalgia Reviewer Academy, Fellows receive personalised mentorship from internationally recognised experts in headache medicine and research. Over the coming year, Chisato will work closely with Patricia, gaining hands-on experience in peer review through structured training, supervised reviews, and constructive feedback.
We are excited to see this mentorship develop and look forward to following their journey as they contribute to the future of high-quality scientific publishing in headache research.
Please join us in welcoming Chisato and thanking Patricia for supporting the next generation of peer reviewers.
#cephalalgia #cephalalgiareports #revieweracademy #peerreview #mentorship #headacheresearch #neurology #scientificpublishing #medicaleducation #researchintegrity -
Cephalalgia
@JCephalalgia
We are delighted to announce the outstanding mentors who will guide the "Cephalalgia Reviewer Academy" for the 2026–2027 course year.
Our mentors are internationally recognised experts in headache research and peer review, generously volunteering their time, experience, and expertise to support the next generation of reviewers.
Through structured mentorship, supervised peer-review practice, and personalised feedback, they will play a pivotal role in helping our Fellows develop the skills required to become confident, high-quality peer reviewers.
We sincerely thank our mentors for their commitment to fostering excellence in scientific publishing and strengthening the future of headache research.
Please join us in welcoming our 2026–2027 Cephalalgia Reviewer Academy mentors!
#cephalalgia #cephalalgiareports #peerreview #mentorship #headacheresearch #scientificpublishing #researchintegrity #academicmedicine #medicaleducation #neurology
@bradleyongmd
@Di_Antonio_S
@MoIbr_X
@kuanpopeng
@pul_fra
@Simona_Sacco
@ppozorosich -
Cephalalgia
@JCephalalgia
📢 Welcoming our new Associate Editor!
We are delighted to welcome Prof. Zheman Xiao as the newest Associate Editor for Cephalalgia and Cephalalgia Reports.
Prof. Zheman Xiao's expertise and contributions to headache medicine will be a valuable addition to our editorial team. We look forward to working together to advance high-quality research and support the global headache community.
Please join us in welcoming Prof. Zheman Xiao to the editorial board.
#cephalalgia #cephalalgiareports #headacheresearch #migraineresearch #neurology #scientificpublishing #headachemedicine
@Simona_Sacco_ -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
スマホ・PCと頭痛の関係📱💻
医療系学生を対象にした研究では、
スクリーン使用中〜直後の頭痛が 78.6% で報告されました。
特に関連していたのは、
・1日7時間以上のスクリーン使用
・2時間以上休憩なしで使うこと
スマホは一旦置いて、
散歩や瞑想はどうでしょう?🧘🚶
※横断研究であり、因果関係を断定するには不十分です。
📚
Dahshan et al. Cephalalgia Reports, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In this 11-country MENA study (n = 2904 students), 78.6% reported headache during or after screen exposure.
•
Screen use ≥7 h/day and continuous use >2 h without breaks independently increased headache odds.
•
Caffeine, poor hydration, variable sleep, and high stress were significantly associated with screen-related headache.
•
Female sex and family migraine history increased reporting likelihood.
•
Findings suggest modifiable behavioral and ergonomic targets for prevention in academic settings.
journals.sagepub.com/doi/10.1177/25158163261453877
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
オメガ3脂肪酸の片頭痛予防効果🐟 新しいレビューが出ました。
全体としては月間頭痛日数が約2.4日減少
一定の予防効果が示唆されています。
注意点として⚠️
1-2.5g/日では頻度やQOLの改善。
一方で6g/日では上乗せ効果に乏しく、 悪心などの副作用も目立ったよう😣
オメガ3は「多く摂れば摂るほど良い」、 という訳ではありませんね🤔 摂りすぎでの出血や心房細動リスクにも注意とのこと。
📚Alarcon-Ruiz et al. Cephalalgia Reports, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Omega-3 supplements reduce migraine frequency and disability in adults. Optimal effects occur with moderate doses (≈2–2.5 g/day) in episodic migraine, while structured diet in chronic migraine.
journals.sagepub.com/doi/10.1177/25158163261454627
#migraine #headache #brain #pain #neurology #neuroscience
@mariofpperes -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
米国の保険データから、 ナルティーク®︎v s レイボー®︎の比較⚖️
1年以内に再処方される割合は、
・リメゲパント(ナルティーク®︎)77.1% ・ラスミジタン(レイボー®︎)47.2%
単なる効果だけでなく、 「また使いたいと思えるか」も含む興味深いデータですね🤔
ナルティーク®︎は素晴らしい継続率!
レイボー®︎では、めまい・眠気に加えて、 服用後8時間の運転制限があります。
こうした副作用が処方中止に影響しているかも🤔
ただしこの研究は、 リメゲパントの販売元であるPfizerの資金提供を受けている点も注意が必要⚠️
今後、MRさんから情報提供がありそうなデータですね😏
📚Tepper et al. Cephalalgia, 2026
Cephalalgia
@JCephalalgia
New in @JCephalalgia! @IHS_Official Please read new data about #rimegepant @IHSHeadache journals.sagepub.com/doi/10.1177/03331024261447187
-
Cephalalgia
@JCephalalgia
We are excited to share the news that we have selected eleven new Fellows for the Cephalalgia Reviewer Academy for the 2026-2027 course year.
The Cephalalgia Reviewer Academy is a unique, structured, and mentored training programme hosted by Cephalalgia and Cephalalgia Reports. It is specifically designed to support and develop the next generation of expert peer reviewers in headache research.
The program provides our Fellows with:
- Structured peer-review training
- One-on-one mentorship and supervised practice
- Formal certification upon completion
We are looking forward to working with this talented group as they contribute to the future of headache research excellence.
#migraine #headache #brain #pain #neurology #neuroscience
@bradleyongmd
@Di_Antonio_S
@MoIbr_X
@kuanpopeng
@pul_fra
@Simona_Sacco
@ppozorosich -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Beyond headache: Cognitive improvement in patients with migraine responding to anti-CGRP monoclonal antibodies or botulinum toxin” which has been selected as the Editor’s Choice for the June issue of Cephalalgia.
..................................
Effective migraine treatment, with monoclonal antibodies or botulinum toxin, improves performance in some cognitive tasks
journals.sagepub.com/doi/10.1177/03331024261458424
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! @IHS_Official @IHS_Headache #cgrp blocking and #cerebrovascular risk. Gül S et al. Cerebrovascular risk with calcitonin gene-related peptide monoclonal antibodies versus onabotulinumtoxinA in patients with migraine: A real-world pharmacoepidemiologic study in the National Institutes of Health All of Us Research Program. Cephalalgia. 2026;46(7). doi:10.1177/03331024261464438
journals.sagepub.com/doi/10.1177/03331024261464438 -
Cephalalgia
@JCephalalgia
Please read a new artcile in @JCephalalgia! #rimegepant and #vertigo. Li Y, Yu L, Deng D, Cao X, Lu X, Bing D. Effectiveness and clinical predictors of rimegepant for acute vertigo in vestibular migraine: A real-world cohort study. Cephalalgia. 2026;46(7). doi:10.1177/03331024261463533 @IHS_Official @IHS_Headache
journals.sagepub.com/doi/10.1177/03331024261463533 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Evers S, Grube HCB, Gendolla A, et al. Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trial. Cephalalgia. 2026;46(7). doi:10.1177/03331024261459744 @IHS_Official @IHS_Headache
journals.sagepub.com/doi/10.1177/03331024261459744 -
Cephalalgia
@JCephalalgia
Please read new publication in @JCephalalgia! @IHSHeadache @IHS_Headache
Altamura C, Iannone LF, Castro FL, et al. SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study). Cephalalgia. 2026;46(6). doi:10.1177/03331024261435922
journals.sagepub.com/doi/10.1177/03331024261435922 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! @IHS_Official @IHSHeadache @Simona_Sacco_
van Veelen N, Ornello R, Terwindt GM, Sacco S. Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality. Cephalalgia. 2026;46(6). doi:10.1177/03331024261439282 -
Cephalalgia
@JCephalalgia
New in @CephReports! Hjelholt AJ, Laugesen K, Tei RMH, Kasch H, Diener H-C, Jørgensen JOL. Cabergoline for migraine prevention (PROTECT): Protocol for a randomized, placebo-controlled, double-blind trial. Cephalalgia Reports. 2026;9. doi:10.1177/25158163261464939 @IHS_Official @IHSHeadache
journals.sagepub.com/doi/10.1177/25158163261464939 -
Cephalalgia
@JCephalalgia
Letter to the Editor @CephReports! Tavasoli AR, Hastriter EV, Rastogi RG. Beyond headache days: Refining the framework for understanding CGRP monoclonal antibody discontinuation. Cephalalgia Reports. 2026;9. doi:10.1177/25158163261462940 @IHS_Official @IHSHeadache
-
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
@JCephalalgia @IHS_Official. Sandrini G, Bono G, Blandini F, Nappi R, Sances G, Tassorelli C. Obituary for Professor Giuseppe Nappi. Cephalalgia. 2026;46(6). doi:10.1177/03331024261453285
journals.sagepub.com/doi/10.1177/03331024261453285 -
Cephalalgia
@JCephalalgia
@JCephalalgia @IHS_Official New publication! Caronna E, Mas-de-les-Valls R, Egeo G, et al. Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort. Cephalalgia. 2026;46(6). doi:10.1177/03331024261440370
journals.sagepub.com/doi/10.1177/03331024261440370 -
Cephalalgia
@JCephalalgia
Please read a great @JCephalalgia New article! @IHS_Official Hoang Pham MY, Asheer J, Ali F, Hilker R, Videbech P, Schytz HW. Methodological limitations of anxiety screening tools used in migraine studies -a narrative review. Cephalalgia. 2026;46(6). doi:10.1177/03331024261453541
-
Cephalalgia
@JCephalalgia
New in @JCephalalgia! @IHS_Official Haro M, et al. Impaired bone status in high frequency episodic or chronic #migraine women: A case-control study with blood and densitometric parameters. Cephalalgia. 2026;46(6). doi:10.1177/03331024261453582
journals.sagepub.com/doi/10.1177/03331024261453582 -
Cephalalgia
@JCephalalgia
@JCephalalgia @IHSHeadache @IHS_Official Tiebl L, et al. Distribution of intranasal lidocaine and its effect on electrically-evoked calcium signals in mouse trigeminal ganglion neurons. Cephalalgia. 2026;46(6). doi:10.1177/03331024261453548
journals.sagepub.com/doi/10.1177/03331024261453548 -
Cephalalgia
@JCephalalgia
New in @CephReports! @IHS_Official @IHSHeadache Ekizoğlu E, et al. Sex differences in cluster headache, treatment insights, and burden of disease in Türkiye: A multi-center cross-sectional study. Cephalalgia Reports. 2026;9. doi:10.1177/25158163261462937
journals.sagepub.com/doi/10.1177/25158163261462937 -
Cephalalgia
@JCephalalgia
New in @CephReports! @IHS_Official @IHSHeadache Amarasena P, et al. Migraine care in India and Sri Lanka: Current practice standards and the road ahead. Cephalalgia Reports. 2026;9. doi:10.1177/25158163261456124
journals.sagepub.com/doi/10.1177/25158163261456124 -
Cephalalgia
@JCephalalgia
Please read about #burning Mouth Syndrome in the @CephReports
Briski N, Gerhardstein B. Resolution of burning mouth syndrome symptoms after galcanezumab: A case report. Cephalalgia Reports. 2026;9. doi:10.1177/25158163261447441
journals.sagepub.com/doi/10.1177/25158163261447441 -
Cephalalgia
@JCephalalgia
Please read about #weekend #headache in @JCephalalgia! @IHS_Official @IHSHeadache Ruscheweyh R, et al. Weekend headache in migraine – fact or fiction? An observational study from DMKG-app data. Cephalalgia. 2026;46(6). doi:10.1177/03331024261444664
journals.sagepub.com/doi/10.1177/03331024261444664 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! @IHS_Official @IHSHeadache Chiasserini D, et al. CGRP, VIP and PACAP plasmatic levels in migraine patients before and after anti-CGRP(R) monoclonal antibodies treatment. Cephalalgia. 2026;46(6). doi:10.1177/03331024261429802
journals.sagepub.com/doi/10.1177/03331024261429802 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Martins IP et al. Beyond headache: Cognitive improvement in patients with migraine responding to anti-CGRP monoclonal antibodies or botulinum toxin. Cephalalgia. 2026;46(6). doi:10.1177/03331024261458424 @IHSHeadache @IHS_Official
journals.sagepub.com/doi/10.1177/03331024261458424 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! @IHS_Official Please read new data about #rimegepant @IHSHeadache journals.sagepub.com/doi/10.1177/03331024261447187
-
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Vitamin D deficiency is independently associated with migraine chronification and increased musculoskeletal tenderness, suggesting a potential musculoskeletal–sensitization contribution to migraine progression.
journals.sagepub.com/doi/10.1177/25158163261456250
#migraine #headache #brain #pain #neurology #neuroscience
@DrManju_Neuro
@drprakashs
@VaroonVadodaria -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The real-world INFUSE study is evaluating the effectiveness of IV eptinezumab for the preventive treatment of migraine in participants in whom ≥1 CGRP-targeted preventive therapy had previously failed
•
Switching to eptinezumab treatment was associated with reduced migraine burden and improvements in multiple participant-reported migraine outcomes, including headache frequency, disability, disease status, and brain fog, despite substantial baseline disease burden.
journals.sagepub.com/doi/10.1177/25158163261455673
#migraine #headache #brain #pain #neurology #neuroscience
@AmaalStarlingMD -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In this 11-country MENA study (n = 2904 students), 78.6% reported headache during or after screen exposure.
•
Screen use ≥7 h/day and continuous use >2 h without breaks independently increased headache odds.
•
Caffeine, poor hydration, variable sleep, and high stress were significantly associated with screen-related headache.
•
Female sex and family migraine history increased reporting likelihood.
•
Findings suggest modifiable behavioral and ergonomic targets for prevention in academic settings.
journals.sagepub.com/doi/10.1177/25158163261453877
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Nirmal Pandey MD DM Neurologist
@nirmalregency
~30% of chronic refractory migraines,
& perhaps a greater quantity of CTTH may be persistently ascribed to the cervical spine & the sinuses.
🤕
We clinicians should REFINE ourselves.
@JCephalalgia @ihs_official -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Misdiagnosis is common in migraine—28% were wrongly diagnosed with conditions like sinusitis or cervical issues. Resistant/refractory cases had more testing, but not more misdiagnoses. Timely and accurate diagnosis is needed.
journals.sagepub.com/doi/10.1177/03331024261443712
#migraine #headache #brain #pain #neurology #neuroscience
@lab_neu2024, @fededs00, @Simona_Sacco, @RaffaeleOrnello -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study is the first to test the diagnostic performance of the most commonly used diagnostic criteria for Burning mouth syndrome and provides the first data-driven set of diagnostic criteria for the condition.
journals.sagepub.com/doi/10.1177/03331024261455835
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Good news for Cephalalgia: the new Journal IF is 5.8.
Thanks to all those who have contributed to the journal’s success over the past years: authors, reviewers, associate editors, social media and graphical abstract team, managing editor and the wider headache community.
Cephalalgia
@JCephalalgia
We are delighted to announce that Cephalalgia’s impact factor has increased to 5.8
The journal has remained in Q1 for decades and continues to rank strongly at 29 out of 296 in Clinical Neurology and 55 out of 330 in Neuroscience.
This milestone reflects the dedication of our authors, reviewers, and editorial community. Thank you to everyone contributing to the ongoing success of the journal.
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@wkrank1
@faradoost
@NinaRiggins
@Bohemian_Wu
@ap_andreou
@SaitAshina
@ramiburstein
@debbie_hay
@headacheMD
@ppozorosich
@pul_fra
@Raffaelli_B
@schwedtt
@HenrikSchytz
@ErlingTronvik
@CaronnaEdoardo
@Luigi_Ian_
@petergoadsby
@daviddodick -
Cephalalgia
@JCephalalgia
We are delighted to announce that Cephalalgia’s impact factor has increased to 5.8
The journal has remained in Q1 for decades and continues to rank strongly at 29 out of 296 in Clinical Neurology and 55 out of 330 in Neuroscience.
This milestone reflects the dedication of our authors, reviewers, and editorial community. Thank you to everyone contributing to the ongoing success of the journal.
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@wkrank1
@faradoost
@NinaRiggins
@Bohemian_Wu
@ap_andreou
@SaitAshina
@ramiburstein
@debbie_hay
@headacheMD
@ppozorosich
@pul_fra
@Raffaelli_B
@schwedtt
@HenrikSchytz
@ErlingTronvik
@CaronnaEdoardo
@Luigi_Ian_
@petergoadsby
@daviddodick -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
降圧薬「カンデサルタン」の片頭痛予防効果
メタ解析の論文が出てきました👏
去年Lancet NeurologyのRCTが話題でしたが 今回はそれを含め、ARB全体のエビデンスです。(カンデサルタン中心)
4試験659人を統合すると、 ・月間片頭痛日数はプラセボ比較で-1.00日 ・50%以上改善した人は43%(vs22%) とメタ解析でも予防効果が示されました🤔
素晴らしいですね!
📚Riise et al. Cephalalgia, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review and meta-analysis provide robust evidence on the effect of angiotensin II receptor blockers (ARBs), particularly candesartan, in the prevention of episodic migraine, supporting the rationale for reconsidering its position in international guidelines.
journals.sagepub.com/doi/10.1177/03331024261451481
#migraine #headache #brain #pain #neurology #neuroscience
@norhead -
Cephalalgia reposted
Mia Minen, MD, MPH, FAAN, FAHS
@MiaMinenMD
Check out our new data on which people with #migraine may respond better to biofeedback @ahsheadache @AANmember @WNGtweets @nyulangone @NYUPainResearch
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Specific subgroups of individuals with migraine may respond better to biofeedback (i.e., improvements in Migraine-Specific Quality of Life Role Function Restrictive (MSQv2.1-RFR)) based on baseline characteristics (i.e.,mindfulness traits and interest in physical exercise).
journals.sagepub.com/doi/10.1177/03331024261441579
#migraine #headache #brain #pain #neurology #neuroscience
@MiaMinenMD -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A ≥50% reduction in monthly migraine days (MMDs) does not always reflect meaningful clinical benefit, as most patients who met this threshold did not achieve IHS-aspired optimal migraine control with <4 MMDs.
journals.sagepub.com/doi/10.1177/03331024261456247
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Severity of dependence on analgesics in patients with medication-overuse headache (MOH) is strongly associated with headache burden, nicotine dependence, psychological distress, and addiction-related personality traits.
journals.sagepub.com/doi/10.1177/03331024261453544
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Specific subgroups of individuals with migraine may respond better to biofeedback (i.e., improvements in Migraine-Specific Quality of Life Role Function Restrictive (MSQv2.1-RFR)) based on baseline characteristics (i.e.,mindfulness traits and interest in physical exercise).
journals.sagepub.com/doi/10.1177/03331024261441579
#migraine #headache #brain #pain #neurology #neuroscience
@MiaMinenMD -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Omega-3 supplements reduce migraine frequency and disability in adults. Optimal effects occur with moderate doses (≈2–2.5 g/day) in episodic migraine, while structured diet in chronic migraine.
journals.sagepub.com/doi/10.1177/25158163261454627
#migraine #headache #brain #pain #neurology #neuroscience
@mariofpperes -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In real-world practice, CGRP monoclonal antibodies substantially reduce migraine frequency, but achieving optimal migraine control remains challenging, particularly in patients with higher baseline migraine burden.
journals.sagepub.com/doi/10.1177/03331024261453284
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review and meta-analysis provide robust evidence on the effect of angiotensin II receptor blockers (ARBs), particularly candesartan, in the prevention of episodic migraine, supporting the rationale for reconsidering its position in international guidelines.
journals.sagepub.com/doi/10.1177/03331024261451481
#migraine #headache #brain #pain #neurology #neuroscience
@norhead -
Cephalalgia
@JCephalalgia
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
Cephalalgia
@JCephalalgia
📢 Welcoming our new Associate Editor!
We are delighted to welcome Prof. Zhao Dong as the newest Associate Editor for *Cephalalgia* and *Cephalalgia Reports*.
Prof. Dong's expertise and contributions to headache medicine will be a valuable addition to our editorial team. We look forward to working together to advance high-quality research and support the global headache community.
Please join us in welcoming Prof. Dong to the editorial board.
#cephalalgia #cephalalgiareports #headacheresearch #migraineresearch #neurology #scientificpublishing #headachemedicine
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
#migraine #awareness Month! Please listen to the excellent message from The International Headache Society #president @IHS_official Dr. Mario Peres @DrMarioPeres @IHSheadache
-
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
IL-6受容体に関わる遺伝子多型が、 前兆のある片頭痛と関連する可能性?
免疫や遺伝子の解釈に明るくないので、 余計なコメントはやめておきます😓
日本発の研究なので紹介だけ、、、🇯🇵
📚
Takigawa et al. Cephalalgia Reports, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study examined associations between IL-6R gene polymorphisms and migraine in a Japanese population. Our results suggest a possible link between IL-6R variants and migraine, supporting a role for inflammatory pathways in migraine.
journals.sagepub.com/doi/10.1177/25158163261447417
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Dr. Kelly Nicol
@knicol15
Our recent publication on longer term (4 yr) Vyepti treatment, enjoy!
@JHCDrScott @ahsheadache @JCephalalgia
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study reports 48-month real-world eptinezumab outcomes in a highly refractory cohort.
•
Multiple exposure-defined cohorts (all-initiator, on-treatment, continuation, discontinuation) were used to address the complexity of long-term real-world treatment trajectories.
•
Symptom improvement was modest and most apparent among patients who remained on eptinezumab, while overall treatment persistence declined over time.
•
Post-discontinuation pathways were heterogeneous, with frequent switching and re-engagement with anti-CGRP therapy, reflecting iterative preventive management in chronic migraine.
journals.sagepub.com/doi/10.1177/03331024261451427
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
薬剤の使用過多による頭痛(MOH)
「原因薬剤をとにかく我慢!」 という根性論の治療では不十分。
教育+CGRP関連抗体薬を適切に追加し、
・頭痛の生活への影響 ・片頭痛による障害 ・仕事効率 ・QOL ・治療満足度
様々なアウトカムの改善が得られたという”RCT”
「ちゃんと予防薬でアシストしようね?」 というメッセージですかね🤔
📚
Tepper et al. Cephalalgia, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
When added to patient education, eptinezumab was associated with more favorable improvements than placebo in patient-reported outcomes related to disease burden, work productivity, and quality of life at Week 4 and Week 12 in adults with chronic migraine and medication-overuse headache.
journals.sagepub.com/doi/10.1177/03331024261449814
#migraine #headache #brain #pain #neurology #neuroscience
@Cristina4ihs
@rj_rigmor -
Cephalalgia reposted
島らっきょう大好きバナナさん🍌
@SimarakyoBanana
へぇー!IL-6R遺伝子多型(SNPs)🧬が片頭痛に関係しそうなのか😳
この論文で調べたSNPsは…
❶ −183G/A(rs4845617):IL-6R遺伝子のプロモーター領域
❷ 48892A/C(rs8192284):IL-6R遺伝子のエクソン9
の2つ✌️
それらを
・前兆のある片頭痛(MA) 63例
・前兆のない片頭痛(MO) 113例
・緊張型頭痛(TTH) 35例
・健常対照(CTL) 62例
で調べると、
✅❷ のCアレルはMAで有意に多かった
✅MOやTTHでは有意な関連はなし🙅♂️
✅❶は頭痛との有意な関連はなし🙅♂️
ちなみに❷は、IL-6Rの切断部位に影響し、膜結合型IL-6Rから可溶性IL-6R(sIL-6R)が生じるシェディングに関係すると考えられています
実際に48892CアレルはAアレルよりsIL-6R濃度が高いって報告されていますしね
それでsIL-6Rが増えるとIL-6シグナルが強まって炎症反応、血管反応性、中枢性感作、疼痛感受性が高まる可能性があるってことか🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study examined associations between IL-6R gene polymorphisms and migraine in a Japanese population. Our results suggest a possible link between IL-6R variants and migraine, supporting a role for inflammatory pathways in migraine.
journals.sagepub.com/doi/10.1177/25158163261447417
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
A message from Prof. Simona Sacco, Editor-in-Chief of Cephalalgia and Cephalalgia Reports, for Migraine Awareness Month.
It is time for action.
#migraineawareness #migraine #headachedisorders #cephalalgia #migraineresearchThis media couldn't be displayed. See it on the original post. -
Cephalalgia
@JCephalalgia
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Conceptual perspective proposing the Oral Dysaesthetic and Perceptual Disorder (ODPD) construct to better capture the broader spectrum of chronic idiopathic oral dysaesthetic conditions beyond burning-centered diagnostic frameworks.
journals.sagepub.com/doi/10.1177/03331024261452682
#headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study reports 48-month real-world eptinezumab outcomes in a highly refractory cohort.
•
Multiple exposure-defined cohorts (all-initiator, on-treatment, continuation, discontinuation) were used to address the complexity of long-term real-world treatment trajectories.
•
Symptom improvement was modest and most apparent among patients who remained on eptinezumab, while overall treatment persistence declined over time.
•
Post-discontinuation pathways were heterogeneous, with frequent switching and re-engagement with anti-CGRP therapy, reflecting iterative preventive management in chronic migraine.
journals.sagepub.com/doi/10.1177/03331024261451427
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Environmental and psychological risk factors for migraine chronification in China: A multicenter prospective cohort study” which has been selected as the Editor’s Choice for the May issue of Cephalalgia.
..................................
Prospective study of 1,642 patients reveals Anxiety and Analgesic Overuse as key drivers of Migraine Chronification in China, while Exercise offers protection.
journals.sagepub.com/doi/10.1177/03331024261446614
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
Cephalalgia reposted
Mia Minen, MD, MPH, FAAN, FAHS
@MiaMinenMD
Ever wonder who might benefit the most from biofeedback in people with #migraine? Our team conducted an analysis!
doi.org/10.1177/03331024261441579
@AANmember @ahsheadache @WNGtweets @JCephalalgia @nyulangone @NYUneurologyres @NYUPainResearch -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
When added to patient education, eptinezumab was associated with more favorable improvements than placebo in patient-reported outcomes related to disease burden, work productivity, and quality of life at Week 4 and Week 12 in adults with chronic migraine and medication-overuse headache.
journals.sagepub.com/doi/10.1177/03331024261449814
#migraine #headache #brain #pain #neurology #neuroscience
@Cristina4ihs
@rj_rigmor -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Consistent with prior work, this study indicates that the transition from non-continuous to continuous headaches in children occurs more quickly than adults.
•
There were no significant differences in headache-related disability for children who had a sudden-onset headache compared to children who had a rapid or gradual evolution of headache to continuous.
•
Headache-related disability was greater if the onset of continuous headache was associated with a trigger.
journals.sagepub.com/doi/10.1177/03331024261446961
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
The Cephalalgia Reviewer Academy is a structured, mentored training programme designed to help develop the next generation of expert peer reviewers in headache research.
In this video, Dr Nina Riggins interviews Dr Jason Ray, who successfully completed the 2025–2026 Cephalalgia Reviewer Academy. He shares his experience, what he learned through the programme, and why reviewer training is important for improving the quality of peer review in headache research.
You can find the video on our YouTube channel.
www.youtube.com/watch?v=G57v5pesOIY
If you are interested, applications are now open for the 2026–2027 Academy. Click here for information on how to apply.
Deadline for applications: 14 June 2026.
ihs-headache.org/en/resources/cephalalgia/
@simonateba @Simona_Sacco_ @dr_jray1 -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
脳外科医は知っておきたい。
頭部外傷後頭痛の薬物治療のレビュー📚
「で、何を処方するのが正解?」🤔 聞かれると、よく分からない領域です。
今回のレビューでも、外傷後頭痛に対して 「これを第一選択で全員に使う」 と言えるほど強いエビデンスの薬剤はなさそうです。
限られた報告からでいうと、、 ・片頭痛様
→CGRP薬、トピラマート、ボツリヌス ・神経障害性疼痛様
→ガバペンチンなど ・脳震盪後症候群に伴う頭痛
→アマンタジンなど
うーん、結局は頭痛の表現型に合わせて、 個別化して考える必要があるのですね🤔
また、研究の多くは軍人・退役軍人、爆風外傷など、日本の日常診療とは少し違う集団の研究が多いことも注意が必要です。
📚Saleh et al. Cephalalgia. 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review summarizes the evidence on pharmacologic treatments for post-traumatic headache. Some therapies show potential benefit, but the overall evidence base remains limited and higher-quality trials are needed.
Given the limited high-quality evidence overall, no specific clinical recommendations can be made at this time.
journals.sagepub.com/doi/10.1177/03331024261441563
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
「週あたりの運動時間が長いほど、片頭痛が慢性化しにくい」🏃♂️🏃♀️
中国のデータから示されました📝
特に興味深い点は、前向き研究であり、
"時間的な順序付き"で運動と頭痛予防の関連が示された点。
従来の相関関係に対する、 「そりゃ頭痛が軽い人は運動時間も長いでしょ?」 という反論に、1つ対抗するデータといえますかね🤔
もちろん、頭痛の日に無理して運動する必要はありません。
痛くない日に、散歩くらいから😌
📚Ma et al. Cephalalgia, 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Prospective study of 1,642 patients reveals Anxiety and Analgesic Overuse as key drivers of Migraine Chronification in China, while Exercise offers protection.
journals.sagepub.com/doi/10.1177/03331024261446614
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
The Cephalalgia Reviewer Academy is a structured, mentored training programme designed to help develop the next generation of expert peer reviewers in headache research.
In this video, Dr Nina Riggins interviews Dr Nina Vaschenko, who successfully completed the 2025–2026 Cephalalgia Reviewer Academy. She shares her experience, what she learned through the programme, and why reviewer training is important for improving the quality of peer review in headache research.
You can find the video on our YouTube channel.
youtu.be/gdZSQBuc4uU
If you are interested, applications are now open for the 2026–2027 Academy. Click here for information on how to apply.
Deadline for applications: 14 June 2026.
ihs-headache.org/en/resources/cephalalgia/
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
What is it like to be part of the Cephalalgia Reviewer Academy?
In this video, Dr Nina Riggins interviews Dr Omid Kohandel, who successfully completed the 2025–2026 Academy.
The Cephalalgia Reviewer Academy is a structured, mentored training programme designed to support the next generation of expert peer reviewers in headache research.
Dr Kohandel shares his experience, what he learned, and why peer review training matters for the future of headache science.
You can find the video on our YouTube channel.
youtu.be/7zePEL494cw
If you are interested, applications are now open for the 2026–2027 Academy. Click here for information on how to apply.
Deadline for applications: 14 June 2026.
ihs-headache.org/en/resources/cephalalgia/
#migraine #headache #brain #pain #neurology #neuroscience
@ninadobrev @NinaRiggins @Simona_Sacco_ -
Cephalalgia
@JCephalalgia
In this video, Dr Nina Riggins interviews Dr Zixuan Alice Zhang and Professor Messoud Ashina about their publication in Cephalalgia, selected as the Editor’s Choice for the April issue.
The study examined whether blocking hyperpolarisation-activated cyclic nucleotide-gated channels with ivabradine could modify KATP-induced migraine in humans or hypersensitivity in mice.
The main finding: ivabradine failed to modify KATP-induced migraine in humans or hypersensitivity in mice.
This suggests that hyperpolarisation-activated cyclic nucleotide-gated channels are unlikely to be key downstream mediators, while vascular-to-neuronal signalling may be important in migraine initiation.
You can find the video on our YouTube channel.
youtu.be/rVbElkcVhAg
Link to the paper:
journals.sagepub.com/doi/10.1177/03331024261431770
#migraine #headache #brain #pain #neurology #neuroscience
@NinaRiggins @Simona_Sacco_ @MessoudAshina -
Cephalalgia
@JCephalalgia
Applications are now open for the 2026–2027 Cephalalgia Reviewer Academy! 🧠📚
A unique mentored training programme by Cephalalgia and Cephalalgia Reports, designed to support the next generation of expert peer reviewers in headache research.
✅ Structured peer-review training
✅ Mentorship and supervised practice
✅ Formal certification
✅ Open to researchers and healthcare professionals
✅ No age limit
📅 Deadline: 14 June 2026
A great opportunity to develop your peer-review skills, strengthen headache research, and contribute to the scientific community.
🔗 Apply now / More information: ihs-headache.org/en/news/application-open-for-2026-7-ceph…
#cephalalgia #headacheresearch #migraine #peerreview #neurology #headachemedicine #academicmedicine #earlycareerresearchers -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine mechanisms remain unclear. Magnetic resonance spectroscopy (MRS) non-invasively measures brain neurochemical changes across diffrent region, but ictal findings across brain regions are inconsistent. More research is needed.
journals.sagepub.com/doi/10.1177/03331024261441576
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina
@h_ashina
@HaidarAlKhazal2 -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study aimed to compare nortriptyline monotherapy and combination therapy in the treatment of recurrent migraine of moderate frequency.
Combination prophylaxis may offer superior frequency reduction in moderate-frequency episodic migraine.
•
Improved efficacy may enhance adherence and persistence.
•
Lower-dose polytherapy may preserve tolerability.
journals.sagepub.com/doi/10.1177/25158163261453610
#migraine #headache #brain #pain #neurology #neuroscience
@neurocefaleia
@doresdecabeca -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Prospective study of 1,642 patients reveals Anxiety and Analgesic Overuse as key drivers of Migraine Chronification in China, while Exercise offers protection.
journals.sagepub.com/doi/10.1177/03331024261446614
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study examined associations between IL-6R gene polymorphisms and migraine in a Japanese population. Our results suggest a possible link between IL-6R variants and migraine, supporting a role for inflammatory pathways in migraine.
journals.sagepub.com/doi/10.1177/25158163261447417
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study reports an 84-year-old with Acute Confusional Migraine mimicking stroke. This case highlights acute confusional migraine as a critical differential in the elderly, challenging its pediatric exclusivity.
journals.sagepub.com/doi/10.1177/25158163261447291
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A Delphi study assessed how non-factual impressions aid headache diagnosis. Only two statements reached consensus: a “familiar” headache suggests a primary cause, while an “unfamiliar” one may indicate a secondary headache.
journals.sagepub.com/doi/10.1177/25158163261420753
#migraine #headache #brain #pain #neurology #neuroscience
@HeikoPohl1 -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
First case of interstitial pneumonia linked to galcanezumab for migraine. Key finding: inverted CD4/CD8 ratio on BAL. Full recovery after stopping treatment. Anti-CGRP antibodies may rarely cause pulmonary adverse events
journals.sagepub.com/doi/10.1177/25158163261437991
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A Delphi round with 19 headache experts helped achieve consensus on: treatment response assessment criteria and timepoint, defining non-response to therapy, triptan usage, tolerability, and comorbidities within the Indian clinical context.
journals.sagepub.com/doi/10.1177/25158163261444610
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In this study, migraine patients showed no increased video head impulse testing (vHIT) asymmetry vs controls, supporting preserved Vestibulo-ocular reflex (VOR). Yet, higher asymmetry—even within normal range—was associated with greater dizziness-related disability. 🧠🌀
journals.sagepub.com/doi/10.1177/25158163261443698
#migraine #headache #brain #pain #neurology #neuroscience
@Alex__Jaimes -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Flow cytometry reveals a link between T-cell immunoglobulin and mucin-domain containing-3 (TIM3) expression on cytotoxic T cells and headache frequency. TIM3, a potential biomarker of migraine chronification? Further studies are needed!
journals.sagepub.com/doi/10.1177/25158163261444000
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Some individuals without headache consider headaches a trivial problem, with females being more empathetic toward peopl with headache. Headache-related stigma appears to be a real problem, even among administrative body employees.
journals.sagepub.com/doi/10.1177/03331024261444665
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study shows that people with migraine may face driving risks similar to those with epilepsy. Individualized assessment—considering aura, cognitive fog, vestibular symptoms, and patients’ own perceptions—could help improve driving safety.
journals.sagepub.com/doi/10.1177/25158163261443991
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The estimated disability weight (DW) of 0.432 indicates a substantial patient-reported health loss specific to Spontaneous intracranial hypotension (SIH) prior to definitive treatment.
journals.sagepub.com/doi/10.1177/03331024261444662
#migraine #headache #brain #pain #neurology #neuroscience
@KathaDCwolf
@Niklas_Luetzen -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review summarizes the evidence on pharmacologic treatments for post-traumatic headache. Some therapies show potential benefit, but the overall evidence base remains limited and higher-quality trials are needed.
Given the limited high-quality evidence overall, no specific clinical recommendations can be made at this time.
journals.sagepub.com/doi/10.1177/03331024261441563
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Across 21 trials with 7,032 patients, CGRP-targeted therapies may reduce migraine days and improve response in those with prior preventive treatment failure. Findings rely on limited evidence and longer independent studies are still needed
journals.sagepub.com/doi/10.1177/03331024261441287
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Domain-specific machine-learning models currently provide more reliable diagnostic performance compared to large language models (LLMs).
A supervised machine-learning model trained on real-world clinical data showed better agreement with a specialist-confirmed diagnosis than a general-purpose, zero-shot, non-domain-adapted LLM.
journals.sagepub.com/doi/10.1177/03331024261441574
#migraine #headache #brain #pain #neurology #neuroscience
@MasahitoKatsuki -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Minimal physical activity was associated with lower migraine-related disability and better life satisfaction.
The identification of an activity engagement threshold and distinct patient clusters suggests a staged care model where pharmacologic stabilization enables physical activity, which may itself serve as a marker of recovery.
journals.sagepub.com/doi/10.1177/03331024261426569
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!.
Green-enriched white light is the most visually comfortable and causes the least physiological sensitivity compared to blue- and cyan-enriched white lights.
journals.sagepub.com/doi/epdf/10.1177/03331024261439257
#migraine #headache #brain #pain #neurology #neuroscience
@schwedtt -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Improving 'sinus headache' diagnosis to stop mismanaged #migraine. New proposal aligns #sinusitis pain definition in #ichd / #icop with #epos 2020 & #icar-RS: adds negative predictors (no nausea/photophobia) & removes pressure tenderness.
journals.sagepub.com/doi/10.1177/03331024261439265
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study is the first large-scale retrospective cohort analysis to systematically evaluate spinal trigeminal nucleus (STN) lesions as a potential imaging biomarker for Trigeminal zoster-associated neuralgia (TZAN).
....
STN lesions are highly specific for TZAN and may serve as an auxiliary diagnostic indicator.
journals.sagepub.com/doi/10.1177/03331024261435927
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Visually-induced hemodynamic response did not differ between middle-aged women with ischemic stroke, migraine with aura, and patients with neither condition.
journals.sagepub.com/doi/10.1177/03331024261439256
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Genetic markers in BMAL1 and NPAS2 were found to be associated with an increased risk for cluster headache
•
The combinations of risk alleles carried by individuals with cluster headache are enriched in the positive feedback arm of the transcription-translation feedback loops (TTFL)
•
The analysis of risk associated with combination of non-pathogenic genetic markers can be used for identifying new treatment targets
journals.sagepub.com/doi/10.1177/03331024261440136
#migraine #headache #brain #pain #neurology #neuroscience
@carminebelinlab -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
【片頭痛治療はCGRP抗体薬の以前と以後に分かれる💉】
抗体薬の登場によって予防治療はより積極的になされるように💪 一方で、仕事の欠勤など社会的な数値の改善はまだわずか😔
その背景には、まだ新薬へのアクセスが十分に確立していない現状があります。
だからこそ重要なのは、
「どこまで悪くなってから使うか」😣
ではなく、
「どれだけ早く使うか」
片頭痛の社会的損失を減らすには、
早期の周知と適切な支援が大事ですね😌
Liseth Hansen et al. Cephalalgia Reports. 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
After market entry of CGRP mAbs, newly diagnosed patients with migraine initiated and cycled through preventative migraine medications more rapidly than those diagnosed in earlier years.
journals.sagepub.com/doi/10.1177/25158163261421617
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Gabriele Sebastianelli
@Gabriele_Seba
Is it better to take atogepant in the morning ☀️or in the evening 🌙? Discover the effects of chronotherapy in #migraine in our latest real-world study @Luigi_Ian_ @JCephalalgia, on behalf of the Italian Headache Registry (RICe) Study Group🚀🧠journals.sagepub.com/doi/10.1177/03331024261416490?url_ve…
-
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
ARBはやっぱり凄い薬なのかも。
最近、カンデサルタンの片頭痛予防効果を示す研究が流行ってますね、、📝
今回は従来予防薬トピラマートと比較⚖️
☑️カンデサルタンの方が続けやすいし、効果も高いとのこと。
・中止率: (カ)29.7% vs (ト)67.3%、
・50%反応率: (カ)47% vs (ト)29%
最近は、従来予防薬どうしで明確に優劣を比較する研究はあまりなく興味深いです。
また、、、
「カンデサルタンでの50%反応率は47%」
→去年のLancetに引き続き、この研究もめちゃくちゃ高い数値ですね🤔
去年のLancet カンデサルタンのRCTの話はこちら↓
x.com/dr_hifumi/status/1976404274700849617
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Oosterlee ASJC et al. Superior outcomes of candesartan over topiramate in the treatment of migraine: A comparative cohort study. Cephalalgia. 2026;46(3). doi:10.1177/03331024261426952
journals.sagepub.com/doi/10.1177/03331024261426952 -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
新薬アトゲパントの「飲み方」による効果の比較⚖️
・朝内服 vs 夕内服
・食後 vs 空腹時
内服タイミングで、有効性・忍容性に大差はありませんでした。
一方で、
☑️夕投与群はMIDASの改善が大きめ
☑️空腹時投与群はMHDsの減少が大きめ
このようなわずかな違いも。
毎日内服するアトゲパント💊
最適な飲み方は、今後さらに見えてくるかもしれません🤔
📚
Iannone LF, et al. Cephalalgia. 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Atogepant reduces migraine frequency and disability regardless of dosing time or meals. Evening use showed greater disability improvement, and intake without food led to larger headache day reduction.
journals.sagepub.com/doi/10.1177/03331024261416490
#migraine #headache #brain #pain #neurology #neuroscience
@Luigi_Ian_
@Simona_Sacco_
@Gabriele_Seba -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
新発売のアトゲパント(アクイプタ®︎)
最新の論文📚
vs 難治片頭痛での実臨床データ🌏
・74%が慢性片頭痛
・予防治療失敗が6剤(中央値)
・54%が抗CGRP抗体薬が効果不十分
こんな難しい片頭痛患者さんでも、、
・3か月投与で頭痛日数は有意に減少📉
・約3分の1が50%以上改善😳
抗CGRP関連抗体薬で十分な効果が得られなかった患者さんでも、
アトゲパントは十分に期待できる可能性を示した点がすごいですね😌
Gago-Veiga AB, et al. Cephalalgia. 2026
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In a real-world cohort of over 500 treatment-resistant migraine patients, atogepant achieved clinically meaningful reductions in headache days at 3 months, with further improvement at 6 months. Tolerability was good, and fewer prior failures
journals.sagepub.com/doi/10.1177/03331024261431337
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
Migraine in pregnancy? 2025 review says: prioritise lifestyle & non‑drug options—education, hydration, sleep, stress relief & gentle exercise. For acute attacks, use paracetamol first; NSAIDs only mid‑pregnancy; sumatriptan as a later option. journals.sagepub.com/doi/10.1177/03331024251393945
-
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
「女性ホルモンの変動は、片頭痛の誘因になる」🤦♀️
月経に伴う片頭痛が代表的です。
一方で、「排卵のタイミングでは片頭痛が起きやすい訳ではないよ」とのこと。
女性の頭痛周期やホルモンとの関係を考える上で、興味深い研究ですね🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Using daily e-diaries and LH-validated ovulation, this study found no rise in migraine attacks during the ovulatory window. Only the perimenstrual period showed increased incidence, supporting menstruation as a trigger for migraine.
journals.sagepub.com/doi/10.1177/03331024261436415
#migraine #headache #brain #pain #neurology #neuroscience
@HeadacheLUMC -
Cephalalgia reposted
Teshamae Monteith, M.D., FAHS, FAAN
@headacheMD
Congratulations all! Very proud of you! @JCephalalgia @cephreports
International Headache Society
@ihs_official
The Cephalalgia Reviewer Academy has officially concluded its 2026 program, celebrating the successful graduation of an outstanding cohort. Congratulations to the 2025/2026 Cephalalgia Reviewer Academy graduates 🎓✨
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Women with menstrual-related migraine (MRM) had higher rates of recent changes in frequency, consistent attack sites, and family history of headaches. MRM participants reported more prodromal symptoms and better response to triptans.
journals.sagepub.com/doi/10.1177/25158163261437831
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In the overall study cohort and those with migraine with aura, the rapid number naming task was significantly slower during all phases compared to the interictal phase.
journals.sagepub.com/doi/10.1177/25158163261436784
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Work has been underway for some time developing the new version of the International Classification of Headache Disorders, ICHD-4, and consideration should be given to broadening the system to include factors other than diagnosis.
journals.sagepub.com/doi/epdf/10.1177/03331024261439266
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
The Cephalalgia Reviewer Academy has officially concluded its 2026 program, celebrating the successful graduation of an outstanding cohort. Congratulations to the 2025/2026 Cephalalgia Reviewer Academy graduates 🎓✨
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Using daily e-diaries and LH-validated ovulation, this study found no rise in migraine attacks during the ovulatory window. Only the perimenstrual period showed increased incidence, supporting menstruation as a trigger for migraine.
journals.sagepub.com/doi/10.1177/03331024261436415
#migraine #headache #brain #pain #neurology #neuroscience
@HeadacheLUMC -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Digital information use is widespread among migraine patients in the Middle East and North Africa (MENA) region, with over 80% searching online and 72% using AI tools.
journals.sagepub.com/doi/10.1177/03331024261435594
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
We’re delighted to share that the paper “Efficacy and effectiveness of anti-CGRP monoclonal antibodies treatment in the prevention of cluster headache attacks: A systematic review and meta-analysis”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco! @Simona_Sacco_
Congratulations to all authors and collaborators on this important contribution, which suggests that anti-CGRP monoclonal antibody treatment may be beneficial for episodic cluster headache but not for chronic cluster headache.
journals.sagepub.com/doi/full/10.1177/03331024261434209
#clusterheadache #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
@JCephalalgia Editor's Choice @Simona_Sacco_ Neuroimaging-based subtyping of #migraine identifies clinically distinct phenotypes. Sridhar J, Babaei M, et al. Cephalalgia 2026;46(3). doi:10.1177/03331024261433982
www.youtube.com/watch?v=GKzWgkpRzB8 @NinaRiggins -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review and meta-analysis suggest that anti-CGRP monoclonal antibody treatment may be beneficial for episodic cluster headache but not for chronic cluster headache.
journals.sagepub.com/doi/full/10.1177/03331024261434209
#clusterheadache #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Migraine induced by vascular KATP channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation” which has been selected as the Editor’s Choice for the April issue of Cephalalgia.
..................................
Blocking hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels with ivabradine failed to modify KATP induced migraine in humans or hypersensitivity in mice.
HCN channels are unlikely to be key downstream mediators.
Vascular-to-neuronal signalling may drive migraine initiation.
journals.sagepub.com/doi/10.1177/03331024261431770
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina @Simona_Sacco_ -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In this study, combination preventive treatment for chronic migraine (CM) with onabotulinumtoxinA and atogepant was safe and generally well-tolerated. Furthermore, the addition of atogepant to those stable on onabotulinumtoxinA resulted in clinically meaningful reductions in migraine days and improvement in responder rates, suggesting a benefit of combining treatments with distinct and complementary mechanisms of action for suppression of CM.
journals.sagepub.com/doi/10.1177/03331024261429118
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Systematic review of 14 human pharmacological migraine aura provocation studies (7 agents) suggests CGRP signaling and KATP channel activation (levcromakalim) are leading candidates to trigger migraine aura.
journals.sagepub.com/doi/10.1177/03331024261429112
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In migraine of children and adolescents, brain networks play different roles by sex: males show altered sensory–affective circuits, females altered cognitive–attentive ones—the instruments and conductors of pain processing.
journals.sagepub.com/doi/10.1177/03331024261416494
#migraine #headache #brain #pain #neurology #neuroscience
@maxval67 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Transcultural Headache Medicine is a framework that links culture, traditional therapies, and health systems to headache diagnosis, treatment, and policy, and proposes a global research agenda to improve equitable, person-centred care.
journals.sagepub.com/doi/10.1177/03331024261432929
#migraine #headache #brain #pain #neurology #neuroscience
@drmarioperes -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study reports a refractory case of chronic cluster headache successfully treated with morning ergotamine and bedtime lasmiditan. This day–night tailored combination reduced attack frequency and severity without adverse effects, suggesting a novel
journals.sagepub.com/doi/10.1177/25158163261435608
#clusterheadache #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Behind every published paper, there are dedicated reviewers who give their time, energy, and expertise.
Cephalalgia Reports sincerely thanks all individuals who reviewed one or more manuscripts during 2025. Your contributions are essential, appreciated, and never taken for granted.
See the full list of reviewers here:
journals.sagepub.com/doi/10.1177/25158163261428526
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Mediation modeling indicated that approximately three-quarters of the effect of rimegepant on functioning is mediated through reductions in pain intensity during the acute migraine attack phase.
journals.sagepub.com/doi/10.1177/25158163261433912
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Blocking hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels with ivabradine failed to modify KATP induced migraine in humans or hypersensitivity in mice.
HCN channels are unlikely to be key downstream mediators.
Vascular-to-neuronal signalling may drive migraine initiation.
journals.sagepub.com/doi/10.1177/03331024261431770
#migraine #headache #brain #pain #neurology #neuroscience
@ZxZhAlice -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In a real-world cohort of over 500 treatment-resistant migraine patients, atogepant achieved clinically meaningful reductions in headache days at 3 months, with further improvement at 6 months. Tolerability was good, and fewer prior failures
journals.sagepub.com/doi/10.1177/03331024261431337
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
New real-world data on CGRP antibodies in drug-resistant migraine: Among 252 patients, 74.6% stayed on treatment. Most stopped early due to lack of effectiveness, while many who continued reported noticeable qualitative improvements.
journals.sagepub.com/doi/10.1177/25158163261433966
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study found that migraine is not increased in multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), or myasthenia gravis (MG), while tension-type headache is more common in MS and NMOSD. Headache severity was not linked to disease activity or treatment.
journals.sagepub.com/doi/10.1177/03331024261429158
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Atogepant reduces migraine frequency and disability regardless of dosing time or meals. Evening use showed greater disability improvement, and intake without food led to larger headache day reduction.
journals.sagepub.com/doi/10.1177/03331024261416490
#migraine #headache #brain #pain #neurology #neuroscience
@Luigi_Ian_
@Simona_Sacco_
@Gabriele_Seba -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
1278 patients visited the pediatric emergency department for acute headache, accounting for 3.6% of all Pediatric Emergency Department (PED) visits. Brain MRI was performed in 19.1% of cases. Red flag symptoms were significantly associated with abnormal brain MRI findings.
journals.sagepub.com/doi/10.1177/03331024261431339
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In clinical settings, the focus, understandably, is normally on treating the more severe condition (typically complex regional pain syndrome [CRPS] in patients with comorbid CRPS and migraine). However, recognizing that migraine and chronic daily headaches frequently develop after the onset of CRPS is crucial for optimal management of these comorbid conditions.
journals.sagepub.com/doi/10.1177/03331024261430856
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
CGRP-targeted therapies work—but not for all pain.
This case illustrates a clear therapeutic dissociation between migraine and complex regional pain syndrome (CRPS) under CGRP blockade. While both a CGRP monoclonal antibody and a CGRP receptor antagonist were highly effective for migraine prevention and acute treatment, neither intervention altered the severity of chronic CRPS.
journals.sagepub.com/doi/10.1177/03331024261430857
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
In this nationwide register-based study, more than one-third (35.7%) of migraine patients in Sweden in 2015-2023 had comorbid depression or anxiety. There was a higher risk of comorbidity in the most versus the least deprived areas within Sweden.
journals.sagepub.com/doi/10.1177/03331024261430855
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Neuroimaging-based subtyping of migraine identifies clinically distinct phenotypes” which has been selected as the Editor’s Choice for the March issue of Cephalalgia.
@Simona_Sacco_
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
..........................
Data-driven multimodal neuroimaging-based clustering identified two distinct migraine subgroups with different clinical characteristics.
•
One subgroup showed widespread increases in cortical–subcortical functional connectivity and diffuse cortical volume reductions and was associated with greater symptom burden.
•
Functional connectivity contributed most strongly to subgroup differentiation, while structural variation provided complementary, orthogonal information, highlighting heterogeneity in brain organization within migraine.
journals.sagepub.com/doi/10.1177/03331024261433982
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Behind every published paper, there are dedicated reviewers who give their time, energy, and expertise.
Cephalalgia sincerely thanks all individuals who reviewed one or more manuscripts during 2025. Your contributions are essential, appreciated, and never taken for granted.
See the full list of reviewers here:
journals.sagepub.com/doi/10.1177/03331024261420094
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Data-driven, multimodal imaging-based clustering of migraine reveals subgroups with distinct structural, functional, and symptom profiles, providing complementary evidence to support subgroup characterization.
journals.sagepub.com/doi/10.1177/03331024261433982
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Virtual education is now a permanent part of headache training. When designed with quality, equity, and interactivity in mind, it can expand global access and strengthen competency-based learning.
Virtual education should not be an alternative to clinical apprenticeship, but an amplifier of it.
journals.sagepub.com/doi/10.1177/03331024261433598
#migraine #headache #brain #pain #neurology #neuroscience
@HenrikSchytz
@MarcioNattan -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
WHO’s essential medicines list (EML) recent report emphasises that headache disorders remain neglected despite the ill health and disability they cause.
journals.sagepub.com/doi/10.1177/03331024261420835
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This Norwegian registry-based matched cohort study found a substantial and increasing burden of comorbidities, and lower income and education in people with cluster headache compared to controls.
journals.sagepub.com/doi/10.1177/03331024261428583
#clusterheadache #migraine #headache #brain #pain
@einamoen -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This cross-sectional study describes post-traumatic headache phenotypes and treatment patterns in adults with moderate to severe post-traumatic headache and a high post-concussion symptom burden 2-4 months after mild traumatic brain injury.
journals.sagepub.com/doi/10.1177/03331024261423477
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Al-Khazali HM, et al. Hypersensitivity to phosphodiesterase-5 inhibition in post-traumatic headache: Evidence of cGMP-dependent signaling. Cephalalgia. 2026;46(3). doi:10.1177/03331024261419409
-
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Lisicki M, et al. Pan-American migraine prevalence: Findings from the Americas’ migraine observatory study (AMIGOS). Cephalalgia. 2026;46(3). doi:10.1177/03331024261420837
-
Cephalalgia
@JCephalalgia
An excellent new publication #pth in @JCephalalgia! Nabity PS, et al. Post-traumatic headache phenotypic characteristics and treatment utilization. Cephalalgia. 2026;46(3). doi:10.1177/03331024261421527
-
Cephalalgia
@JCephalalgia
New publication! @JCephalalgia Jiang J, et al. Predictive value of preoperative white and gray matter microstructural alterations for microvascular decompression outcome in classical trigeminal neuralgia. Cephalalgia. 2026;46(3). doi:10.1177/03331024261423444
-
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Pellesi L, et al. Where are the men? A systematic review of sex bias in human provocation models of migraine. Cephalalgia. 2026;46(3). doi:10.1177/03331024261425258
-
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Oosterlee ASJC et al. Superior outcomes of candesartan over topiramate in the treatment of migraine: A comparative cohort study. Cephalalgia. 2026;46(3). doi:10.1177/03331024261426952
journals.sagepub.com/doi/10.1177/03331024261426952 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia! Tana C et al. Digital and virtual interventions for migraine: A systematic review of randomized controlled trials. Cephalalgia. 2026;46(3). doi:10.1177/03331024261422276
journals.sagepub.com/doi/10.1177/03331024261422276 -
Cephalalgia
@JCephalalgia
New in @JCephalalgia journals.sagepub.com/doi/10.1177/03331024261418290
Christensen RH et al. PET and fMRI insights into experimentally-induced premonitory symptoms in migraine: A systematic review. Cephalalgia. 2026;46(3). doi:10.1177/03331024261418290 -
Cephalalgia
@JCephalalgia
ihs-headache.org/en/news/newsflash-ihc-2025-presentation-…
Newsflash: IHC 2025 presentation videos now available for IHS members @IHSheadache -
Cephalalgia reposted
Sage Journals
@SageJournals
Last call!
The submission deadline for the Jes Olesen Awards is 28 March 2026.
Don’t miss the chance to gain international recognition for your headache research: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
#cephalalgia #headacheresearch @JCephalalgia @ihs_official -
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona.Sacco_ Editor's Choice Article! @IHSheadache
#migraine as a primary care-sensitive condition: Building pathways to accessible care. doi:10.1177/03331024261418704
Video interview with an Author Dr Welber Souza Oliveira 👏@HeadacheSpecialistNinaRiggins -
Cephalalgia
@JCephalalgia
#clusterheadache Awareness @IHSheadache @ihs_official @JCephalalgia has newest #research and #treatments updates @Simona.Sacco_ @Headache SpecialistNinaRiggins @Bohemian.wu @Faraidoon.haghdoost
-
Cephalalgia reposted
S Blitshteyn MD, FAAN, FANA, Dysautonomia Clinic
@dysclinic
🚨 Our new paper is published in @JCephalalgia!
🧠 We discuss the importance of including #pots and #dysautonomia more broadly in the differential diagnosis of chronic dizziness that neurologists often encounter, especially in patients with #migraine.
🧠 A subset of patients with chronic dizziness or chronic migraine are deemed treatment-refractory when they have not responded to treatment of PPPD or #migraine.
🧠 In many of these patients, etiology may be an undiagnosed and untreated #autonomic disorder.
👇 Read here:
journals.sagepub.com/doi/10.1177/03331024261420838
@ihs_official @AANmember @Jacobs_Med_UB @NinaRiggins @Dysautonomia -
Cephalalgia reposted
Sage Journals
@SageJournals
Over 1 billion people globally suffer from migraines.
Find the newest research and recommended treatments from journals like @JCephalalgia on the Neuroscience hub.
Explore now: journals.sagepub.com/neuroscience-neurology-psychiatry #migraines #neuroscience -
Cephalalgia reposted
Sage Journals
@SageJournals
Deadline approaching!
Submit your original research to the Jes Olesen Awards for the Advancement of Headache Medicine.
🏆 Clinical & Basic Science Awards
💶 €10,000 each
📅 Deadline: 28 March 2026
Learn more and submit: journals.sagepub.com/page/cep/call-for-papers/jo-health-a… @JCephalalgia @ihs_official -
Cephalalgia reposted
BibliotecaHUVH
@BibliotecaHUVH
WHO's essential medicines list: Additions for migraine and cluster headache journals.sagepub.com/doi/10.1177/03331024261420835 #hvhebron #neuro [Text complet] @JCephalalgia
-
Cephalalgia reposted
Sage Journals
@SageJournals
Tune into this interview with Cephalalgia’s newest Editor’s Choice article author & learn about the connection between complex regional pain and migraine.
Watch now: journals.sagepub.com/page/cep/collections/editors-choice
@JCephalalgia @ihs_official -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
新しい不眠症治療薬のダリドレキサント(クービビック®︎)💊
「慢性片頭痛+慢性不眠」患者さんに投与
→不眠は良くなった😀
→でも頭痛は良くならなかった😣
やはりオレキシン系は、頭痛への直接的な改善効果はなかなか結果が出ないですね。
もちろん、不眠症治療薬としては重宝すべき素晴らしいお薬です😌
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In patients with chronic migraine and chronic insomnia, daridorexant improved sleep quality, but not headache frequency.
journals.sagepub.com/doi/10.1177/25158163251415344
#migraine #headache #brain #pain #neurology #neuroscience
@juliopascualg -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study offers evidence of the efectiveness of Galcanezumab in real life for the preventive treatment of episodic and chronic migraine, including an impact on psychiatric variables, contributing to daily practice and treatment guidelines
journals.sagepub.com/doi/10.1177/25158163261418597
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
After market entry of CGRP mAbs, newly diagnosed patients with migraine initiated and cycled through preventative migraine medications more rapidly than those diagnosed in earlier years.
journals.sagepub.com/doi/10.1177/25158163261421617
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
CT-guided Gasserian ganglion injection may be a minimally invasive option for elderly or medically refractory trigeminal neuralgia patients unsuitable for surgery, with preliminary evidence of symptomatic benefit and acceptable safety.
journals.sagepub.com/doi/10.1177/25158163261418598
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The clinical reasoning behind the interpretation of the findings of the assessment of migraine patients is described, using three migraine patients with different clinical presentation and individualised interventions
•
Individualized physiotherapy treatments can be safely delivered to patients with migraine.
•
The therapeutic benefit of physiotherapy interventions depends on the clinical reasoning and the individualization of the treatments, including education and lifestyle management.
•
Manual therapy and exercises can be used to either target cervical musculoskeletal impairments related to a CMD or improve cervical hypersensitivity through pain modulation.
journals.sagepub.com/doi/10.1177/25158163251414038
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Many women with enlarged breast tissue have frequent headaches. After breast reduction, this study showed that most saw headaches, neck pain, and sleep apnea risk improve—but surgery isn’t a guaranteed treatment. More research is needed.
journals.sagepub.com/doi/10.1177/25158163261416853
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In patients with chronic migraine and chronic insomnia, daridorexant improved sleep quality, but not headache frequency.
journals.sagepub.com/doi/10.1177/25158163251415344
#migraine #headache #brain #pain #neurology #neuroscience
@juliopascualg -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In daily practice, management of trigeminal traumatic neuropathic pain is a challenge.
•
The use of perineural botulinum toxin may be useful in the management of neuropathic pain.
•
This study presents the first report of perineural botulinum toxin injection with ultrasound guidance in the trigeminal innervation for the management of post-traumatic pain.
•
Traumatic craniofacial pain of trigeminal origin may improve with the application of botulinum toxin.
journals.sagepub.com/doi/10.1177/25158163251414012
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Specialist workforce shortage: The surveyed Caribbean islands reported very few practicing neurologists, with virtually none having fellowship training in migraine/headaches.
journals.sagepub.com/doi/10.1177/25158163251415565
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Migraine as a primary care-sensitive condition: Building pathways to accessible care” which has been selected as the Editor’s Choice for the February issue of Cephalalgia.
@Simona_Sacco_
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
..........................
Migraine meets internationally established criteria for classification as a Primary Care-Sensitive Condition (PCSC), supporting early intervention to reduce avoidable hospitalizations and improve patient outcomes.
•
The absence of migraine from PCSC classifications perpetuates gaps in public health policies and delays the implementation of effective care models.
•
Recognizing migraine as a PCSC can increase its visibility in public health agendas and drive the development of structured, equitable, and cost-effective care pathways.
journals.sagepub.com/doi/10.1177/03331024261418704
#migraine #headache #brain #pain #neurology #neuroscience
@ramiburstein
@mariofpperes -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine meets internationally established criteria for classification as a Primary Care-Sensitive Condition (PCSC), supporting early intervention to reduce avoidable hospitalizations and improve patient outcomes.
•
The absence of migraine from PCSC classifications perpetuates gaps in public health policies and delays the implementation of effective care models.
•
Recognizing migraine as a PCSC can increase its visibility in public health agendas and drive the development of structured, equitable, and cost-effective care pathways.
journals.sagepub.com/doi/10.1177/03331024261418704
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Migraine is a leading cause of disability in Eastern Europe.
This regional study (Moldova, Ukraine, Romania, Serbia) shows big gaps in diagnosis, limited access to modern therapies, and low awareness.
journals.sagepub.com/doi/10.1177/25158163251414020
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This real-world matched control study (n=37,054) found that people with migraine had significantly higher rates of certain comorbidities and significantly higher healthcare resource utilization compared to controls.
journals.sagepub.com/doi/10.1177/25158163251414041
#migraine #headache #brain #pain #neurology #neuroscience
@MatanyaTirosh @ShVinker -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
While chronic dizziness has a wide differential diagnosis, three common neurologic etiologies need to be considered in an outpatient evaluation: vestibular migraine, persistent postural-perceptual dizziness and dysautonomia/Postural Orthostatic Tachycardia Syndrome.
Dysautonomia is a common cause of chronic dizziness.
journals.sagepub.com/doi/10.1177/03331024261420838
#migraine #headache #brain #pain #neurology #neuroscience
@dysclinic -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
There is a compelling argument for the inclusion of Solitary Pontine
Lesion–Related Trigeminal Neuralgia as a distinct subgroup within Secondary Trigeminal Neuralgia in ICHD-4
journals.sagepub.com/doi/10.1177/03331024261419766
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Solitary pontine lesion–related trigeminal neuralgia may be a distinct condition. Emerging evidence calls for updating the ICHD to recognize this unique form of trigeminal neuralgia.
journals.sagepub.com/doi/10.1177/03331024261419757
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Fractal dimension-based structural MRI analysis is more sensitive to cortical changes than cortical thickness, even in low-frequency migraine.
journals.sagepub.com/doi/10.1177/03331024251414616
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The current systematic review highlights areas of agreement and disagreement between existing guidelines on the management of childhood and adolescent migraine and emphasizes the current gaps and opportunities
journals.sagepub.com/doi/10.1177/03331024251413283
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Eptinezumab is effective in real-world practice, both evaluating the percentage of reduction and using the IHS novel criteria.
•
Treatment with eptinezumab showed consistent and clinically meaningful reductions in both monthly migraine and headache days across episodic and chronic migraine patients, demonstrating real-world effectiveness in a refractory cohort.
•
According to the International Headache Society (IHS) categories, about 15–20% of patients achieved optimal control and 20–26% modest control after 24 weeks of treatment.
journals.sagepub.com/doi/10.1177/03331024251414659
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Early physical, cognitive, and emotional symptoms after mild traumatic brain injury may help identify those at risk for persistent post-traumatic headache. Continued monitoring and support for sleep and emotional issues are key in delayed recovery.
journals.sagepub.com/doi/10.1177/03331024251414856
#migraine #headache #brain #pain #neurology #neuroscience
@schwedtt -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia reposted
Gabriele Sebastianelli
@Gabriele_Seba
Peer review is essential for advancing science. Supporting authors and editors in enhancing research quality is both a responsibility and a privilege for every researcher.
Honoured and grateful to @JCephalalgia for this recognition #outstandingpeerreviewer in 2025 🚀🧠
International Headache Society
@ihs_official
Peer review is one of the most important — and often unseen — pillars of scientific progress.
Congratulations to Dr Gabriele Sebastianelli for being recognised as Outstanding Peer Reviewer for Cephalalgia in 2025.
Your thoughtful, rigorous, and constructive reviews help maintain the highest standards in headache research. Thank you for your dedication to strengthening our scientific community.
#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba -
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona_Sacco_ Editor's Choice Article Video Interview with Authors #clinical and genetic characterization of non-optimal triptan response among migraine patients. Brenna E, Ferro M, Sumelahti M-L, et al. Cephalalgia 2026;46(1). doi:10.1177/03331024251414621 @NinaRiggins
www.youtube.com/watch?v=4_E0NWd8bsQ -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Novel advanced MRI reveals altered cortical microstructure in persistent post-traumatic headache, including signs of neuroinflammation and cellular swelling that are partially distinct from migraine.
journals.sagepub.com/doi/10.1177/03331024251409317
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sage Journals
@SageJournals
Cephalalgia’s newest Editor’s Choice article investigates the connection between complex regional pain and migraine. @JCephalalgia @ihs_official
Read the article: journals.sagepub.com/doi/full/10.1177/03331024251404910 -
Cephalalgia
@JCephalalgia
Peer review is one of the most important — and often unseen — pillars of scientific progress.
Congratulations to Dr Gabriele Sebastianelli for being recognised as Outstanding Peer Reviewer for Cephalalgia in 2025.
Your thoughtful, rigorous, and constructive reviews help maintain the highest standards in headache research. Thank you for your dedication to strengthening our scientific community.
#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba -
Cephalalgia
@JCephalalgia
Excellence in peer review deserves to be celebrated.
Congratulations to Prof Mona Nada for being named Outstanding Peer Reviewer for Cephalalgia Reports in 2025.
Your expertise, fairness, and commitment to quality make a meaningful impact on the advancement of headache science. Thank you for your invaluable contribution to the field.
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Corneal confocal microscopy reveals reduced corneal nerve fibers in migraine patients, regardless of migraine type or visual sensitivity, pointing to a wider role of peripheral nerve dysfunction in migraine beyond just sensory symptoms.
journals.sagepub.com/doi/10.1177/03331024251414172
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in sex and gender differences in migraine
Irene de Boer and Caroline M. Kopruszinski
Sex and gender affect migraine risk, presentation, and treatment. This paper highlights 2025 clinical and preclinical studies that have contributed to understanding sex differences in migraine pathophysiology and therapeutic management.
journals.sagepub.com/doi/10.1177/03331024261417385
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Great news for researchers! The submission deadline has been extended — you now have until 📅 28 March 2026 to submit your original research papers for the Jes Olesen Awards in Basic Science and Clinical Science.
Cephalalgia is proud to honour outstanding early‑career researchers whose work drives innovation in headache medicine. Two awards — one in Basic Science and one in Clinical Science — will each grant €10,000 and an opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old
🔹 Submission type: Original research only
🔹 Limit: One submission per participant
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards empower the next generation of headache researchers worldwide.
🌍 Don’t miss this chance to elevate your work, gain international visibility, and contribute to the future of headache science!
#jesolesenawards #headacheresearch #cephalalgia #ihs #callforpapers #researchopportunity -
Cephalalgia
@JCephalalgia
🌟 Welcome to the Cephalalgia & Cephalalgia Reports Editorial Boards! 🌟
We are delighted to welcome our newly appointed Graphical Abstracts Editors, who will play a key role in advancing the visual communication and scientific impact of our journals.
🎨 Olivia Grech, MD
Graphical Abstracts Editor, Cephalalgia
University of Birmingham, College of Medical and Dental Sciences
United Kingdom
🎨 Wanakorn Rattanawong, MD, FRCP(T)
Graphical Abstracts Editor, Cephalalgia Reports
King Mongkut's Institute of Technology Ladkrabang
Thailand
Their expertise will strengthen the clarity, accessibility, and visual quality of the research we publish.
Please join us in warmly welcoming them to the Editorial Boards! 🙌✨
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
🌟 Welcome to the Cephalalgia Editorial Board! 🌟
We are delighted to introduce our newest Associate Editors, bringing exceptional expertise and global leadership to our publications:
🧠 Debashish Chowdhury, MD
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, India
🧪 Debbie Hay, BSc(Hons), PhD
University of Otago, Pharmacology & Toxicology, New Zealand
🔬 Hsiangkuo (Scott) Yuan, MD, PhD
Thomas Jefferson University, USA
Their scientific excellence and dedication to advancing headache research will continue to elevate the impact and quality of our journals.
Please join us in giving them a warm welcome! 🙌✨
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Clinical and genetic characterization of non-optimal triptan response among migraine patients” which has been selected as the Editor’s Choice for the January issue of Cephalalgia.
@Simona_Sacco_
..............................................................
Non-optimal triptan response was associated with several clinical risk factors such as fibromyalgia and the use of gastro-oesophageal reflux medications, oral cavity disorders, intestinal disorders, and gynecological diagnoses.
journals.sagepub.com/doi/10.1177/03331024251414621
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
@JCephalalgia New Publication!
journals.sagepub.com/doi/10.1177/03331024261416488
Li X, Li R, Liu G, et al. Iron deposition network mapping of disease occurrence and clinical manifestations in migraine: A prospective study. Cephalalgia. 2026;46(1). doi:10.1177/03331024261416488 -
Cephalalgia
@JCephalalgia
@JCephalalgia New publication!
journals.sagepub.com/doi/10.1177/03331024251414634 -
Cephalalgia
@JCephalalgia
@JCephalalgia New Publication!
journals.sagepub.com/doi/10.1177/03331024251414621
Brenna E, Ferro M, Sumelahti M-L, et al. Clinical and genetic characterization of non-optimal triptan response among migraine patients. Cephalalgia. 2026;46(1). doi:10.1177/03331024251414621 -
Cephalalgia
@JCephalalgia
@JCephalalgia New Publication!
journals.sagepub.com/doi/10.1177/03331024251414834
Daghlas I, Chasman DI. Mendelian randomization applied to migraine research: Opportunities and challenges. Cephalalgia. 2026;46(1). doi:10.1177/03331024251414834 -
Cephalalgia
@JCephalalgia
Excited to share a new Call for Papers in Cephalalgia — the official journal of the International Headache Society.
🧠 Special Issue: Managing and Understanding Headache in the Context of Comorbid Conditions
Guest Editors: Faraidoon Haghdoost and Henrik Winther Schytz
Headache disorders such as migraine and tension-type headache rarely exist in isolation. They often sit alongside high blood pressure, dyslipidaemia, depression, anxiety, gastrointestinal disorders, and more. This special issue focuses on integrated, real-world approaches to care — from shared pathophysiology and overlapping risk factors to multidisciplinary management and treatments that address both headache and comorbid conditions.
We welcome:
• Original research and clinical trials
• Systematic reviews and network meta-analyses
• Real-world evidence
• Viewpoints and perspectives
If your work explores headache in the context of comorbidities — cardiovascular, mental health, gastrointestinal, or beyond — we would love to hear from you.
📅 Submission deadline: 31 December 2026
📌 Please note in your cover letter that your manuscript is for the “Headache and Comorbidities” special issue.
Let’s move toward more holistic, patient-centred headache care. Looking forward to your submissions and to advancing this important conversation together.
surl.lt/wadtdt
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost @Simona_Sacco_ @HenrikSchytz -
Cephalalgia
@JCephalalgia
@JCephalalgia A nationwide cohort study of headache disorders using survey, smartphone and registry data journals.sagepub.com/doi/10.1177/03331024251404430
-
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in post-traumatic headache
Rune Häckert Christensen and Haidar M. Al-Khazali
• Persistent post-traumatic headache is emerging as a chronic pain disorder with symptom burden comparable to chronic migraine, reinforcing shared underlying mechanisms
• Neuroimaging studies reveal overlapping brain signatures between post-traumatic headache and migraine, particularly in pain-processing networks involved in photophobia and sensory integration
• Experimental models identify critical early therapeutic windows, where timely intervention may alter long-term headache outcomes
• New molecular insights highlight roles for CGRP, endocannabinoid signalling, and cGMP pathways in driving post-traumatic headache persistence
• Machine learning approaches are advancing prediction of headache chronification, helping classify recovery trajectories after brain injury
• Bottom line: 2025 research positions post-traumatic headache alongside migraine in both biology and disability, while opening doors to earlier intervention and personalised prognosis.
journals.sagepub.com/doi/10.1177/03331024251409706
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in resistant and refractory migraine
Jennifer Robblee
• 2025 brought clearer international definitions for resistant and refractory migraine, helping standardise research and clinical care
• New longitudinal data show migraine resistance is dynamic — many people move between responsive, resistant, and refractory states over time
• Growing evidence supports multimodal care, combining CGRP-based treatments with targeted neuromodulation approaches
• Real-world studies highlight atogepant and eptinezumab as effective options even after multiple preventive failures
• Emerging pathways beyond CGRP, including PACAP-targeted therapies, offer hope for people who have exhausted current options
• A shift is underway: from counting failed treatments to understanding biological mechanisms behind resistance
• Bottom line: 2025 reflects steady progress toward precision care for resistant migraine — while the most refractory cases remain the next frontier for discovery
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251401231
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in digital technology in headache
Anker Stubberud
• 2025 saw rapid growth in digital headache care, spanning internet platforms, mobile apps, social media, wearables, and artificial intelligence
• Online tools are expanding access to education and self-management — but also raise challenges around misinformation and lack of personalised guidance
• App-based and internet-delivered therapies show promise, yet rigorous trials reveal mixed results, highlighting the need for stronger evidence
• New concepts such as digital phenotyping and “digital twins” aim to personalise diagnosis, treatment selection, and attack forecasting using real-time data from smartphones and wearables
• Artificial intelligence is advancing the prediction of treatment response and uncovering migraine genetics, while underscoring the importance of standardised study design and validation
• Generative chatbots may support education and research — but must be balanced against risks of over-reliance on AI
• Bottom line: digital technology offers powerful opportunities in headache care, but clinical adoption must be guided by robust evidence and careful implementation
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251401232
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in migraine prevention
Raffaele Ornello and Roberto De Icco
• Our editorial brings together the most impactful migraine prevention studies published in 2025, spanning clinical trials, real-world data, and new international guidance
• The 2025 International Headache Society and Italian Society guidelines place CGRP-pathway therapies at the top for preventive efficacy, while traditional options like amitriptyline, propranolol, candesartan, lisinopril, and anti-seizure medicines remain important tools
• A landmark randomized trial confirmed candesartan as an effective, well-tolerated, and low-cost option for episodic migraine prevention
• OnabotulinumtoxinA continues to be a cornerstone for chronic migraine, with reassuring real-world data even during pregnancy, while it showed no benefit for episodic migraine
• Short-term prevention with rimegepant showed promise for fasting-triggered headache, opening doors to situational preventive strategies
• PACAP-targeted therapies remain an exciting frontier, although recent phase 2 results highlight the need for further studies
• Bottom line: 2025 strengthened evidence-based migraine prevention and reinforced a shift toward earlier, more ambitious, and more personalised preventive care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251411865
#migraine #headache #brain #pain #neurology #neuroscience
@RaffaeleOrnello -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in acute migraine treatment
Bianca Raffaelli and Marcio Nattan Portes Souza
• 2025 brought major advances in acute migraine care, supported by new international guidelines and a wave of controlled trials plus real-world evidence
• Ten key studies reviewed in this editorial highlight how gepants are becoming central to acute treatment, showing effectiveness even in people who did not respond to triptans
• Data confirm similar efficacy in men and women, reassuring safety in people with anxiety or depression, and compatibility with preventive CGRP therapies
• Early treatment matters: both trials and real-world studies show higher response rates when gepants are taken early in an attack
• Long-term and real-world data demonstrate higher treatment persistence with rimegepant compared with triptans, suggesting more durable benefit in everyday practice
• Bottom line: 2025 consolidates gepants as a cornerstone of acute migraine management, with evidence now spanning clinical trials, long-term follow-up, and real-world care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251405467
#migraine #headache #brain #pain #neurology #neuroscience
@drmarcionattan, @Raffaelli_B -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in new targets for migraine treatment
Kristian A. Haanes and Håkan Ashina
• 2025 expanded migraine therapeutics beyond CGRP, spotlighting several new biological pathways with translational promise
• PACAP emerged as the most advanced new target, confirmed as a CGRP-independent pathway with early preventive efficacy
• Substance P returned as a validated human headache trigger, reopening discussion around neurokinin-based treatments
• Vascular KATP channels appear to act as a convergence point for multiple migraine mediators, positioning them as a potential broad-spectrum target
• TRPM3 channels link trigeminal activation with sex hormone modulation, offering insight into sex differences in migraine biology
• PAR2 highlights neuro–immune crosstalk as a novel therapeutic direction, with preclinical antibody data showing migraine-like pain reduction
• Bottom line: migraine treatment is moving toward mechanism-based precision care, with multiple new targets now opening doors beyond CGRP
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251413488
#migraine #headache #brain #pain #neurology #neuroscience
@h_ashina -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in non-invasive neurostimulation and neuromodulation for headache management
Chai Ching Ng and Hsiangkuo Yuan
• Neuromodulation is rapidly reshaping headache care, backed by new International Headache Society guidelines and growing clinical evidence
• Early use of remote electrical neuromodulation improves pain freedom and relief in acute migraine — with promising results even in children
• Kinetic oscillation stimulation shows preventive benefit in chronic migraine, offering a new mechanism-based option
• Targeted brain stimulation (TMS and tDCS) advances precision approaches by modulating pain and emotion networks
• Applications are expanding beyond migraine to cluster headache (CH), cervicogenic headache (CGH), and post-dural puncture headache (PDPH)
• Real-world data support safety and long-term use, while highlighting the need for better trial design and adherence strategies
• Bottom line: neuromodulation is evolving into a versatile, mechanism-driven part of headache care — next steps are rigorous trials and real-world integration
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251405935
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
Our editorial on 2025 Highlights in comorbidities and headache is now published in Cephalalgia, part of the 2025 Highlights series.
journals.sagepub.com/doi/full/10.1177/03331024251409779
#headache #migraine -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in cluster headache
Roemer B. Brandt and Rolf Fronczek
• Cluster headache remains one of the most severe headache disorders, with a major unmet need — especially in the chronic form
• 2025 trials of CGRP monoclonal antibodies in episodic and chronic cluster headache did not meet primary endpoints, highlighting limits of translating migraine therapies directly to cluster headache
• Attention is shifting beyond CGRP, with PACAP-38 and inflammatory biomarkers emerging as potential new therapeutic directions
• Neuromodulation approaches (including vagal nerve stimulation, occipital nerve stimulation, TENS, and TMS) continue to expand, though high-quality randomized data remain limited
• New work also deepens understanding of circadian biology, disease progression, premonitory symptoms, and medication overuse in cluster headache
• Bottom line: meaningful progress was made in 2025, but a true causal treatment is still not in sight — ongoing trials into psychedelics and neuromodulation offer hope for more effective options ahead
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251411870
#clusterheadache #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in central and peripheral interactions in migraine
Anders Hougaard and Gabriele Sebastianelli
• 2025 research moves beyond the “central versus peripheral” debate, showing migraine arises from dynamic interaction between brain networks and peripheral generators
• New imaging studies suggest migraine does not cause permanent white-matter damage, while cortical thickness changes appear reversible with effective preventive treatment
• Peripherally acting therapies, including CGRP monoclonal antibodies, can reshape central brain connectivity in responders — highlighting how peripheral treatments drive central recovery
• Experimental studies show that peripheral vascular and meningeal mechanisms can directly activate trigeminal pain pathways, linking vascular events to central signalling
• Evidence also supports a bidirectional link: central activation can trigger peripheral CGRP release, reinforcing migraine as an integrated system disorder
• Ongoing work continues to refine the role of cortical spreading depression, aura, and pain, pointing toward multiple parallel pathways rather than a single origin
• Bottom line: migraine is best understood as a complex disorder emerging from continuous crosstalk between central and peripheral processes — guiding future mechanism-based care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251406579
#migraine #headache #brain #pain #neurology #neuroscience
@drhougaard -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights from real world studies in migraine
Edoardo Caronna and Marta Torres-Ferrús
• 2025 marks a turning point in migraine real-world research with the release of the new International Headache Society guidelines for real-world evidence studies
• A surge of real-world data is reshaping clinical practice, especially for CGRP therapies and gepants
• Long-term studies confirm sustained benefit of CGRP monoclonal antibodies — but also show many people continue to live with residual disease burden
• Real-world findings challenge forced treatment interruptions, showing symptom worsening after stopping and incomplete recovery after restarting in some patients
• Growing evidence supports atogepant and rimegepant as effective options, even in people with prior CGRP treatment failure
• Real-world safety data remain reassuring, including cardiovascular outcomes
• Bottom line: real-world evidence is no longer just observing care — it is actively shaping guidelines, policy, and how we treat people with migraine
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251407207
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
Our article is published! 2025 Highlights in comorbidities and #headache - Nina Riggins, Faraidoon Haghdoost, 2026k @JCephalalgia @ihs_official 👏💜 @WNGtweets @AANmember @miles4migraine @ahsheadache journals.sagepub.com/doi/10.1177/03331024251409779
-
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in headache in children and adolescents
Laura Papetti
• Migraine in young people is no longer seen as just a neurological condition — it’s a developing, biopsychosocial process shaped by brain, behaviour, and environment
• 2025 research highlights how psychological factors, resilience, and early life experiences strongly influence migraine severity and long-term outcomes
• Studies show that anxiety, depression, pain catastrophising, and multisite pain can all affect disability and treatment response
• Education matters: stigma often begins in adolescence, making awareness among parents, teachers, and caregivers a vital part of care
• Early psychological, educational, and biopsychosocial interventions can change the trajectory of migraine across the lifespan
• A key focus for the future: integrated care models and smoother transitions from paediatric to adult services
• Bottom line: supporting a child with migraine today helps shape a healthier adult tomorrow
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251407208
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights – progress towards discovery of molecular and neuroimaging biomarkers for migraine
Marina Romozzi and Roberta Messina
• 2025 marked major progress in migraine biomarker research, spanning both molecular and brain imaging discoveries
• New studies highlighted key molecular signals linked to migraine mechanisms, including neuropeptides and markers of neuroinflammation
• Neuroimaging continues to reshape our understanding of migraine as a brain network disorder, with growing evidence of widespread connectivity changes
• Advances in imaging revealed alterations in trigeminal pathways, brainstem activity, and large-scale pain and visual networks
• Emerging data also point to sleep, glymphatic function, and brain plasticity as important contributors to migraine biology
• Bottom line: combining molecular markers with advanced neuroimaging is bringing us closer to mechanism-based, personalised migraine care
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251408766
#migraine #headache #brain #pain #neurology #neuroscience
@MRomozzi @_RobertaMessina -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in medication overuse and medication overuse headache
Wanakorn Rattanawong and Luigi Francesco Iannone
• Medication overuse headache is now recognised as a complex neurological and biobehavioral disorder — not simply “too much medication”
• New 2025 evidence suggests that with CGRP-targeted therapies, stopping acute medication may not always be necessary to achieve improvement
• Mindfulness-based approaches show promise, with brain connectivity changes linked to pain control, emotion regulation, and medication use
• The endocannabinoid system may play an important role, pointing to new biological pathways behind medication overuse
• Long-standing assumptions are being challenged — medication overuse may extend beyond migraine, with emerging data in cluster headache
• Bottom line: MOH is multidimensional, involving biology, behaviour, and psychology — and future care will need personalised, multidisciplinary strategies
More Cephalalgia 2025 editorials coming soon — stay tuned.
journals.sagepub.com/doi/10.1177/03331024251409313
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
2025 Highlights in comorbidities and headache
Nina Riggins and Faraidoon Haghdoost
• Migraine and headache disorders rarely exist alone — they often overlap with conditions like endometriosis, fibromyalgia, temporomandibular disorders, epilepsy, and depression
• 2025 research highlights shared biological pathways, including calcitonin gene-related peptide signalling, stress mechanisms, and genetic overlap
• Key clinical insights:
– Prolactin may increase migraine vulnerability in endometriosis
– Higher migraine attack frequency is linked to fibromyalgia
– Nearly half of people with epilepsy experience headache
– Migraine is closely linked with depression
• Bottom line: recognising comorbidities matters — and multidisciplinary care plus precision medicine will be essential for improving outcomes
journals.sagepub.com/doi/10.1177/03331024251409779
#migraine #headache #brain #pain #neurology #neuroscience
@faradoost
@NinaRiggins -
Cephalalgia
@JCephalalgia
The International Headache Society (IHS) invites applications from early-career investigators for its Clinical and Basic Science Headache Research Fellowship. The award supports innovative, high-impact basic and/or clinical research, fosters career development, and advances knowledge in headache disorders.
🔹 Who can apply: Researchers within 6 years of completing their most recent professional training (excluding non-professional periods)
🔹 Funding: £50,000
🔹 Deadline: 1 April 2026
👉 Click below for details and the application form.
ihs-headache.org/en/resources/grants-awards-and-training-… -
Cephalalgia reposted
Amy Gelfand, MD
@aagelfand
Thrilled to have been part of this collaboration between @HeadacheJournal and @JCephalalgia!
International Headache Society
@ihs_official
New in Cephalalgia and Headache!
A strong example of international collaboration in the headache research community.
Professor Simona Sacco, Editor-in-Chief of Cephalalgia, has published an editorial in Headache highlighting selected high-impact papers from 2025 in Cephalalgia, the official journal of the International Headache Society.
headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/…
At the same time, Professor Amy Gelfand, Editor-in-Chief of Headache, has published an editorial in Cephalalgia to share important 2025 research from the journal of the American Headache Society.
journals.sagepub.com/doi/10.1177/03331024251403509
This cross-journal exchange helps ensure that impactful research reaches a broader global audience.
An excellent initiative that supports knowledge sharing and advances the field of headache research.
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@aagelfand -
Cephalalgia reposted
Scott W Powers, PhD, ABPP, FAHS
@ScottWPowers
Terrific collaboration. We are here to advocate for people of any age living with a headache disorder. Thanks Drs. Sacco and Gelfand. Great leaders & colleagues. @ahsheadache @HeadacheJournal
Cephalalgia
@JCephalalgia
New in Cephalalgia and Headache!
A strong example of international collaboration in the headache research community.
Professor Simona Sacco, Editor-in-Chief of Cephalalgia, has published an editorial in Headache highlighting selected high-impact papers from 2025 in Cephalalgia, the official journal of the International Headache Society.
headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/…
At the same time, Professor Amy Gelfand, Editor-in-Chief of Headache, has published an editorial in Cephalalgia to share important 2025 research from the journal of the American Headache Society.
journals.sagepub.com/doi/10.1177/03331024251403509
This cross-journal exchange helps ensure that impactful research reaches a broader global audience.
An excellent initiative that supports knowledge sharing and advances the field of headache research.
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@aagelfand
@HeadacheJournal -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
個人的に興味深い論文📚
「仕事・家事・社会活動の制限、生活の質の低下」
頭痛による疾病負担は片頭痛の日数に依存するかもという研究📝
現行の慢性片頭痛の診断は、、
「月15日以上の頭痛日数」&「月8日以上の片頭痛日数」
つまり“総頭痛日数”が条件に入っています🤕
例えば、、
月16日の頭痛で半分が片頭痛→慢性頭痛⭕️
月10日の頭痛で全部片頭痛→慢性頭痛じゃない❌
でも後者の方が疾病負担は大きいのでは?という話。
慢性片頭痛と高頻度反復性片頭痛の負担差は
診断名ではなく「月間片頭痛日数」でほぼ説明できた📝
現行の診断基準に一石を投じる内容で、興味深いですね🤔
次の診断基準では考え方が変わるかも?
Engstrand H, et al. Cephalalgia 2025
Cephalalgia
@JCephalalgia
New in Cephalalgia!
What drives the burden of migraine? This study found that self-reported migraine days explained the disease burden. This should be considered when revising the definition of chronic migraine in the future ICHD-4.
journals.sagepub.com/doi/10.1177/03331024251406103
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sage Journals
@SageJournals
Are migraines linked to endometriosis or PCOS in women?
New research from Cephalalgia explores the potential link between these conditions.
Read the article here: journals.sagepub.com/doi/full/10.1177/03331024251386776
@JCephalalgia #migraines #womenshealth -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This subgroup analysis demonstrates effectiveness of fremanezumab in preventing migraine following failure of previous preventive treatments, including onabotulinumtoxinA.
journals.sagepub.com/doi/10.1177/03331024251395029
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina -
Cephalalgia
@JCephalalgia
New in Cephalalgia and Headache!
A strong example of international collaboration in the headache research community.
Professor Simona Sacco, Editor-in-Chief of Cephalalgia, has published an editorial in Headache highlighting selected high-impact papers from 2025 in Cephalalgia, the official journal of the International Headache Society.
headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/…
At the same time, Professor Amy Gelfand, Editor-in-Chief of Headache, has published an editorial in Cephalalgia to share important 2025 research from the journal of the American Headache Society.
journals.sagepub.com/doi/10.1177/03331024251403509
This cross-journal exchange helps ensure that impactful research reaches a broader global audience.
An excellent initiative that supports knowledge sharing and advances the field of headache research.
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@aagelfand
@HeadacheJournal -
Cephalalgia reposted
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
Great collaboration! @JCephalalgia @HeadacheJournal 👏
Cephalalgia
@JCephalalgia
@JCephalalgia Editor’s @Simona_Sacco fantastic Editorial "A year of milestones in headache: Highlights from Cephalalgia 2025"
published in the @HeadacheJournal @ahsheadache
headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/… -
Cephalalgia reposted
Headache Journal
@HeadacheJournal
It's been a year of major advances in #headache #medicine! A new @HeadacheJournal editorial by @Simona_Sacco_ highlights key 2025 papers from @JCephalalgia, reflecting global collaboration & progress across #migraine research, guidelines, & care.
Paper: headachejournal.onlinelibrary.wiley.com/share/ZGHRVP5RQYC… -
Cephalalgia reposted
Ayako Shibata@女性の健康支援の活動中
@ayako700
片頭痛のある女性と低用量ピルの血栓症リスクに関するリアルワールドデータ研究
journals.sagepub.com/doi/10.1177/03331024251404924
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This real-world large-scale study, including >27k patients with migrain,e showed estrogen-containing combined hormonal contraceptive exposure was not associated with increased vascular risks in young women with migraine, regardless of subtypes.
journals.sagepub.com/doi/10.1177/03331024251404924
#migraine #headache #brain #pain #neurology #neuroscience
@ChiaChunChiang @KIharaMD -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The authors created the composite 4D migraine scale, which includes four parameters: monthly migraine days, monthly acute medications, pain intensity, and MIDAS. This scale proved more sensitive than single measures in fully quantifying the migraine burden.
journals.sagepub.com/doi/10.1177/03331024251398020
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
What drives the burden of migraine? This study found that self-reported migraine days explained the disease burden. This should be considered when revising the definition of chronic migraine in the future ICHD-4.
journals.sagepub.com/doi/10.1177/03331024251406103
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
CGRP sensitizes Piezo1 channels in human induced pluripotent stem cell derived endothelial cells, boosting calcium signaling and cellular remodeling, relevant to migraine.
journals.sagepub.com/doi/10.1177/03331024251404478
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This real-world large-scale study, including >27k patients with migrain,e showed estrogen-containing combined hormonal contraceptive exposure was not associated with increased vascular risks in young women with migraine, regardless of subtypes.
journals.sagepub.com/doi/10.1177/03331024251404924
#migraine #headache #brain #pain #neurology #neuroscience
@ChiaChunChiang @KIharaMD -
Cephalalgia
@JCephalalgia
@JCephalalgia Editor’s @Simona_Sacco fantastic Editorial "A year of milestones in headache: Highlights from Cephalalgia 2025"
published in the @HeadacheJournal @ahsheadache
headachejournal.onlinelibrary.wiley.com/doi/epdf/10.1111/… -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This exploratory prospective study of 100 consecutive patients at a tertiary headache clinic found associations between certain patient-reported migraine triggers and premonitory symptoms.
journals.sagepub.com/doi/10.1177/25158163251404485
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Atogepant demonstrated significantly greater reduction in mean monthly acute medication use days and significant improvement in MSQ v2.1 Role Function-Restrictive domain score compared with rimegepant in Japanese participants with episodic migraine.
journals.sagepub.com/doi/10.1177/25158163251399924
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Photophobia and forehead hyperalgesia are more intense ipsilateral than contralateral to complex regional pain syndrome in patients with comorbid migraine.
journals.sagepub.com/doi/10.1177/03331024251404910
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review shows a bidirectional link between migraine and endometriosis, each raising the risk of the other and increasing disease burden. The migraine-polycystic ovarian syndrome connection remains unclear.
journals.sagepub.com/doi/10.1177/03331024251386776
#migraine #headache #brain #pain #neurology #neuroscience
@vallhebron, @AdaptativeBrain -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
There is a high risk of medication overuse headache in post-traumatic headache. Early and effective preventive strategies are required, including patient and clinician education.
journals.sagepub.com/doi/10.1177/03331024251404912
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This systematic review analyzes evoked potential studies in migraine, revealing distinct neurophysiological patterns and habituation deficits across migraine subtypes, especially between migraine with and without aura.
journals.sagepub.com/doi/10.1177/03331024251398792
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Complex regional pain syndrome and migraine: Clinical relationships and possible common aetiology” which has been selected as the Editor’s Choice for the December issue of Cephalalgia.
@Simona_Sacco_
....................................................
Photophobia and forehead hyperalgesia are more intense ipsilateral than contralateral to complex regional pain syndrome in patients with co-morbid migraine
journals.sagepub.com/doi/10.1177/03331024251404910
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This paper highlights headache education in the sub-Saharan Africa region, barriers to migraine care, availability of migraine medications across the region and contributes suggestions to improving migraine education and management.
journals.sagepub.com/doi/10.1177/25158163251402983
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Migraine is a prevalent and disabling neurological disorder requiring effective acute treatment. However, access to optimal therapies varies significantly across healthcare systems in Mexico.
journals.sagepub.com/doi/10.1177/25158163251399923
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Medication overuse headache hospitalisation rates, and length of stay have declined over time in Australia. Females and individuals aged over 60 were consistently overrepresented in admissions.
journals.sagepub.com/doi/10.1177/03331024251404451
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
There is limited RCT evidence supporting Greater occipital nerve block (GONB) for the treatment of migraine. Existing systematic reviews should be interpreted with caution. RCTs with homogenous methodologies are required to evaluate GONB in the management of migraine.
journals.sagepub.com/doi/10.1177/03331024251398390
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Corticosteroids increase CGRP expression in cell lines as well as in rodent. The present study suggests that the interplay among endogenous CGRP signaling, corticosteroids and migraine is more complex than previously envisaged.
journals.sagepub.com/doi/10.1177/03331024251367043
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
miR-34a and miR-382-5p show higher expression in peripheral blood mononuclear cells compared to monocytes, with this difference being largely driven by chronic migraine-medication overuse-related alterations, emphasizing the need for cell-specific analyses.
journals.sagepub.com/doi/10.1177/03331024251386769
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The present Delphi study has established internationally derived consensus guidelines and recommendations for the evaluation and comprehensive management of patients with persistent idiopathic facial pain.
journals.sagepub.com/doi/10.1177/03331024251399927
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
While AI has demonstrated success in predicting migraine treatment responses, future research incorporating novel AI techniques and diverse data sources could pave the way to advance personalized migraine treatment.
journals.sagepub.com/doi/10.1177/03331024251395541
#migraine #headache #brain #pain #neurology #neuroscience
@ChiaChunChiang -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The addition of atogepant to OnabotulinumtoxinA is effective and well tolerated in real-world patients with Chronic migraine, including those previously exposed to multiple preventives.
journals.sagepub.com/doi/10.1177/03331024251398011
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study provides evidence that gepants reach the mouse brain, suggesting that they can exert antimigraine effects through a central action.
journals.sagepub.com/doi/10.1177/03331024251378713
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This review summarizes the management of migraine in pregnancy, when planning pregnancy, and when breastfeeding.
journals.sagepub.com/doi/10.1177/03331024251393945
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ @RaffaeleOrnello @faradoost @ppozorosich @pul_fra -
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona_Sacco_ Editor's Choice Article: Abnormal neurovascular coupling in the precuneus associated with migraine chronification: A multimodal magnetic resonance imaging study. Lin C, et al. Cephalalgia 2025;45(11). doi:10.1177/03331024251396031
Watch on the IHS YouTube channel an interview Dr Wang & Dr Lin with Social Media Editor @NinaRiggins
www.youtube.com/watch?v=66wGi93jMVU -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This review highlights the urgent challenges in delivering effective migraine care across North African countries—where access, diagnosis, and treatment remain limited, especially for women and rural populations.
journals.sagepub.com/doi/10.1177/25158163251403011
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Headache care in Africa: The IHS Regional Outreach Program trains non-physician clinicians to diagnose & manage headaches in Malawi. A scalable model supporting WHO IGAP goals & health equity through global-local partnerships. #globalhealth
journals.sagepub.com/doi/10.1177/03331024251404465
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Bridging headache neurology and orofacial pain: this invited commentary highlights diagnostic nuance and pragmatic treatment in persistent idiopathic facial pain.
journals.sagepub.com/doi/10.1177/03331024251399929
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Please watch our @JCephalalgia Editor’s great @Simona_Sacco_ Essential Reading Video with an author Dr Andreas Husøy "GBD, secondary analyses, paper mills and abuse of a valuable but vulnerable resource: A problem that must be confronted" Cephalalgia 2025;45(11). doi:10.1177/03331024251392884 @NinaRiggins @IHS_official
-
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Altered brain network connectivity found in both mnstrually-related migraine (MRM) and non-menstrual migraine (NMM) patients; MRM shows stronger connectivity in the left frontoparietal network vs. NMM; Weaker dorsal attention–default mode connectivity unique to MRM
journals.sagepub.com/doi/10.1177/03331024251396102
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌍 Expanding Our Global Community
The International Headache Society is pleased to share that four national organisations have recently joined our growing family of Affiliate Member Societies:
🇮🇪 Irish Headache Society – Migraine Ireland (IHS-MI)
🇮🇩 Headache Working Group, Indonesian Neurological Association
🇵🇱 Polish Headache Society
🇸🇦 Saudi Association: Neurology
Their participation further enriches our international collaborations and strengthens our collective efforts to improve headache care and research.
🔗 Link to announcement: ihs-headache.org/en/news/ihs-welcomes-new-national-headac…
🔗 Find the full list of IHS Affiliate Member Societies on our page: ihs-headache.org/en/about-ihs/affiliate-member-societies/
#migraine #headache #global -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
New Austrian Network for Idiopathic Intracranial Hypertension (AN4IH) consensus sets the standard for interdisciplinary care in idiopathic intracranial hypertension (IIH) in Austria defining structure, diagnostics, treatment, and monitoring for specialized centers. A major step toward optimized care
journals.sagepub.com/doi/10.1177/03331024251391374
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This trial rigorously demonstrated the efficacy of rimegepant for the preventive treatment of episodic migraine in participants with a documented history of inadequate response to prior oral preventive medications.
journals.sagepub.com/doi/10.1177/03331024251391378
#migraine #headache #brain #pain #neurology #neuroscience
@ppozorosich -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Abnormal neurovascular coupling (NVC) in the precuneus was involved in migraine chronification, with depression serving as a mediator in this process. NVC metric may serve as a biomarker for migraine chronification in the future
journals.sagepub.com/doi/10.1177/03331024251396031
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This is the first randomized study to demonstrate efficacy of a gepant for acute treatment of migraine in individuals unsuitable to triptans and provides evidence that rimegepant may be an appropriate therapeutic option in this population.
journals.sagepub.com/doi/10.1177/03331024251395298
#migraine #headache #brain #pain #neurology #neuroscience
@hmru_cph, @Janu_MD_, @MessoudAshina -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A substantial variety exists in definitions used for a migraine day, even in recent large robust clinical trials. There is a pressing need for a standardized accepted definition of a migraine day, both from a clinical and research perspective.
journals.sagepub.com/doi/10.1177/03331024251393986
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Happening now at the 2025 Taiwan Headache Society Annual Meeting:
Prof. Sait Ashina is delivering an insightful lecture on 'The CGRP-Targeted Therapy Era and Emerging Targeted Treatments for Migraine.'
#headache #migraine #ths #congresss -
Cephalalgia
@JCephalalgia
Editor's @Simona_Sacco_ Recognition #essential Reading Article @JCephalalgia. Please see Video Episode with an amazing author Dr. Pozo-Rosich! doi:10.1177/03331024251387721 "Early treatment in #migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society" @IHS_official @NinaRiggins
www.youtube.com/watch?v=jhILO5K04wU -
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The results show that cannabidiol (CBD) and tetrahydrocannabinol (THC) can prevent both photophobia (light aversion) and pain (squint) caused by a centrally acting migraine trigger in mice. This further supports the likelihood that cannabinoids could be effective therapeutics.
journals.sagepub.com/doi/10.1177/03331024251392103
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study of 100 consecutive patients who attended a tertiary headache clinic in Australia found significant delays between time of migraine symptom onset and receiving a formal diagnosis of migraine as well as preventive treatment.
journals.sagepub.com/doi/10.1177/25158163251398869
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Existing results show the potential to predict migraine attacks and improve the quality of life of those with migraine.
journals.sagepub.com/doi/10.1177/03331024251391207
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Vestibular migraine is a frequent cause of vertigo with limited acute treatment options. This study reports a patient who experienced relief from lasmiditan, highlighting its potential as a novel therapeutic approach.
journals.sagepub.com/doi/10.1177/25158163251397366
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Prof. Sait Ashina, the newly elected Honorary Secretary of IHS, offers a message to our members and the global headache community. 🎉
-
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Headache care in Africa: The IHS Regional Outreach Program trains non-physician clinicians to diagnose & manage headaches in Malawi. A scalable model supporting WHO IGAP goals & health equity through global-local partnerships. #globalhealth
journals.sagepub.com/doi/10.1177/25158163251396915
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 The Migraine Trust Webinar
Join The Migraine Trust and Claremont as they present new research on how gender, ethnicity, and social grade shape the migraine experience.
Chaired by Rob Music, CEO of The Migraine Trust, the webinar features Phillipa Williams on key findings, Abigail sharing her lived experience, and a Q&A panel with Dr. Niranjanan Nirmalananthan and Kate Sanger.
Find out more and sign up here: events.teams.microsoft.com/event/53205b5a-95db-47f9-a223-… -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The Committee plans to consider further whether the terms “medication overuse” and “medication-overuse headache” are pejorative and if there are better terms to be used in the ICHD-4.
journals.sagepub.com/doi/10.1177/03331024251391371
#migraine #headache #brain #pain #neurology #neuroscience
@schwedtt -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
This study embedded a neurology clinic offering headache services within a primary care clinic treating an underserved populations. The study reports on access, diagnoses and prescriptions of migraine-specific medications over three years.
journals.sagepub.com/doi/10.1177/25158163251391825
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
An estimated 4.9-5.9% of all time in Pakistan is spent with headache leading to substantial productivity loss. According to this data almost one third of the Pakistani would be expected to benefit from professional headache care.
journals.sagepub.com/doi/10.1177/03331024251386101
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
[IHS Announcement] Honorary Secretary Elected
The International Headache Society is pleased to confirm the election of Dr. Sait Ashina as the IHS's new Honorary Secretary. We extend our congratulations as he takes on this distinguished role! -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In 100 patients with refractory migraine, 66% remained on anti-CGRP monoclonal antibodies after 3 years. Switching or temporary discontinuation improved persistence, supporting individualized treatment strategies.
journals.sagepub.com/doi/10.1177/25158163251388920
#migraine #headache #brain #pain #neurology #neuroscience
@taniagarri -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A correction to International guidelines on the pharmacological treatment of migraine will soon come thanks to the report of drs. Tfelt-Hansen and Hougaard.
journals.sagepub.com/doi/10.1177/03331024251393936
#migraine #headache #brain #pain #neurology #neuroscience
@RaffaeleOrnello
@Simona_Sacco -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Suggested implementation: When the full evidence is included and accurately tabulated, the recommendation for nasal zolmitriptan 5 mg warrants a change from “suggest against” to “recommend for” acute treatment of migraine attacks, with “high quality of evidence” and “strong strength of the recommendation”.
journals.sagepub.com/doi/10.1177/03331024251393937
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
頭痛教育の効果をこれだけの規模の前向き研究で示したのは初めてではないでしょうか、、🤔
素晴らしいですね。
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Regular patient education every two weeks by a trained medical doctor using a WHO-recommended educational material, along with the standard of care, improved quality of life, disability, and headache impact in chronic migraine patients.
journals.sagepub.com/doi/10.1177/25158163251391185
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The latest estimates of the Global Burden of Disease (GBD) study are now
published. Headache disorders once again rank among the top causes of healthloss quantified as years lived with disability (YLDs).
journals.sagepub.com/doi/10.1177/03331024251392884
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
New IHS practice guidelines: First evidence-based recommendations for non-invasive neuromodulation devices in migraine! #migraine #neuromodulation
journals.sagepub.com/doi/10.1177/03331024251388377
@JHCDrScott @Simona_Sacco_ @ppozorosich @rj_rigmor @MessoudAshina
@daviddodick -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Cannabinoid compounds may represent safe and effective alternatives for the treatment of episodic and chronic #migraine.
journals.sagepub.com/doi/10.1177/03331024251386794
#migraine #headache #brain #pain #neurology #neuroscience
@labdororofacial -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
International Classification of Orofacial Pain (ICOP) – Towards version 2.0: Update of the comprehensive classification system for orofacial pain
journals.sagepub.com/doi/10.1177/03331024251393111
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
BibliotecaHUVH
@BibliotecaHUVH
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic #migraine in adults with a history of inadequate response... journals.sagepub.com/doi/10.1177/03331024251391378 #hvhebron #neuro [Text complet] @JCephalalgia
-
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
New Australian data reveal significant delays in the diagnosis and treatment of migraine, emphasising the need for timely intervention in headache care.
journals.sagepub.com/doi/10.1177/25158163251398869
#migraine #headache #neurology -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Higher Selenium levels are associated with a lower risk of migraine. Sex-specific effects showed reduced risk of migraine without aura in men and chronic migraine in female. #elsa_brasil @usponline
journals.sagepub.com/doi/10.1177/03331024251386768
#migraine #headache #brain #pain #neurology #neuroscience
@Arao_B_Oliveira -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Men showed a later headache onset with a higher risk of secondary headaches, were less likely to be diagnosed or treated, and had a higher prevalence of trigeminal autonomic cephalalgias.
journals.sagepub.com/doi/10.1177/25158163251390417
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
「単純ヘルペスウイルスが片頭痛に関連するかも?」
HSV-1は三叉神経節に潜伏し、中枢神経にサブクリニカルな炎症や神経過敏性を引き起こす可能性があるとのことです📝
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
For millions of people with migraine, new hope may be on the horizon. This study uncovered an association between the herpes simplex virus and migraine headaches. This research might open a door to developing innovative new treatments.
journals.sagepub.com/doi/10.1177/25158163251391285
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
[IHS Webinar]
The Latest Research on Headaches in Children and Adolescents
Join us this Friday, November 21, 2025
CET 15:30 | GMT 14:30 | EST 09:30
Hear the latest updates in pediatric and adolescent headache research from leading investigators supported by the IHS Child and Adolescent Committee.
For registration, please go to: us02web.zoom.us/webinar/register/WN_HNGuL7K1QXKvncph3b49nA
#ihs #webinar #child #adolescence #headache_research -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This review explores how monogenic disorders contribute to our understanding of migraine mechanisms. By analyzing key genes and clinical phenotypes, this study highlights potential therapeutic targets and new directions for precision medicine.
journals.sagepub.com/doi/10.1177/03331024251389241
#migraine #headache #brain #pain #neurology #neuroscience
@Davide_Masca -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
For millions of people with migraine, new hope may be on the horizon. This study uncovered an association between the herpes simplex virus and migraine headaches. This research might open a door to developing innovative new treatments.
journals.sagepub.com/doi/10.1177/25158163251391285
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Dr Faraidoon Haghdoost, Social Media Editor for Cephalalgia and Cephalalgia Reports, talks about the new paper titled “International Headache Society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine”. The guidelines summarise evidence from 15 randomised controlled trials on devices such as SAVI Dual, Cefaly, Relivion, Nerivio, and gammaCore Sapphire, highlighting their safety, tolerability, and growing role as alternatives or additions to traditional drug treatments. The authors note that while the results are promising, the quality of evidence varies and more research is needed.
journals.sagepub.com/doi/10.1177/03331024251388377
#migraine #headache #neurologyThis media couldn't be displayed. See it on the original post. -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Regular patient education every two weeks by a trained medical doctor using a WHO-recommended educational material, along with the standard of care, improved quality of life, disability, and headache impact in chronic migraine patients.
journals.sagepub.com/doi/10.1177/25158163251391185
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
IHS proposes a new #migraine preventive strategy based on the early initiation of effective and tolerable preventive therapies. According to current clinical data, early treatment improves patient outcomes.
journals.sagepub.com/doi/10.1177/03331024251387721
#headache #brain #pain #neurology #neuroscience
@ppozorosich -
Cephalalgia
@JCephalalgia
Do you know ICHD-3 also includes external-traction headache?
Formerly called 'ponytail headache,' it occurs when sustained traction on the scalp’s pericranial soft tissues provokes pain despite leaving the skin unharmed.
If you want to know more, go to: ichd-3.org/other-primary-headache-disorders/4-6-external-…
#ichd33matters #ponytail #headache -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Neck pain can be a trigger, symptom, or comorbidity in #migraine and is frequently misdiagnosed. This review outlines a framework for accurate assessment and treatment using both pharmacological and non-pharmacological approaches.
journals.sagepub.com/doi/10.1177/03331024251387449
#headache #brain #pain #neurology #neuroscience
@TaylaARees -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Study on 100 pediatric primary headache patients: 17% had obsessive-compulsive symptoms, more frequent in females and with neurovegetative symptoms. Routine screening is recommended.
journals.sagepub.com/doi/10.1177/25158163251391144
#migraine #headache #brain #pain #neurology #neuroscience
@martinagna8 -
Cephalalgia
@JCephalalgia
This video, presented by Dr Faraidoon Haghdoost, Social Media Editor of Cephalalgia, discusses the paper titled: Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society.
The message is clear: migraine prevention should begin early, long before disability becomes severe. By shifting from reacting to attacks toward protecting long-term brain health, early preventive treatment can improve quality of life and potentially change the natural course of migraine.
Paper link: journals.sagepub.com/doi/10.1177/03331024251387721
#migraine #headache #brainhealth #cephalalgia #internationalheadachesociety #earlyintervention #neurologyThis media couldn't be displayed. See it on the original post. -
Cephalalgia
@JCephalalgia
Please watch a great Interview with @JCephalalgia Reviewers Academy Graduate Dr Vaghi. Editor's @Simona_Sacco_ an amazing initiative & program! @IHS_Official @NinaRiggins
www.youtube.com/watch?v=EKkLuSJ7ppE -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This letter proposes specific and actionable recommendations for the forthcoming ICHD-4 to better align it with ICOP criteria for orofacial trigeminal autonomic cephalalgias and migraine.
journals.sagepub.com/doi/10.1177/03331024251391751
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
All late-breaking abstracts from the 22nd International Headache Congress (IHC 2025) have been published in Cephalalgia.
Check the link below to access. the abstracts
journals.sagepub.com/toc/cepa/45/1_suppl
#ihc2025 #cephalalgia2025 #migraine #headache #conference -
Cephalalgia reposted
MariaCarmela Pera
@MariMarionNani
When pain meets obsession: Investigating the association between headache and obsessive-compulsive symptoms in a pediatric cohort journals.sagepub.com/doi/10.1177/25158163251391144
Studio di correlazione tra #cefaleainfantile e #disturboossessivocompulsivo -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
@JCephalalgia fantastic Editor’s @Simona_Sacco_ Choice Article! Interview with author Dr Sen. Introducing a risk score for predicting ischemic stroke in migraine with or without visual aura. Cephalalgia 2025;45(10). doi:10.1177/03331024251388094 @NinaRiggins
-
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
BibliotecaHUVH
@BibliotecaHUVH
International Classification of #headache Disorders 4: Classification committee comments on differentiating primary from secondary headache and recognizing "medication overuse" journals.sagepub.com/doi/10.1177/03331024251391371 #hvhebron #neuro [Text complet] @JCephalalgia
-
Cephalalgia
@JCephalalgia
@JCephalalgia Editor’s @Simona_Sacco_ Recognition #essential Reading Article. Video Program Episode with a fantastic author @Ozge.Aynur #headache care from childhood to adulthood! A position paper of the IHS Child and Adolescent Committee. Özge A, Valeriani M, Guidetti V, et al. Cephalalgia 2025;45(9). doi:10.1177/03331024251374686 @Simona.Sacco_ @HeadacheSpecialistNinaRiggins
www.youtube.com/watch?v=dFoGvc-5fgc -
Cephalalgia
@JCephalalgia
@JCephalalgia Editor’s @Simona_Sacco_ Recognition #essential Reading Article! Please watch our Video Program Episode @NinaRiggins with Dr. Yuan and Dr. Orr @ihs_official #guidelines #neuromodulation #migraine. Yuan H, Orr SL, Al-Karagholi MAM, et al. Cephalalgia 2025;45(10). doi:10.1177/03331024251388377
www.youtube.com/watch?v=elJdv30AJGg -
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia reposted
BarrowNeurological
@BarrowNeuro
Dr. Jennifer Robblee, a #neurologist in the #lewisheadachecenter at Barrow, was interviewed by @Medscape @MedscapeNeuro about newly proposed international consensus criteria for refractory #migraine published in @JCephalalgia. Watch here: bar.rw/definingheadache
-
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Introducing a risk score for predicting ischemic stroke in migraine with or without visual aura” which has been selected as the Editor’s Choice for the October issue of Cephalalgia. @Simona_Sacco_
..................................................
New migraine associated risk of stroke score (MARS+) predicts stroke risk in migraine patients! Study of 1,485 people found that those with a score ≥5 have 4x higher stroke risk. The first tool made specifically for patients with migraine.
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/03331024251388094 -
Cephalalgia
@JCephalalgia
New In Cephalalgia!
New migraine associated risk of stroke score (MARS+) predicts stroke risk in migraine patients! Study of 1,485 people found that those with a score ≥5 have 4x higher stroke risk. The first tool made specifically for patients with migraine.
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/03331024251388094 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study evaluates ChatGPT-4o's accuracy on migraine-related topics, comparing its responses to medical literature. While generally reliable, the AI showed conceptual errors and false citations, highlighting the need for expert oversight
journals.sagepub.com/doi/10.1177/03331024251387684
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
🔬 New study protocol: Investigating how cilostazol triggers migraine in men vs. women with migraine without aura. Exploring sex differences in cAMP pathways to improve personalized treatments.
journals.sagepub.com/doi/10.1177/25158163251388611
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Children and adolescents with migraine demonstrate cervical musculoskeletal impairments (neck pain, reduced cervical mobility—especially in lateral flexion and upper cervical rotation—and heightened sensitivity) in craniocervical muscles.
journals.sagepub.com/doi/10.1177/03331024251387033
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Whole-body resistance exercise was shown to reduce attack frequency and intensity of migraine, but there was little evidence. For patients seeking non-pharmacological approaches, this provides a potential complimentary option.
journals.sagepub.com/doi/10.1177/25158163251383149
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Karlee
@karleeburns_atc
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Collegiate student athletes with a history of migraine performed worse on visual-motor tasks than their peers without migraine history.
journals.sagepub.com/doi/10.1177/25158163251378621
#migraine #headache #brain #pain #neurology #neuroscience
@Karleeburns_atc -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study showed a pattern of increasing migraine-related disability with rising headache frequency.
The results also suggest that high-frequency episodic migraine (8-14 monthly headache days) is a severely disabling migraine subtype.
journals.sagepub.com/doi/10.1177/03331024251385965
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In 328 new daily persistent headache patients, white matter hyperintensities were seen in ~20%. Acute and preventive treatments were largely ineffective. Desvenlafaxine (54.6%) and venlafaxine (25%) were the best preventives for migraine and tension-type phenotypes, respectively.
journals.sagepub.com/doi/10.1177/25158163251386409
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study confirms the gradual decrease of standard preventive treatments during anti-CGRP therapy. A comorbid condition maintained the concomitant standard preventive treatments after 1 year of treatment.
journals.sagepub.com/doi/10.1177/03331024251378776
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Collegiate student athletes with a history of migraine performed worse on visual-motor tasks than their peers without migraine history.
journals.sagepub.com/doi/10.1177/25158163251378621
#migraine #headache #brain #pain #neurology #neuroscience
@Karleeburns_atc -
Cephalalgia
@JCephalalgia
✅ The answer to this week’s Sunday Quiz is B! 🎯
According to the ICHD-3, Primary stabbing headache consists of brief, spontaneous stabs of head pain—each lasting only seconds—recurring irregularly from one to many times per day, WITHOUT cranial autonomic symptoms.
#headacheknowledge #ichd3 #primarystabbingheadache #mededucation -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Greater occipital nerve block improved acute migraine pain and 30-day outcomes in a randomized trial conducted in emergency care.
journals.sagepub.com/doi/10.1177/03331024251381764
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Elena RuizdelaTorre
@ElenaEMHA
@ElenaEMHA @EMHAlliance @marsotordlt
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study uses Magnetoencephalography (MEG) and graph theory to reveal frequency-specific network disruptions in Tension-type headache (TTH), highlighting altered connectivity and topology in pain-related brain regions, offering insights for diagnosis and therapeutic strategies.
journals.sagepub.com/doi/10.1177/03331024251386425
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We’re delighted to share that the paper “Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
journals.sagepub.com/doi/10.1177/03331024251387721
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Rimegepant 75 mg administered PRN for up to 52 weeks demonstrated a favorable safety profile and was well-tolerated.
journals.sagepub.com/doi/10.1177/03331024251371686
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Have you ever wondered what ‘migraine’ is called in other languages, like Arabic? Interestingly, in Arabic, there are two common synonyms for migraine: al-shaqiqah and ṣudā‘ niṣfī. To learn more, check out this paper!
journals.sagepub.com/doi/10.1177/25158163251379885
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Greater occipital nerve injection in combination with standard verapamil treatment provides faster reduction in attack frequency than verapamil alone and decreases the adverse events over the first 4 weeks after injection.
journals.sagepub.com/doi/10.1177/03331024251370324
#migraine #headache #brain #pain #neurology #neuroscience
@clusterhoofdpijn_leiden -
Cephalalgia
@JCephalalgia
We’re delighted to share that the paper “International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine”, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution.
journals.sagepub.com/doi/10.1177/03331024251388377
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The phase 3, randomized, double-blind, placebo-controlled SUNRISE trial evaluated eptinezumab 100 mg, 300 mg, or placebo for prevention of chronic migraine among a predominantly Asian population.
Eptinezumab demonstrated statistically significant greater reductions in monthly migraine days compared with placebo.
journals.sagepub.com/doi/10.1177/03331024251386095
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Real-world study shows that the external combined occipital and trigeminal neurostimulation (eCOT-NS) neurostimulation device reduces monthly headache days over three months, especially with higher adherence, but larger confirmatory studies are needed.
journals.sagepub.com/doi/10.1177/25158163251377996
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Classification research is emerging as an important avenue of headache research. It has a multitude of different designs available and many of them do not need advanced equipment.
The international headache classification ICHD has developed significantly from edition to edition. Even after ICHD-3 a lot remains, however, to be studied.
journals.sagepub.com/doi/10.1177/03331024251377753
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Headaches are disabling, overlooked, and untreated in the armed forces. This study of 900+ German soldiers shows an urgent need for structured headache care in military settings. #migrainecare #cephalalgia #headacheawareness
journals.sagepub.com/doi/10.1177/03331024251374310
#migraine #headache #brain #pain #neurology #neuroscience
@HartmutGobel
@Schmerzklinik1 -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
The Chordate System S020 delivers kinetic oscillation to the nasal mucosa, which is supposed to modulate the parasympathetic outflow
Treatment with the Chordate System S020 had no statistically significant effect on acute migraine headache relief.
journals.sagepub.com/doi/10.1177/25158163251377699
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Transcranial magnetic stimulation of the dorsolateral prefrontal cortex could be a non-pharmacological treatment option for chronic migraine patients refractory to monoclonal antibodies against CGRP.
journals.sagepub.com/doi/10.1177/03331024251364843
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The importance of treating migraine attacks early – even in youth: A real-world argument for neuromodulation
journals.sagepub.com/doi/10.1177/03331024251370675
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The PRECLUDE trial demonstrated that onabotA was well tolerated but did not show significant efficacy compared to placebo for the endpoint reducing migraine days from baseline in patients with episodic migraine (EM).
The discrepancy in results between the PREEMPT chronic migraine (CM) trials and the PRECLUDE EM trial highlights the complexity and variability in migraine pathophysiology between CM and EM and the challenges in managing the different subtypes of migraine.
journals.sagepub.com/doi/10.1177/03331024251370769
#migraine #headache #brain #pain #neurology #neuroscience
@ppozorosich -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Data from 55,261 patients and 586,981 treatments shows that treating within 1-hour of migraine onset with Remote Electrical Neuromodulation (REN) doubles pain-freedom rates, emphasizing the importance of “treat as early as possible”.
journals.sagepub.com/doi/10.1177/03331024251370696
#migraine #headache #brain #pain #neurology #neuroscience
@Theranica and @NerivioMigraine -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Qualitative interviews with uncontrolled headache patients offers valuable insights for systems-level care.
journals.sagepub.com/doi/10.1177/25158163251378644
#migraine #headache #brain #pain #neurology #neuroscience
@justin.kosman -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to cortical spreading depression and decreases their number in female mice. OnabotA may have a non-neuronal mechanism of action in migraine.
journals.sagepub.com/doi/10.1177/03331024251378730
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
An international consensus using the Delphi method led to the development of 4 proposed definitions of refractory migraine: refractory migraine, probable refractory migraine, resistant migraine, and treatment-responsive migraine.
journals.sagepub.com/doi/10.1177/03331024251367767
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
OnaBTX-A offers a promising option for managing post-traumatic headaches, particularly in cases involving temporalis muscle hypertrophy.
journals.sagepub.com/doi/10.1177/25158163251376557
#migraine #headache #brain #pain #neurology #neuroscience
@HanySaeid9 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Atogepant treatment demonstrated statistically significant and clinically meaningful reductions in mean monthly migraine days compared with placebo across the 12-week double-blind treatment period in Japanese participants with episodic migraine.
journals.sagepub.com/doi/10.1177/03331024251374569
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Visual Snow Syndrome represents a distinct neurological disorder, not just a migraine or aura variant. New review shows unique brain network changes and calls for targeted treatments.
journals.sagepub.com/doi/10.1177/03331024251365908
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Neuroimaging evidence suggests that, although migraine with aura and migraine without aura share many characteristics, there are differences in functional connectivity, brain activity, and some structural parameters that may contribute to the different clinical manifestations.
journals.sagepub.com/doi/10.1177/03331024251365807
#migraine #headache #brain #pain #neurology #neuroscience
@F_Casillo -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Letter to the Editor
It's not either-or: Why migraine care needs both real-world evidence studies and randomized controlled trials
journals.sagepub.com/doi/10.1177/03331024251381337
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Letter to the Editor
Complementary, but not equivalent: Clarifying the role of real-world evidence and randomized controlled trials in migraine research.
journals.sagepub.com/doi/10.1177/03331024251381333
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Looking both ways: understanding the future of cluster headache.
In this insightful Cephalalgia editorial, authors reflect on the new prospective study by Lee et al., which reveals that the disease activity of episodic cluster headache tends to rise after onset and later decline over time — offering patients and clinicians a clearer view of what lies ahead.
journals.sagepub.com/doi/10.1177/03331024251368258
#cephalalgia #clusterheadache #headacheresearch #ihs #editorial -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine is increasingly understood as a brain network dysfunction, where altered connectivity, cortical hyperexcitability, and sensory hypersensitivity contribute to its associated cognitive impairment.
journals.sagepub.com/doi/10.1177/03331024251368328
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
New data on the prognosis of cluster headache (CH) have been released, including subtype shift, incidence rate of primary chronic CH, and relapse rate of bouts, based on a prospective observation of 295 patients with CH.
journals.sagepub.com/doi/10.1177/03331024251368259
#clusterheadache #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The optimization of the management of migraine and temporomandibular disorders (TMDs) when they are comorbid requires the integrated care of medicine and dentistry, where the dental discipline and specialty of orofacial pain is the meeting point.
journals.sagepub.com/doi/10.1177/03331024251368882
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Generative AI chatbots can transform headache care by tackling major gaps in education and research. With targeted innovation and strong evaluation, they hold real promise to revolutionize how we understand and manage #headache #ai
journals.sagepub.com/doi/10.1177/03331024251372117
#migraine #brain #pain #neurology #neuroscience
@alejandro_labas, @RbEloisa -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The impact of psychiatric comorbidities in children and adolescents with headache disorders is better understood through a biopsychosocial perspective, underscoring the critical role of resilience and executive function.
journals.sagepub.com/doi/10.1177/03331024251364204
#migraine #headache #brain #pain #neurology #neuroscience
@dr.marcoarruda -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Migraine burden in the Middle East is an emerging public health focus.
•
In Gulf Cooperation Council (GCC) countries, patients with migraine are managed by a network of healthcare professionals composed of three levels: primary care physicians, general neurology clinics, and headache clinics.
•
To improve the care of migraine patients, we should improve patient education and awareness of migraine, improve the education of general practitioners, increase the number of headache specialists and specialized headache clinics, and improve the role of nurses in caring for migraine patients.
•
Most GCC countries have access to a broad spectrum of migraine medications, including simple pain relief in addition to prescription drugs like triptans, BoNT-A injections, and monoclonal antibodies.
journals.sagepub.com/doi/10.1177/25158163251374141
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This review synthesizes the latest preclinical findings comparing PACAP and CGRP in migraine models, highlighting both shared and divergent pathways in their roles as neuropeptide modulators.
journals.sagepub.com/doi/10.1177/03331024251364242
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We’re delighted to share that the paper “Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care”, a position paper of the IHS Child and Adolescent Committee, has been selected as essential reading by our Editor-in-Chief, Simona Sacco!
Congratulations to all authors and collaborators on this important contribution, which highlights the need for coordinated, patient-centred models of care to support young people transitioning from paediatric to adult headache services.
journals.sagepub.com/doi/full/10.1177/03331024251374686
#cephalalgia #headacheresearch #ihs #childandadolescentcommittee #essentialreading
@Simona_Sacco_
@aynurozge1 -
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
How can we ensure young people with headache disorders don’t fall through the cracks as they grow? This new position paper by the IHS Child & Adolescent Committee explores models, gaps, and solutions in the transition of care.
doi.org/10.1177/03331024251374686
#migraine #headache #brain #pain #neurology #neuroscience
@aynurozge -
Cephalalgia
@JCephalalgia
new in cephalalgia reports!
Despite strong empirical support and endorsement by professional practice organizations, behavioral interventions are not widely accessible to headache patients. Telemedicine-based cognitive behavioral therapy (TENACITY) tests a cognitive behavioral therapy for headache delivery model.
doi.org/10.1177/25158163251374156
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine auras are often followed by headache and sometimes not. Sometimes headaches occur shortly after the aura starts. How should we think about it, and what is going on in the brain?
doi.org/10.1177/03331024251370629
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Probable medication overuse headache was seen in 16% of Danish cluster headache sufferers. It was associated with concurrent migraine, chronic cluster headache, and a worse effect of acute and preventive treatment.
doi.org/10.1177/03331024251364241
#migraine #headache #brain #pain #neurology #neuroscience
@nunu.lund -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine is poorly understood with significant stigma that can lead to social isolation, reduced support, and increased psychological distress.
doi.org/10.1177/03331024251368251
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
new in cephalalgia reports!
CGRP-mAbs are generally well tolerated for migraine prevention. However, this study reports a rare case of severe allergic reaction after switching agents. Further studies are needed to clarify the safety of switching CGRP-mAbs.
doi.org/10.1177/25158163251373091
#migraine #headache #brain #pain #neurology #neuroscience
@nagahakui @don_ikko19035 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Atogepant 60 mg daily demonstrated meaningful clinical benefit and good tolerability in real-world patients with treatment-resistant chronic migraine over a 24-week period. These findings extend RCT data and previous real-world settings.
doi.org/10.1177/03331024251370608
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine aura symptoms are polyhedric with hundreds of scenarios. In this study, all their variables were collected and their spectrum of presentations was explored.
The findings of this review show that migraine auras present a wide and multi-faceted spectrum of symptoms, generating hundreds of possible scenarios. Therefore, a detailed aura diary to complete during attacks will be of utmost importance to move toward a precise phenotypic classification.
doi.org/10.1177/03331024251372621
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
new in cephalalgia reports!
Migraine-related sensory hypersensitivity, such as hyperacusis, may be mediated by CGRP pathways, supporting a shared pathophysiological mechanism.
doi.org/10.1177/25158163251373059
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Transient receptor potential vanilloid 2 (TRPV2) promotes NLRP3 inflammasome activation and microglial M1 polarization in vestibular migraine. Blocking TRPV2 reduces neuroinflammation and central sensitization, highlighting it as a potential therapeutic target for VM.
journals.sagepub.com/doi/10.1177/03331024251364753
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
High migraine prevalence may not reflect the unchecked perpetuation of a flawed human genome but rather a feature of societies that evolved to prioritize inclusion, interdependence, and cognitive labor.
doi.org/10.1177/03331024251374315
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
new in cephalalgia reports!
A Systematic Review of Case Reports and Case Series" explores the effectiveness of Botulinum Toxin A (BoNT-A) in managing post-craniotomy headaches (PCH).
doi.org/10.1177/25158163251371150
#migraine #headache #brain #pain #neurology #neuroscience
@HanySaeid9 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Non-invasive stimulation of the vagus nerve is a well-tolerated and should be considered early in the preventive treatment of trigeminal autonomic cephalalgias.
doi.org/10.1177/03331024251370339
#cluster #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Non-invasive neuromodulation, especially vagus nerve stimulation, is a key therapeutic option in cluster headache and other TACs. Its role deserves greater recognition in clinical practice.doi.org/10.1177/03331024251370318
#cluster #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
As the full moon shines bright, may it bring you joy, reunion, and good health. Warm wishes from the International Headache Society this Mid-Autumn Festival! 🌕✨
#midautumnfestival #headache -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
A substantial overlap between commonly reported migraine triggers and premonitory symptom were found in this study. These finding suggests that some trigger factors might potentially be early warning signs or vice versa.
doi.org/10.1177/03331024251364234
@Janu_MD_ @MessoudAshina @h_ashina @hmru_cph -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The current study demonstrates altered brain structure in persistent post-traumatic headache using MRI. Changes in pain-processing brain regions similar to migraine suggest shared neurobiological mechanisms.
journals.sagepub.com/doi/10.1177/03331024251362830
#migraine #headache #brain #pain #neurology #neuroscience
@RuneHaeckert @MessoudAshina @h_ashina -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
How safe and effective is atogepant as a preventive therapy for migraine? This new study reports long-term results showing consistent benefit and no alarming safety surprises — a major step forward in migraine care.
Long-term treatment with atogepant is safe, well-tolerated, and effective for the preventive treatment of migraine.
journals.sagepub.com/doi/10.1177/03331024251365206
#migraine #headache #brain #pain #neurology #neuroscience
@SaitAshina -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Exploring the role of EEG in diagnosing pediatric migraine, especially in children with a family history of migraine/epilepsy or those with aura. Learn how EEG supports diagnosis and treatment decisions for better care. #pediatricmigraine
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/25158163251371154 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine
In both phase 1 and phase 2 testing, the incidence of treatment-emergent adverse events (TEAEs), as well as the mean changes in clinical laboratory values and vital signs, were similar between groups, with no treatment-related serious adverse events (SAEs).
journals.sagepub.com/doi/10.1177/03331024251368757
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Migraine is associated with higher Work–family conflict (WFC), especially in strain-based domains, with a stronger effect in men. These findings emphasize the need for workplace and clinical strategies to support migraine patients in managing work-life balance.
journals.sagepub.com/doi/10.1177/03331024251352533
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Neurological symptoms associated with migraine change over time with fewer migraine-associated symptoms, particularly resolution of nausea and vomiting, being associated with improvement, but did not predict improvement.
journals.sagepub.com/doi/10.1177/25158163251371152
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Jes Olesen Awards for the Advancement of Headache Medicine 🧠✨
Cephalalgia is proud to launch the Jes Olesen Awards, celebrating excellence in clinical and basic science research in headache medicine. Two awards – one for Basic Science and one for Clinical Science – will honour the best original research papers, each with a €10,000 prize and the opportunity to present at a major scientific meeting.
🔹 Eligibility: First author under 45 years old, original research only, one submission per participant.
📅 Submission opens: 1 October 2025 | Closes: 28 February 2026
📖 Full guidelines: journals.sagepub.com/page/cep/call-for-papers/jo-health-a…
Funded by Professor Jes Olesen through JO Health, these awards aim to inspire and support the next generation of headache researchers worldwide.
Don’t miss this chance to showcase your work and gain international recognition! 🌍
#headacheresearch #jesolesenawards #cephalalgia #ihs -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Nerve matters: Longitudinal microstructural change in the trigeminal nerve is associated with durable pain relief after surgery for trigeminal neuralgia” which has been selected as the Editor’s Choice for the September issue of Cephalalgia.
..................................................
High resolution MRI diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia shows that specific, early, and sustained microstructural changes need to be induced in the nerve for durable long-term pain relief.
journals.sagepub.com/doi/10.1177/03331024251369827
#migraine #headache #brain #pain #neurology #neuroscience
@DrTejasSankar -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
High resolution MRI diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia shows that specific, early, and sustained microstructural changes need to be induced in the nerve for durable long-term pain relief.
journals.sagepub.com/doi/10.1177/03331024251369827
#migraine #headache #brain #pain #neurology #neuroscience
@DrTejasSankar -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Did you know cluster headache often strikes at the same time each day or season? ⏰ This new paper explores the fascinating link between our body’s circadian clock and cluster headache — opening doors to more targeted treatments and understanding. 🔍🧠
journals.sagepub.com/doi/10.1177/03331024251365858
#clusterheadache2023 #awarenessday #clusterheadache #ichd3matters #ihs
@CarmineBelinLab -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
First report of eyebrow psoriasiform lesions linked to galcanezumab in migraine treatment, resolving after switch to fremanezumab. Highlights CGRP's role in skin immunity & need for dermatological monitoring. #cgrp #migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/25158163251371684
@DrMunozVendrell @NeurologiaHUB @Patriciaa_diaz -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Chronic cluster headache meets rare disease criteria but lacks recognition. Patients face 5.7-year diagnostic delays, €20K+ costs, and limited treatments. Formal designation could improve funding and care.
journals.sagepub.com/doi/10.1177/03331024251369752
#clusterheadache #awarenessday #clusterheadache #ichd3matters #ihs -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
The opening of KATP channels activates meningeal nociceptors underlying migraine pain. These findings reveal a mechanism for migraine induction and highlight KATP channels as promising therapeutic targets.
journals.sagepub.com/doi/10.1177/03331024251359237
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
In individuals with migraine and a hypothalamic blood-brain barrier sleep improvement with fremanezumab may be independent of headache relief.
journals.sagepub.com/doi/10.1177/25158163251359611
#migraine #headache #brain #pain #neurology #neuroscience
@SaitAshina -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
片頭痛治療の次のターゲット”PACAP”🧠
日本人の生理学者である有村章先生が1989年に発見しました。
CGRP製剤では効かない患者さんへの有効な治療選択肢となる事が期待されています😌
Cephalalgia
@JCephalalgia
PACAP was found in numerous human brain regions, some of which have since been related to CNS disorders and migraine, and is related to the trigeminovascular and autonomic systems.
journals.sagepub.com/doi/10.1177/03331024251368748
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Acute confusional migraine: Proposal for inclusion in the International Classification of Headache Disorders – 4th edition (ICHD-4)
journals.sagepub.com/doi/10.1177/03331024251370305
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🧠 New study: No difference in plasma adrenomedullin (AM) between people with migraine (n=667) & healthy controls (n=147). 👉 Episodic migraine showed slightly lower AM vs controls (P=0.04). 👉 AM levels ↑ with BMI & monthly migraine days.
journals.sagepub.com/doi/10.1177/03331024251360234
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
Persistent idiopathic dentoalveolar pain (PIDAP) Insights: This study reveals reduced gray matter in the primary somatosensory cortex of PIDAP patients, linked to higher pain catastrophizing scores. This highlights central mechanisms and the need for holistic treatment approaches.
journals.sagepub.com/doi/10.1177/25158163251359643
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Reply to Wasserman et al.: Elucidating the “Triggers” versus “Maintenance” in burning mouth syndrome/oral dysaesthetic and perceptual disorder
journals.sagepub.com/doi/10.1177/03331024251369533
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
PACAP was found in numerous human brain regions, some of which have since been related to CNS disorders and migraine, and is related to the trigeminovascular and autonomic systems.
journals.sagepub.com/doi/10.1177/03331024251368748
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Please watch a fantastic @JCephalalgia @Simona_Sacco_ Editor’s Choice Article discussion with Dr Rune Häckert Christensen. Christensen RH, Strassman AM, Ashina M, et al. "Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache". Cephalalgia 2025;45(8). doi:10.1177/03331024251359237 @NinaRiggins @IHS_official @RamiBurstein
www.youtube.com/watch?v=VaBhhCZJcC0 -
Cephalalgia
@JCephalalgia
22-28 September marks Migraine Awareness Week 2025.
Migraine is far more than “just a headache.” This year, let’s work together to change that perception.
💡 Migraine means disruption
💡 Migraine means missing out
💡 Migraine means feeling let down
Join us in spreading the word and reshaping how migraine is understood. Together, we can raise awareness and support the millions worldwide living with migraine.
The video brought to you by the IHS Communication Committee and the IHS Education Committee.
#migraineawarenessweek #migraine #ihs -
Cephalalgia
@JCephalalgia
Congratulations to our Cephalalgia campaign winners at IHC2025 in São Paulo — Víctor García Ortiz and Tuğba Erdoğan! 🎉
Each winner will receive a free 1-year membership to the International Headache Society. Thank you for helping us raise visibility and strengthen our global community. 💙
#ihc2025 #cephalalgia2025 #headacheresearch -
Cephalalgia
@JCephalalgia
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia reposted
Vitoria Acar
@VitoriaAcarMD
PACAP and CGRP = parallel, non-redundant roles in migraine. Could targeting multiple neuropeptides open the door to the next generation of therapies?
Cephalalgia
@JCephalalgia
Fresh insights into migraine biology 🧠✨
PACAP versus CGRP in migraine: From mouse models to clinical translation
Presented today by Andrew F. Russo.
Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a treatment strategy targeting multiple neuropeptides — rather than just one — could unlock more effective therapies for patients.
👏 Congratulations to the authors for bridging basic science and clinical translation in such an important area!
journals.sagepub.com/doi/full/10.1177/03331024251364242
#headacheresearch #migrainescience #pacap #cgrp #ihc2025 #cephalalgia2025
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia reposted
Sait Ashina
@SaitAshina
Temporomandibular disorders (TMDs) & #migraine often overlap, amplifying burden via shared trigeminal pathways. Evidence highlights the need for multidisciplinary, integrated care. Future? Anti-CGRP therapies may target both? #dentistry #pain #tmj
shorturl.at/pwj9N -
Cephalalgia
@JCephalalgia
Cephalalgia Editorial Board Meeting during IHC2025 📚🧠
Reviewing past work and discussing exciting plans for the future. #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
🏆 Best Poster — as voted by the IHS Juniors Group!
Congratulations to Clémence Deborgies for her outstanding work on Hormonal influence on cluster headache severity in females. 👏🎉
#ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Visual snow vs. migraine aura: debate summary and novel insights into the syndrome
Visual Snow Syndrome (VSS) is a persistent visual disturbance that overlaps with migraine with aura in mechanisms like serotonergic involvement and cortical hyperexcitability — yet remains a distinct neurological disorder.
Neuroimaging and electrophysiological studies consistently reveal abnormalities in visual, salience, and attentional networks, along with glutamatergic dysregulation and impaired top-down control.
This review highlights the urgent need for research into VSS-specific network dysfunctions to guide targeted therapies.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251365908
👏 Congratulations to the authors for advancing our understanding of this fascinating syndrome!
#headacheresearch #visualsnow #migrainescience #aura #ihc2025 #cephalalgia2025 -
Cephalalgia reposted
Marta Waliszewska-Prosół
@MartaWaliszews1
Congratulations Professor Arne! 🧠🤩
Cephalalgia
@JCephalalgia
Cephalalgia Award 2025 goes to Professor Arne May for the article “Functional brainstem representations of the human trigeminal cervical complex” 🏆✨
This important work reveals a functional inter-inhibitory network between the trigeminal branches and the greater occipital nerve in healthy humans. It also shows that functional trigeminal representations intermingle perioral and periauricular facial dermatomes with individual branches of the trigeminal nerve — arranged in an onion-shaped, overlapping somatotopic pattern.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024231174862
#cephalalgia #headacheresearch #cephalalgiaaward2025 #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
Jes Olesen Award 2025 – Clinical Science 🏆
Congratulations to the authors of “Subtype shift, relapse rate, and risk factors of frequent relapse in cluster headache: a multicenter, prospective, longitudinal observation” for receiving this year’s award! 👏🎉
Key findings from this important study:
• The incidence of chronic cluster headache during prospective observation was 3.8% in patients with first-onset cluster headache (primary chronic) and 1.4% in those with a history of episodic cluster headache (secondary chronic).
• The average relapse rate of episodic cluster headache was 0.29 per person-year (95% CI = 0.27–0.32).
• In patients with episodic cluster headache, older age, longer disease duration, and first-onset cluster headache were associated with fewer relapses, while seasonal rhythmicity and increasing attack intensity across bouts were linked to more frequent relapse.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024251368259
#cephalalgia #headacheresearch #jesolesenaward2025 #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
Jes Olesen Award 2025 – Basic Science 🏆
Congratulations to the authors of “Sex Differences in Photophobic Behaviors Following Cortical Spreading Depression in Rats” for receiving this year’s award! 👏🎉
This research highlights striking sex-related differences:
• Female rats showed a more intense and prolonged photophobic response to KCl injections compared to males.
• KCl injections triggered significant light-aversion in females, while males showed no meaningful change.
• No sex differences were observed in pupil-to-iris ratios after either KCl or aCSF injections.
• Females also exhibited greater eye closure and periorbital allodynia, indicating stronger pain-related responses.
These findings shed light on the biological basis of sex differences in headache-related symptoms.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024241310550
#cephalalgia #headacheresearch #jesolesenaward2025 #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
Cephalalgia Award 2025 goes to Professor Arne May for the article “Functional brainstem representations of the human trigeminal cervical complex” 🏆✨
This important work reveals a functional inter-inhibitory network between the trigeminal branches and the greater occipital nerve in healthy humans. It also shows that functional trigeminal representations intermingle perioral and periauricular facial dermatomes with individual branches of the trigeminal nerve — arranged in an onion-shaped, overlapping somatotopic pattern.
Read the paper here:
journals.sagepub.com/doi/10.1177/03331024231174862
#cephalalgia #headacheresearch #cephalalgiaaward2025 #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
🌍 Voices from around the world echo a shared passion: “I love Cephalalgia”, “I read Cephalalgia”, “I have published in Cephalalgia”, “I review for Cephalalgia”.
On this final day of the Congress, we invite you to stop by the Cephalalgia booth and join our social media contest.
📸 Post your experience using the hashtags #ihc2025 and #cephalalgia2025 for a chance to win one year of free IHS membership.
Let’s celebrate science, community, and the future of headache research together! -
Cephalalgia
@JCephalalgia
New perspectives on migraine and the brain 🧠✨
Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction
Presented today by Raquel Gil-Gouveia.
Migraine attacks involve reversible dysfunction of cognitive and pain-processing networks, leading to transient deficits in attention, processing speed, and executive function — independent of pain intensity.
Even between attacks, disrupted connectivity and reduced cortical inhibition may contribute to subtle but persistent cognitive changes, especially in those with frequent attacks. This raises important questions about the long-term impact of migraine on cognitive health.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368328
👏 Congratulations to the authors for advancing our understanding of this crucial aspect of migraine.
#headacheresearch #migrainescience #cognitivehealth #ihc2025 #cephalalgia2025
@Gil_Gouveia_R
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🎥 Meet us at the IHS & Cephalalgia booth!
Prof. Simona Sacco, Editor-in-Chief of Cephalalgia and Cephalalgia Reports, invites all attendees to stop by the IHS booth during the Congress.
Join our social media initiative and help amplify the voice of the global headache community.
📸🎥 Take part in our posting contest: snap a photo or record a video at the booth, share it on your social media, tag the International Headache Society, and include the hashtags #ihc2025 and #cephalalgia2025.
You'll be in the running to win a free IHS membership – don’t miss this opportunity!
#ihc2025 #headachescience #cephalalgia #ihs #headachecareforall #sãoPaulo2025 #neurologycongress #globalheadachecommunity -
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Reviewing the complex relationship between circadian rhythms and cluster headache
Cluster headache shows striking circadian features — from its clock-like pattern of attacks to genetic variations in circadian genes found in some patients. Notably, at least six established cluster headache medications directly alter the core circadian molecular oscillator.
The authors propose key next steps: defining circadian attacks clinically, developing animal models to study circadian features of headache, and adapting genetic study designs to capture circadian influences.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251365858
👏 Congratulations to the authors for advancing our understanding of the intricate ties between circadian biology and cluster headache.
#headacheresearch #clusterheadache #circadianrhythms #migrainescience #ihc2025 #cephalalgia2025
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review
Presented today by Marco Antonio Arruda.
Psychiatric comorbidities have a profound impact on children and adolescents with headache disorders — worsening severity, increasing risk of chronification, and affecting quality of life, cognitive performance, and academic achievement.
Reduced resilience, greater vulnerability, and impaired executive function appear central to this impact. This review highlights the importance of routinely assessing psychiatric symptoms, resilience, executive skills, and school functioning — and calls for early interventions that could improve both psychiatric and headache outcomes.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251364204
👏 Congratulations to the authors for shedding light on this critical area for child and adolescent health.
#headacheresearch #migrainescience #childhealth #adolescenthealth #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Optimising combined treatment for migraine and temporomandibular disorders (TMDs)
Presented today by Marcela Romero-Reyes.
Effective care for patients with comorbid migraine and TMDs requires true integration across disciplines. Collaboration with a dentist specialised in orofacial pain is essential, alongside identifying shared mechanisms of sensitisation and developing multidisciplinary management protocols.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368882
👏 Congratulations to the authors for highlighting the importance of collaborative, patient-centred approaches.
#headacheresearch #migrainescience #orofacialpain #tmd #ihc2025 #cephalalgia2025 -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Just presented at IHC2025 and just published in @JCephalalgia
Cephalalgia
@JCephalalgia
New perspectives on migraine and the brain 🧠✨
Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction
Presented today by Raquel Gil-Gouveia.
Migraine attacks involve reversible dysfunction of cognitive and pain-processing networks, leading to transient deficits in attention, processing speed, and executive function — independent of pain intensity.
Even between attacks, disrupted connectivity and reduced cortical inhibition may contribute to subtle but persistent cognitive changes, especially in those with frequent attacks. This raises important questions about the long-term impact of migraine on cognitive health.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368328
👏 Congratulations to the authors for advancing our understanding of this crucial aspect of migraine.
#headacheresearch #migrainescience #cognitivehealth #ihc2025 #cephalalgia2025
@Gil_Gouveia_R
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Professor Simona Sacco (Editor-in-Chief, Cephalalgia and Cephalalgia Reports), Wendy Krank (Managing Editor), and Dr Faraidoon Haghdoost (Social Media Editor) are inviting all Congress participants to visit the IHS/Cephalalgia stand!
📸🎥 Join the posting contest: take a photo or video, share on your social media, tag the International Headache Society, and use #ihc2025 and #cephalalgia2025 for your chance to win a free IHS membership. Don’t miss it! -
Cephalalgia
@JCephalalgia
New perspectives on migraine and the brain 🧠✨
Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction
Presented today by Raquel Gil-Gouveia.
Migraine attacks involve reversible dysfunction of cognitive and pain-processing networks, leading to transient deficits in attention, processing speed, and executive function — independent of pain intensity.
Even between attacks, disrupted connectivity and reduced cortical inhibition may contribute to subtle but persistent cognitive changes, especially in those with frequent attacks. This raises important questions about the long-term impact of migraine on cognitive health.
📄 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251368328
👏 Congratulations to the authors for advancing our understanding of this crucial aspect of migraine.
#headacheresearch #migrainescience #cognitivehealth #ihc2025 #cephalalgia2025
@Gil_Gouveia_R
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Visit the Cephalalgia stand at IHC 2025!
🎥📸 Take a photo or record a short video, tag the International Headache Society, and use both hashtags #ihc2025 and #cephalalgia2025.
By sharing on your social networks, you’ll have the chance to win an IHS membership. Don’t miss it! -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Presented today, published today at ICH 2025 @JCephalalgia @ihs_official #ihc2025 #cephalalgia2025
Cephalalgia
@JCephalalgia
Fresh insights into migraine biology 🧠✨
PACAP versus CGRP in migraine: From mouse models to clinical translation
Presented today by Andrew F. Russo.
Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a treatment strategy targeting multiple neuropeptides — rather than just one — could unlock more effective therapies for patients.
👏 Congratulations to the authors for bridging basic science and clinical translation in such an important area!
journals.sagepub.com/doi/full/10.1177/03331024251364242
#headacheresearch #migrainescience #pacap #cgrp #ihc2025 #cephalalgia2025
@Simona_Sacco_ -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Hot off the stage & Hot off the press at #ihc2025 @JCephalalgia #cephalalgia2025 @ihs_official
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Decoding PACAP signaling: Splice variants, pathways, and designer drugs
Presented today and published today — a milestone in migraine research! PACAP and VIP neuropeptides are key players in migraine, with exciting implications for receptor diversity, novel signaling pathways, and future drug design.
👏 Congratulations to the authors for advancing our understanding of these crucial mechanisms!
journals.sagepub.com/doi/10.1177/03331024251363560
#headacheresearch #migrainescience #pacap #vip #ihc2025 #cephalalgia2025
@debbie_hay
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Fresh insights into migraine biology 🧠✨
PACAP versus CGRP in migraine: From mouse models to clinical translation
Presented today by Andrew F. Russo.
Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a treatment strategy targeting multiple neuropeptides — rather than just one — could unlock more effective therapies for patients.
👏 Congratulations to the authors for bridging basic science and clinical translation in such an important area!
journals.sagepub.com/doi/full/10.1177/03331024251364242
#headacheresearch #migrainescience #pacap #cgrp #ihc2025 #cephalalgia2025
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Fresh insights into migraine biology 🧠✨
PACAP versus CGRP in migraine: From mouse models to clinical translation
Presented today by Andrew F. Russo.
Preclinical and clinical evidence shows PACAP and CGRP act as parallel, non-redundant migraine triggers. This suggests that a treatment strategy targeting multiple neuropeptides — rather than just one — could unlock more effective therapies for patients.
👏 Congratulations to the authors for bridging basic science and clinical translation in such an important area!
journals.sagepub.com/doi/full/10.1177/03331024251364242
#headacheresearch #migrainescience #pacap #cgrp #ihc2025 #cephalalgia2025
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Decoding PACAP signaling: Splice variants, pathways, and designer drugs
Presented today and published today — a milestone in migraine research! PACAP and VIP neuropeptides are key players in migraine, with exciting implications for receptor diversity, novel signaling pathways, and future drug design.
👏 Congratulations to the authors for advancing our understanding of these crucial mechanisms!
journals.sagepub.com/doi/10.1177/03331024251363560
#headacheresearch #migrainescience #pacap #vip #ihc2025 #cephalalgia2025
@debbie_hay
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🚨 Hot off the press & hot off the stage!
Decoding PACAP signaling: Splice variants, pathways, and designer drugs
Presented today and published today — a milestone in migraine research! PACAP and VIP neuropeptides are key players in migraine, with exciting implications for receptor diversity, novel signaling pathways, and future drug design.
👏 Congratulations to the authors for advancing our understanding of these crucial mechanisms!
journals.sagepub.com/doi/10.1177/03331024251363560
#headacheresearch #migrainescience #pacap #vip #ihc2025 #cephalalgia2025
@debbie_hay
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Win a free IHS membership! 🎉 It’s simple:
📸 Take a photo with the Cephalalgia stand
📲 Post it on your social media
🏷️ Add both #ihc2025 #cephalalgia2025 -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
@ramiburstein @headacheMD #ihs2025 #brazil #cephalalgia2025 Cannot wait to the great presentations tomorrow! @ihs_official @JCephalalgia 🧠 @ahsheadache @WNGtweets @AANmember @miles4migraine 🧠👏
-
Cephalalgia
@JCephalalgia
Win a free IHS membership! 🎉 It’s simple:
📸 Take a photo with the Cephalalgia stand
📲 Post it on your social media
🏷️ Add both #ihc2025 #cephalalgia2025
Two lucky winners will be selected after the conference! -
Cephalalgia
@JCephalalgia
Letter to the Editor!
There is growing evidence of a strong comorbid relationship between fibromyalgia and chronic migraine, with fibromyalgia diagnosed in a considerable number of chronic migraine patients.
journals.sagepub.com/doi/10.1177/03331024251360223
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache” which has been selected as the Editor’s Choice for the August issue of Cephalalgia.
..................................................
Opening of ATP-sensitive potassium channels activated meningeal nociceptors implicated in migraine and other headache disorders
•
Similar activation rates were observed for Aδ and C-fibers, as well as between male and female animals.
.................................................
journals.sagepub.com/doi/full/10.1177/03331024251359237
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina
@ramiburstein -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
✨ New Real-World Evidence
CGRP monoclonal antibodies show sustained effectiveness over 3 years of treatment.
🧑🤝🧑 The Study
179 people with migraine
Majority had chronic migraine and medication overuse
Followed across 3 consecutive one-year treatment cycles
📉 The Results
Average reduction of 12.7 monthly migraine days
Residual migraine days remained high (>8 days/month)
38.5% achieved a 50% response after 3 years
💡 What This Means
CGRP mAbs work long term
But migraine burden is still significant
More treatment options and new pathways need to be explored
journals.sagepub.com/doi/10.1177/03331024251353421
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Headaches are common in chiropractic patients, mainly tension-type and having more than one type of headache. Headache was the primary reason for consulting the chiropractor in two out of five headache consultations.
journals.sagepub.com/doi/10.1177/03331024251362126
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Analysis of 1,418 migraine patients confirms the validated e-headache diary has excellent psychometric properties for identifying migraine days, with all but one item showing outstanding discrimination.
journals.sagepub.com/doi/10.1177/03331024251359222
#migraine #headache #brain #pain #neurology #neuroscience
@HeadacheLUMC -
Cephalalgia
@JCephalalgia
Cephalalgia Editor-in-Chief, Prof. Simona Sacco, shares insights on “What Makes a Great Research Manuscript” at ANZHS 2025 in Sydney, Australia.
A good manuscript is:
•Correct
•Structured
•Publishable
A great manuscript is:
•Compelling
•Impactful
•Memorable
#anzhs2025 #migraine #headache -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Substance P has recently been shown to trigger headache and arterial dilation in humans, reinforcing its role in migraine and its potential as a therapeutic target.
journals.sagepub.com/doi/10.1177/03331024251355944
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina
@h_ashina
@RuneHackert
@HaidarAlKhazal2 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Childhood trauma is common in migraine patients and linked to more complex clinical profiles, pointing to a distinct subtype with key treatment and prognostic implications.
journals.sagepub.com/doi/10.1177/03331024251358503
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Diffusion tensor imaging may not reliably predict outcomes of microvascular decompression in patients with classical trigeminal neuralgia due to arterial compression or deformation.
journals.sagepub.com/doi/10.1177/03331024251322505
#migraine #headache #brain #pain #neurology #neuroscience
@maggietugend -
Cephalalgia
@JCephalalgia
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Discover how digital phenotyping is transforming migraine research and management! This study shows how real-time data from wearables and smartphones unveils triggers, refines diagnosis, and enables personalized treatments.
journals.sagepub.com/doi/10.1177/03331024251363568
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Consistent and even long-term treatment with Onabotulinumtoxin A is crucial for initial responders as many real world open studies have shown a cumulative effect of repeated Onabotulinumtoxin A injections.
journals.sagepub.com/doi/10.1177/03331024251363268
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia reposted
視能訓練士COますきみ
@mas_co_kimi
visual snow症候群の屈折値と、片頭痛などとの関連の論文👀✨
大変参考になります💻️
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study examined the situation of visual snow syndrome in Japan. Patients with visual snow syndrome had a high prevalence of migraine, and a possible association with anisometropia.
journals.sagepub.com/doi/10.1177/03331024251360337
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Letter to the editor!
Expanding the classification of burning mouth syndrome. It is important for the classifications to define the patients and not the other way around!
doi.org/10.1177/03331024251362822
#migraine #headache #brain #pain #neurology #neuroscience
@giladwas -
Cephalalgia reposted
BIDMC Headache Center
@bidmcheadache
Fasting during Yom Kippur, Ramadan, or other cultural/religious observances can trigger headaches, especially in people with #migraine. Dehydration, low blood sugar & caffeine withdrawal play a role. New treatments may offer better relief @JCephalalgia #fasting #headache
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This randomized open-label study conducted during Ramadan demonstrates that once-daily rimegepant 75 mg orally disintegrating tablet may be effective and well tolerated for short-term prevention of fasting-related headache.
journals.sagepub.com/doi/10.1177/03331024251355947
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
"降雪視"と片頭痛の関連について、日本人を対象とした論文が出ました📚
降雪視とはテレビの砂嵐のような点々が視える現象で、眼科の先生がよく診られるかと思います🌨️👀
片頭痛患者さんで、たまに降雪視を訴える方がいますが、閃輝暗点などの視覚前兆とは別物であることを理解しなくてはなりません🤔
(降雪視は頭痛の直前に限定されません)
日本人148人を対象とした後方視的な検討の結果📝
・降雪視の約60%が 片頭痛を経験。
・片頭痛は降雪視の独立した説明変数。
・不同視も降雪視の独立した説明変数
そして、個人的に興味深い点として…
・片頭痛の改善が降雪視の症状改善と関連していた。
片頭痛コントロールが「降雪視」改善のカギになるということでしょうか🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study examined the situation of visual snow syndrome in Japan. Patients with visual snow syndrome had a high prevalence of migraine, and a possible association with anisometropia.
journals.sagepub.com/doi/10.1177/03331024251360337
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Please watch Video Interview with Author Dr Dussor discussing @JCephalalgia Editor's Choice Article! @Simona_Sacco_ @ihs_official @ninariggins
www.youtube.com/watch?v=wmrddcmZbUY -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This randomized open-label study conducted during Ramadan demonstrates that once-daily rimegepant 75 mg orally disintegrating tablet may be effective and well tolerated for short-term prevention of fasting-related headache.
journals.sagepub.com/doi/10.1177/03331024251355947
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sait Ashina
@SaitAshina
Long-term data: Atogepant 60 mg daily showed consistent safety and sustained efficacy over 1 year in migraine prevention (CM & EM with prior treatment failures) in the PROGRESS & ELEVATE extension study #migraine #cgrp
journals.sagepub.com/doi/10.1177/03331024251365206 -
Cephalalgia reposted
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
This study examined the situation of visual snow syndrome in Japan. Patients with visual snow syndrome had a high prevalence of migraine, and a possible association with anisometropia.
journals.sagepub.com/doi/10.1177/03331024251360337
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Please watch our interview with @JCephalalgia Reviewers Academy 2024-2025 Graduate Dr Sucharita Ray. @Simona_Sacco_ @ihs_official @ninariggins Congratulations Dr Sucharita Ray!
www.youtube.com/watch?v=d5j09wCkaLM -
Cephalalgia
@JCephalalgia
@JCehalalgia Editor’s Choice @Simona_Sacco_ Video Program Episode with outstanding Dr Todd Schwedt. Longitudinal analysis of pain-induced brain activations in post-traumatic headache. Cephalalgia 2025;45(5). doi:10.1177/03331024251345160 @schwedtt @ninariggins @ihs_official
-
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia reposted
David Ezpeleta
@davidezpeleta
👇👇👇👇👇
Cephalalgia
@JCephalalgia
In this editorial from Cephalalgia, the Editor-in-Chief highlights a concerning trend: a growing number of manuscript submissions using the term “migraines”—a scientific inaccuracy likely fueled by unchecked generative AI tools
Migraine is a disease - singular, well-defined, and not to be pluralized or treated as a vague symptom.
journals.sagepub.com/doi/10.1177/03331024251365833
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
New rimegepant users are more likely to be persistent on acute treatment at one year versus new oral triptan users in a large US cohort of migraine patients.
journals.sagepub.com/doi/10.1177/03331024251352849
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
In this editorial from Cephalalgia, the Editor-in-Chief highlights a concerning trend: a growing number of manuscript submissions using the term “migraines”—a scientific inaccuracy likely fueled by unchecked generative AI tools
Migraine is a disease - singular, well-defined, and not to be pluralized or treated as a vague symptom.
journals.sagepub.com/doi/10.1177/03331024251365833
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Migraine Treatment Inequality: New Swedish Study Reveals Who Gets CGRP Access
🎥 In this video, Dr Faraidoon Haghdoost — one of our social media editors for Cephalalgia and Cephalalgia Reports — talks about a new Swedish study revealing persistent socioeconomic gaps in access to advanced migraine treatments.
📊 Out of nearly 53,000 people with migraine, only just over 3% received CGRP monoclonal antibodies — medications designed to prevent migraine attacks. Despite universal healthcare, people with higher income and education were far more likely to get these treatments, with high socioeconomic status patients being nearly 70% more likely to access them.
💡 The finding is clear: even when cost is covered, access gaps remain. We must ensure these life-changing treatments are available to everyone who needs them — not just the lucky few.
Read the full study here: journals.sagepub.com/doi/10.1177/03331024251348648
#migraine #headache #cgrp #healthcareequity #neurology #cephalalgia #publichealth
To share:
youtube.com/shorts/ji3yr-7I4jQThis media couldn't be displayed. See it on the original post. -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Nearly half of patients with epilepsy have comorbid headache. Among patients with interictal headache, comorbid migraine has the most significant influence on their psychological state and daily life.
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Why do some migraine patients experience tearing, nasal congestion, or facial flushing? This study at King’s College London found that women and those with aura are more likely to have these symptoms!
#migraine #headache #brain #pain #neurology #neuroscience
journals.sagepub.com/doi/10.1177/03331024251359564
@Lola_VillarMar
@petergoadsby -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Interactive voice response delivery of Cognitive Behavioral Therapy for Veterans with Post Traumatic Headache is feasible, acceptable, and cost-effective.
Veterans experienced significant increases in self-efficacy from pre-to-post treatment.
journals.sagepub.com/doi/10.1177/03331024251351598
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia
The ADGRL3 gene is associated with both cephalic hypersensitivity in rats and an increased migraine burden in humans.
journals.sagepub.com/doi/epub/10.1177/03331024251352844
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
【ストレス誘発片頭痛への治療の期待】
ストレスは片頭痛の強力な誘発因子😣
コルチゾールが急上昇するせいと言われています。
この研究では、強いストレスの直後にコルチゾールの阻害薬や少量のコルチゾールを用いることで、片頭痛の発症を防げる可能性が示されました📝
まだマウスでの実験ですが、コルチゾールがどのように頭痛の発症に関与するのかもっと明らかになれば、更に治療の選択肢が広がりますね🤔
Cephalalgia
@JCephalalgia
New in Cephalalgia 🧠🐭
Migraine onset often follows stress resolution, but predicting its timing is difficult. This study suggests modulating hypothalamic-pituitary-adrenal (HPA) axis and melanocortin systems post-stress as a potential treatment, with possible sex differences in the mechanisms.
journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
“The ‘migraines epidemic’” signals a deeper problem in scientific writing.
Careless use of AI tools like ChatGPT risks damaging the field.
We must embrace innovation—but never at the expense of rigor and quality.
🔗 doi.org/10.1177/03331024251365833
@JCephalalgia @ihs_official -
Cephalalgia
@JCephalalgia
🧠 New in Cephalalgia!
A pilot study of Interactive voice response delivery of Cognitive Behavioral Therapy for veterans with post-traumatic headache showed:
✔️ High acceptability and satisfaction
✔️ Improved self-efficacy
✔️ lower therapist cost vs in-person care
Veterans experienced significant increases in self-efficacy from pre-to-post treatment.
journals.sagepub.com/doi/10.1177/03331024251351598
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia
ADGRL3 gene was associated with both cephalic hypersensitivity in STA rats and an increased burden of rare variants in humans with migraine. The gene was expressed in the trigeminovascular system, a central pathophysiological component of cephalic pain. ADGRL3 provides novel insights into the pathophysiology of chronic cephalic pain in migraine.
journals.sagepub.com/doi/epub/10.1177/03331024251352844
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Post-stress modulation of the HPA and melanocortin systems alleviates migraine-like behaviors in mice” which has been selected as the Editor’s Choice for the July issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
..........................
Migraine onset often follows stress resolution, but predicting its timing is difficult. This study suggests modulating hypothalamic-pituitary-adrenal (HPA) axis and melanocortin systems post-stress as a potential treatment, with possible sex differences in the mechanisms.
journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia 🧠🐭
Migraine onset often follows stress resolution, but predicting its timing is difficult. This study suggests modulating hypothalamic-pituitary-adrenal (HPA) axis and melanocortin systems post-stress as a potential treatment, with possible sex differences in the mechanisms.
journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
ミトコンドリアに関連して、更にマニアックな頭痛の話📝
最新の論文でも取り上げられている”KATPチャネル”は、片頭痛の原因として近年注目されてきています🧐
これは、細胞内のATPが「不足」した時に開口するカリウムチャネルです。
神経細胞の興奮や血管平滑筋を弛緩させる作用があり、片頭痛を誘発します。
「片頭痛は脳のエネルギー需要に供給が追いついていない時に、KATPチャネルを介して発症する。」、、かも🤔
これまでのミトコンドリアの機能低下説が最新の研究と結びついてきていて面白いですね👏
Cephalalgia
@JCephalalgia
This new randomised controlled trial tested whether sumatriptan can stop migraine triggered by opening ATP-sensitive potassium (KATP) channels — and the results might surprise you. While sumatriptan didn't prevent the migraine attacks, it did reduce headache intensity when adjusted for baseline. This suggests KATP-induced migraine may happen downstream of where sumatriptan acts. Fascinating insights into migraine mechanisms and the limits of current treatments.
journals.sagepub.com/doi/10.1177/03331024251341464
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina @ZxZhAlice @Alkaragholi_MM @h_ashina @thienpdo -
Cephalalgia
@JCephalalgia
New in Cephalalgia 🧠✨
How does rimegepant perform in people with migraine who have never tried triptans, currently use them, or didn’t respond to them?
This study pooled data from over 3,400 patients and showed that rimegepant was well tolerated and improved patient-reported outcomes across all groups — even those who previously failed triptan treatment.
It offers new confidence for personalised treatment in real-world migraine care.
journals.sagepub.com/doi/10.1177/03331024251343309
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
This new randomised controlled trial tested whether sumatriptan can stop migraine triggered by opening ATP-sensitive potassium (KATP) channels — and the results might surprise you. While sumatriptan didn't prevent the migraine attacks, it did reduce headache intensity when adjusted for baseline. This suggests KATP-induced migraine may happen downstream of where sumatriptan acts. Fascinating insights into migraine mechanisms and the limits of current treatments.
journals.sagepub.com/doi/10.1177/03331024251341464
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina @ZxZhAlice @Alkaragholi_MM @h_ashina @thienpdo -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
Cephalalgia
@JCephalalgia
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
Cephalalgia
@JCephalalgia
Editorial for: Effect of Sumatriptan on ATP-Sensitive Potassium Channel Opening in Migraine: A randomised controlled trial [in press]
This new editorial in Cephalalgia explores the evolving science behind migraine triggering mechanisms.
journals.sagepub.com/doi/10.1177/03331024251342583
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
We are pleased to announce and congratulate the authors on their paper, “Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study” which has been selected as the Editor’s Choice for the June issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....................................
Socioeconomic disparities in access to migraine therapy persist—even in publicly funded healthcare systems.
In a population-based nested case-control study from Region Stockholm (N = 52,996), researchers examined the association between socioeconomic status (SES) and first-time dispensation of CGRP monoclonal antibodies for migraine prevention.
📉 Despite universal reimbursement policies:
Only 3.2% received CGRP inhibitors (CGRPi).
Patients with high SES had a 68% higher likelihood of CGRPi dispensation (aOR 1.68; 95% CI: 1.46–1.92).
Even middle SES conferred a significantly increased chance (aOR 1.41; 95% CI: 1.24–1.61).
➡️ Conclusion: Access to advanced migraine treatments remains unequal, with SES acting as a barrier - even where cost should not be.
journals.sagepub.com/doi/10.1177/03331024251348648
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia 🧠🐭
Can stress leave lasting biological marks that increase migraine risk — and can we reverse them?
This new animal study shows that post-stress changes in the hypothalamic-pituitary-adrenal (HPA) axis and the melanocortin system may underlie migraine-like behaviour in mice.
What’s more, modulating these systems after the stress can reduce migraine-like symptoms.
This opens the door to new research on recovery-based treatments after stress exposure.
journals.sagepub.com/doi/10.1177/03331024251352856
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia
A post-hoc analysis of a phase 2/3, open-label study of rimegepant in the acute treatment of migraine according to current and historical triptan use.
Rimegepant 75 mg administered up to once per day as PRN (52 weeks) or EOD+PRN (12 weeks) was safe and well tolerated in participants with any triptan experience, including those with multiple discontinuations.
journals.sagepub.com/doi/10.1177/03331024251343309
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia
@JCephalalgia
Sumatriptan did not prevent KATP channel opener-induced migraine but reduced headache intensity. Highlights KATP channels as key migraine targets.
journals.sagepub.com/doi/10.1177/03331024251341464
#migraine #headache #brain #pain #neurology #neuroscience
@MessoudAshina @ZxZhAlice @Alkaragholi_MM @h_ashina @thienpdo -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
How does migraine with aura (MA) alter brain structure beyond the visual cortex?
🧠 ⚡Using structural MRI and network-based analysis, this study reveals altered grey-matter (GM) network topology in MA:
➡️ Right lingual gyrus: Increased nodal degree in MA vs. healthy controls (p < 0.001, FDR = 0.018) - Identified as a network hub in MA
➡️ Covariance with pain-related regions (right posterior insula, left ventral postcentral gyrus) negatively correlated with migraine duration
🔎 Conclusion: Migraine with aura is associated with localized structural reorganization in visual and pain-processing networks, possibly reflecting disease chronicity.
🔗 Read the full article: doi.org/10.1177/03331024251353146 -
Cephalalgia
@JCephalalgia
New in Cephalalgia!
Fibromyalgia (FM) is a common comorbidity in chronic migraine (CM), but how it affects treatment response has remained unclear.
📌 This prospective, proof-of-concept study compared treatment responsiveness to flunarizine in patients with:
- Chronic migraine alone (CM)
- Chronic migraine + fibromyalgia (CMFM)
📉 Key findings:
CMFM patients had worse baseline clinical profiles, including more monthly headache days (MHDs) and higher anxiety/depression scores.
Responder rate (≥50% MHD reduction):
▪ CM: 52%
▪ CMFM: 32% (p = 0.033)
FM comorbidity tripled the odds of not converting to episodic migraine (OR: 2.8 [1.1–7.1]).
🧠 Clinical implication: Comorbid FM in CM is associated with poorer preventive treatment outcomes, despite dual-targeted therapy. Early identification and tailored management strategies are essential.
Link to the article: doi.org/10.1177/03331024251353412 -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Welcome on board to the new Fellows of the @JCephalalgia Reviewer Academy @ihs_official
Cephalalgia
@JCephalalgia
📢 We are delighted to officially welcome the 2025/2026 Cephalalgia Reviewer Academy Fellows! 🎉
These outstanding early-career researchers from around the world have been selected for their commitment to excellence in headache research and scientific publishing. Over the next year, they will be mentored by experienced editors to build their skills in peer review.
Welcome to the Cephalalgia community — we look forward to your contributions! -
Cephalalgia
@JCephalalgia
Socioeconomic disparities in access to migraine therapy persist—even in publicly funded healthcare systems.
In a population-based nested case-control study from Region Stockholm (N = 52,996), researchers examined the association between socioeconomic status (SES) and first-time dispensation of CGRP monoclonal antibodies for migraine prevention.
📉 Despite universal reimbursement policies:
Only 3.2% received CGRP inhibitors (CGRPi).
Patients with high SES had a 68% higher likelihood of CGRPi dispensation (aOR 1.68; 95% CI: 1.46–1.92).
Even middle SES conferred a significantly increased chance (aOR 1.41; 95% CI: 1.24–1.61).
➡️ Conclusion: Access to advanced migraine treatments remains unequal, with SES acting as a barrier - even where cost should not be.
🔗 Read the full open-access article in Cephalalgia: doi.org/10.1177/03331024241260540 -
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia
@JCephalalgia
New in Cephalalgia Reports!
A cross-sectional study examines real-world data from patients with cluster headache (CH) referred to a tertiary headache center.
Key findings:
✔️ 54% had chronic CH
❌ 34% lacked first-line acute therapy
❌ 55% had not received guideline-recommended preventives
🚬 Higher rates of smoking and illicit drug use vs. migraine/TTH
⏳ Faster referral compared to migraine, yet still delayed
🧠 Despite correct diagnosis in most cases, treatment remains inadequate before referral.
👉 Read the full open-access study: doi.org/10.1177/25158163251348665 -
Cephalalgia
@JCephalalgia
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports
Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin America, South Asia, the Middle East, and beyond.
We’re calling for papers that explore how migraine is diagnosed, treated, taught, and perceived around the world.
📖 Read the editorial: journals.sagepub.com/doi/10.1177/25158163251339440
#migraine #headache #brain #pain #neurology #neuroscience
@pul_fra @headacheMD @mariofpperes -
Cephalalgia reposted
International Headache Society
@ihs_official
New Research published in @Cephreports! Combined #spg and #gon blocks for patients with refractory #cluster headache @ihs_officialhttps://doi.org/10.1177/25158163251355554 @JCephalalgia @Simona_Sacco_
-
Cephalalgia
@JCephalalgia
Postprandial #lasmiditan intake may be associated with reduced side effects compared with fasting intake @Cephreports @JCephalalgia @Simona_Sacco_ @ihs_official journals.sagepub.com/doi/10.1177/25158163251355591
-
Cephalalgia
@JCephalalgia
📢 We are delighted to officially welcome the 2025/2026 Cephalalgia Reviewer Academy Fellows! 🎉
These outstanding early-career researchers from around the world have been selected for their commitment to excellence in headache research and scientific publishing. Over the next year, they will be mentored by experienced editors to build their skills in peer review.
Welcome to the Cephalalgia community — we look forward to your contributions! -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies for migraine — even with subsidies in place.
Paper: journals.sagepub.com/doi/full/10.1177/03331024251348648
Podcast: youtu.be/nTyO42b7OYI
#migraine #headache #cgrp #healthequity -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🧠 Psychedelics & Ketamine in Cluster Headache: A Case Series 🌈💊
📄 Cephalalgia Reports | doi.org/10.1177/25158163251345472
🔬 Leighton J, Lau C, Granata L, et al.
Can serotonergic psychedelics and ketamine offer relief where standard treatments fail?
This exploratory case series of 9 patients with treatment-resistant cluster headache examined compassionate-use treatment with:
✅ Psilocybin
✅ LSD
✅ Ketamine
📊 Key Findings:
▪️ All patients responded positively to at least one treatment
▪️ 8 out of 9 responded to psilocybin or LSD
▪️ Several patients experienced prolonged attack-free periods
💡 These findings add to the growing body of evidence suggesting a role for serotonergic psychedelics in CH management, and support further exploration—including controlled clinical trials—to validate efficacy and ensure safe access.
📌 Full article: doi.org/10.1177/25158163251345472
#clusterheadache #psychedelics #psilocybin #lsd #ketamine #cephalalgiareports #headachemedicine -
Cephalalgia
@JCephalalgia
💥 New Insights on Oxygen Therapy in Cluster Headache 🧠💨
High Flow vs Ultra-High Flow (Demand Valve) Oxygen Delivery: A Patient Experience Survey
📄 Cephalalgia Reports doi.org/10.1177/25158163251339439))
🔬 Goadsby PJ, Bahra A, Hobbs V et al.
A unique patient-initiated, - funded and - conducted study by OUCH-UK compares standard high flow (15 L/min) with ultra-high flow (up to 250 L/min) demand valve (DV) oxygen in treating cluster headache attacks.
📊 Key Findings (from >1,400 attacks):
▪️ Mean time to abort:
→ High Flow: 36 min
→ Ultra-High Flow DV: 11 min
▪️ Complete relief achieved:
→ High Flow: 70%
→ DV: 89%
💡 Implications: preliminary evidence that ultra high flow DV oxygen may provide faster, more effective relief but randomized controlled trials are urgently needed.
📌 An example of how patient-driven research can generate actionable hypotheses for clinical care.
#clusterheadache #oxygentherapy #cephalalgiareports #patientledresearch -
Cephalalgia
@JCephalalgia
✨🧠 New Topical Collection in Cephalalgia! ✨🧠
"Toward International Classification of Headache Disorders – 4 (ICHD-4)"
📍OPEN TO SUBMISSIONS
As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations, propose evidence-based refinements, and integrate emerging tools such as biomarkers, imaging, and digital phenotyping.
🔍 leran more: journals.sagepub.com/pb-assets/cmscontent/CEP/TOWARD INTE…
📢 Join the global effort to shape a refined and clinically relevant classification.
📝 Accepting: Original research, viewpoints, editorials, and letters
🔗 Submit your research: mc.manuscriptcentral.com/cephalalgia
#cephalalgia #ichd4 #headacheclassification #neurology #migraine #globalheadachecommunity -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🧠 New Case Report Alert 📄 in Cephalalgia Reports
Post-traumatic trigeminal injury leading to novel-onset orofacial migraine
📚 Cephalalgia Reports | doi.org/10.1177/25158163251345141
A compelling case of novel-onset orofacial migraine is described following surgical trauma to the trigeminal nerve during impacted tooth extraction. The patient, with no previous migraine history, initially diagnosed with post-traumatic trigeminal neuropathy—later evolving into migraine-like facial pain.
🔍 Why it matters
It highlights the clinical importance of differentiating post-traumatic neuropathy from emerging migraine in the orofacial region.
👉 Read the full case: doi.org/10.1177/25158163251345141
#migraine #orofacialpain #trigeminalnerve #posttraumaticpain #cephalalgiareports #headachemedicine -
Cephalalgia
@JCephalalgia
🔍 Redefining Burning Mouth Syndrome: Scientific Dialogue in Motion
We’re excited to share a dynamic scholarly exchange published in Cephalalgia Reports on the diagnostic framing of Burning Mouth Syndrome (BMS).
✉️ Suga et al. propose refining ICHD-3 criteria by broadening the sensory descriptors from strictly "burning" to include dysaesthetic qualities.
🔗 doi.org/10.1177/25158163251339141
🗣️ Reply by Musella et al.:
BMS criteria need expansion but caution against overgeneralization. They introduce the concept of Oral Dysaesthetic and Perceptual Disorder (ODPD)—a proposed nosological model distinguishing dysaesthetic from perceptual features.
🔗 doi.org/10.1177/25158163251346956
✅ Additional Reply: Need of a shared vision: better recognition of patients currently misclassified or undiagnosed under existing frameworks.
🔗 doi.org/10.1177/25158163251346957
🧠 Why this matters:
These letters tackle a critical issue in clinical orofacial pain: the risk of diagnostic exclusion due to overly narrow criteria. The proposed BMS–ODPD spectrum could lay the groundwork for future ICHD/ICOP revisions and more targeted care.
📚 Let’s keep the discussion going.
Your thoughts on including perceptual distortions in pain taxonomy?
#neurology #orofacialpain #bms #cephalalgiareports #ichd #paintaxonomy #clinicaldialogue #oralmedicine -
Cephalalgia
@JCephalalgia
🧠 New Study Alert in Cephalalgia Reports!
What drives the fear of migraine attacks?
A recent cross-sectional study sheds light on the interictal burden in episodic migraine patients — particularly, the anticipatory anxiety of future attacks.
🔍 Key findings:
✔️ Allodynia symptoms and headache impact explained 35% of fear variance
✔️ High-attack-anxiety patients had worse scores on:
- Headache Impact Test
- Central Sensitization Inventory
- Allodynia Symptom Checklist
- Neck Disability Index
🎯 Takeaway: Fear of attacks is not just psychological — it’s linked to sensory processing and functional burden. Addressing these may ease the interictal suffering of migraine patients.
📖 Read the full study:
doi.org/10.1177/25158163251345140
#migraine #headachemedicine #neuroscience #chronicpain #allodynia #centralsensitization #patientcare #cephalalgiareports -
Cephalalgia
@JCephalalgia
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
Cephalalgia
@JCephalalgia
🚨 The call for applications to the 2025–2026 Cephalalgia Reviewer Academy is now closed!
72 applications for 6 available slots — a testament to the growing interest in contributing to high-quality peer review in the headache field. 🧠📚
The selection process is currently underway, and all applicants will be informed of the outcome soon.
A heartfelt thank you to everyone who applied — your enthusiasm and commitment to advancing science are truly inspiring!
💡🔬 #cephalalgia #revieweracademy #headacheresearch #peerreview #mentorship #scientificcommunity -
Cephalalgia
@JCephalalgia
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
Cephalalgia
@JCephalalgia
💊 Reevaluating Triptan Contraindications in LATAM Neurology Practice
📄 Cephalalgia Reports | doi.org/10.1177/25158163251347211
🧠 Bancalari E, Robblee J, Velez K, et al.
Are current triptan contraindications still relevant in clinical practice?
This LATAM-wide survey of 225 neurologists offers fresh insights into the real-world comfort level in prescribing triptans for migraine in the presence of commonly cited contraindications.
📊 Key findings:
Stroke: 54% never prescribe triptans
Dissection: 61% never
RCVS: 70% never
Venous thromboembolism: More varied – 27% sometimes
Hemiplegic migraine: 58% never
Prolonged aura: 25% sometimes, 40% never
Pregnancy: 57% never
Age >65: 36% sometimes, 22% never
SSRI co-use: Only 24% rarely avoid
🧠 Conclusion: Many contraindications are treated as absolute despite limited supporting evidence. There is a clear need for updated, evidence-based guidance to avoid unnecessary treatment gaps for patients with migraine.
🔗 Full text: doi.org/10.1177/25158163251347211 -
Cephalalgia
@JCephalalgia
🧠 When trigeminal neuralgia isn't what it seems…
A rare case of lesional insular epilepsy masquerading as treatment-refractory trigeminal neuralgia for over a decade—resolved by epilepsy surgery.
This case report highlights the importance of considering ictal epileptic headache in patients with atypical or refractory neuralgiform pain.
📄 Read the full case:
“Lesional insular epilepsy mimicking treatment refractory trigeminal neuralgia effectively treated with epilepsy surgery”
🔗 doi.org/10.1177/25158163251342806
#epilepsy #headache #trigeminalneuralgia #neurosurgery #cephalalgiareports #neurodiagnostics #casereport -
Cephalalgia
@JCephalalgia
🚨 New publication alert!
Sex matters in migraine – not just in prevalence but in pathophysiology and treatment response.
🧠🔍 In a compelling viewpoint, Porreca, Navratilova & Dodick explore sexual dimorphism in migraine mechanisms, including differences in CGRP and prolactin signaling.
📌 Most migraine data come from women, yet we rarely analyze outcomes by sex.
📌 Evidence suggests male and female nociceptors behave differently – opening the door to precision, sex-informed migraine therapy.
📌 The authors call for better inclusion of men in trials and mechanistic studies.
A must-read for anyone interested in pain research, clinical trial design, or migraine care.
📖 Full text: doi.org/10.1177/03331024251339466
#migraine #painresearch #sexdifferences #headache #cgrp #precisionmedicine -
Cephalalgia reposted
しゅ
@ac78ad8f866b432
いま機械翻訳で読んだだけだけどすごく面白い‼️
頭痛に対するアプローチは『その人』の実存的な痛みに向かい合うことが大切な対応の一つであるとな。(解釈間違いならごめん、ガンダムみてテンションおかしいの)
Cephalalgia
@JCephalalgia
New Article in Cephalalgia! Migraine: Beyond Biology
Migraine is more than a neurological disorder — it is a deeply personal, emotional, and existential experience.
This new review explores migraine through a philosophical lens, bridging neuroscience, clinical care, and patient narratives. What does it mean to suffer? How do we find meaning in pain? Drawing on reflections from Nietzsche, Sartre, and Camus, the work urges us to consider migraine not only as a dysfunction of the brain but as a lived human experience.
Understanding migraine requires more than science — it calls for empathy, reflection, and dialogue. A truly holistic, patient-centered approach must integrate the biological and the existential.
Check the full article here: doi.org/10.1177/03331024251343225 -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Applications open until 23rd of June
Cephalalgia
@JCephalalgia
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy
#headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
Cephalalgia
@JCephalalgia
🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents
Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani
Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of Cephalalgia will explore the unique aspects of headache in children and adolescents - from epidemiology and pathophysiology to diagnosis, management, and long-term outcomes.
🔍 We invite submissions on topics including:
• Pediatric headache epidemiology and burden
• Clinical phenotypes and diagnostic challenges
• Genetic and environmental influences
• Treatment strategies and preventive approaches
• Impact on education, mental health, and quality of life
• Transition from pediatric to adult care
📄 Both invited and spontaneous submissions are welcome.
📌 Follow Cephalalgia’s standard submission guidelines.
📨 Submit your work and be part of this important initiative!
#headache #pediatricneurology #childhealth #cephalalgia #migraine #pediatricheadache #callforpapers #clinicalresearch -
Cephalalgia reposted
Teshamae Monteith, M.D., FAHS, FAAN
@headacheMD
It is #mham! So much to celebrate, such as the recent SISC-IHS migraine guidelines, published in @JCephalalgia! @ihs_official @ahsheadache Miller School Neurologist Co-Authors Guidelines for Treating Migraine news.med.miami.edu/miller-school-neurologist-co-authors-e… #ahsam #ahs2025
-
Cephalalgia
@JCephalalgia
🧠 Highly Interesting Review in Cephalalgia!
“Cortical thickness studies in migraine: Current evidence and future directions”
📅 Published June 6, 2025 | 🔓 Open Access
Cortical thickness is emerging as a key marker of migraine-related brain changes. This comprehensive review synthesizes current evidence from surface-based and voxel-based morphometry studies, highlighting:
🔹 Thickening in pain-processing regions (somatosensory cortex, insula, anterior cingulate) – possibly reflecting hyperexcitability.
🔹 Thinning in regions like the orbitofrontal and visual cortices – suggesting cortical integrity loss.
🔹 Differences between episodic vs chronic migraine, and preliminary signs of reversibility with CGRP-mAbs and botulinum toxin A in responders.
📌 The review underscores the potential of cortical thickness as a biomarker—but also the pressing need for standardized protocols and longitudinal data.
🔗 Read the full article: doi.org/10.1177/03331024251341204
#migraine #neuroimaging #corticalthickness #mri #cephalalgia #headacheresearch #neurology #cgrp #botox -
Cephalalgia
@JCephalalgia
🔍 Can atogepant offer relief for patients unresponsive to anti-CGRP mAbs?
The RESCUE study investigates the effectiveness of atogepant in individuals with episodic or chronic migraine who previously discontinued anti-CGRP monoclonal antibodies due to lack of efficacy.
🧠 Among 44 highly refractory cases:
✔️ 18.2% achieved ≥50% reduction in monthly headache days (MHDs)
✔️ Significant reductions were observed in MHDs, moderate-to-severe headache days, acute medication use, and HIT-6 scores
✔️ 59.1% reported some degree of global improvement
❗ Constipation was the most common adverse event (31.8%)
📌 These observational findings suggest that atogepant may be a viable preventive option for a difficult-to-treat population, meriting further prospective validation. RCTs are needed.
📖 Read the full article: doi.org/10.1177/03331024251346925
#migraine #cgrp #atogepant #realworldevidence #neurology #headachemedicine #rescuestudy -
Cephalalgia
@JCephalalgia
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy
#headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
Cephalalgia
@JCephalalgia
🧠 New Insights from the OVERCOME (US) Study on CGRP Monoclonal Antibody Use in Migraine
In this large population-based analysis, Ashina et al. explore real-world patterns of CGRP mAb use among over 39,000 individuals with migraine.
Key findings:
✔️ Only 5% reported using CGRP mAbs; 46% continued use, 39% discontinued.
✔️ Use was more likely among those with triptan contraindications or current use of recommended acute treatments.
✔️ Continued use correlated strongly with concurrent botulinum toxin treatment.
📌 Despite their efficacy, CGRP mAbs remain underutilized - highlighting the need for improved access.
📖 Read the full paper here: doi.org/10.1177/03331024251341243
#migraine #cgrp #headachemedicine #neurology #overcomestudy -
Cephalalgia
@JCephalalgia
New Article in Cephalalgia! Migraine: Beyond Biology
Migraine is more than a neurological disorder — it is a deeply personal, emotional, and existential experience.
This new review explores migraine through a philosophical lens, bridging neuroscience, clinical care, and patient narratives. What does it mean to suffer? How do we find meaning in pain? Drawing on reflections from Nietzsche, Sartre, and Camus, the work urges us to consider migraine not only as a dysfunction of the brain but as a lived human experience.
Understanding migraine requires more than science — it calls for empathy, reflection, and dialogue. A truly holistic, patient-centered approach must integrate the biological and the existential.
Check the full article here: doi.org/10.1177/03331024251343225 -
Cephalalgia
@JCephalalgia
🗣️ A powerful patient voice in the migraine conversation
In response to "Setting Higher Standards for Migraine Prevention" by Sacco et al., Alleanza Cefalalgici (Al.Ce.), Italy’s national headache patient advocacy group, express strong support for this cultural shift in migraine care—from statistical thresholds to true well-being.
🔹 We welcome the call to aim beyond attack frequency reduction and toward migraine freedom—with minimal side effects.
🔹 We also call for broader access to innovative therapies—currently limited by restrictive reimbursement rules.
🔹 We advocate for an updated, patient-centered classification that reflects comorbidities, interictal disability, and psychosocial factors.
🔹 We urge collaboration between patient organizations and scientific societies to drive meaningful change.
📖 Read the patient perspective: doi.org/10.1177/03331024251343217
#migraine #headacheadvocacy #patientvoice #neurology #cephalalgia #ihs #disabilitymatters #migraineprevention -
Cephalalgia
@JCephalalgia
📢 New publication alert!
“Intact white matter in adults with migraine: A REFORM MRI study”
🧠 Using advanced diffusion tensor imaging (DTI), this large case-control study of nearly 300 migraine patients found no significant differences in white matter integrity compared to healthy controls—across subtypes and even during attacks.
🔍 These findings challenge assumptions about microstructural brain changes in migraine and highlight the need to explore alternative imaging biomarkers and pathophysiologic pathways.
📖 Read the full article: doi.org/10.1177/03331024251339423
#migraine #mri #neurology #headacheresearch #dti #neuroimaging #cephalalgia -
Cephalalgia
@JCephalalgia
🧠 New in Cephalalgia: Behavioral approaches to post-traumatic headache
Persistent post-traumatic headache (PPTH) is a common and disabling consequence of mild traumatic brain injury — yet treatment remains challenging.
🔍 This systematic review (n=12 studies; 2293 individuals) highlights:
✅ Cognitive behavioral therapy (CBT) as the most studied and promising approach
✅ The importance of integrated care models
✅ Strong link between PPTH and affective distress
📌 Key message: Effective PPTH management must address both pain and psychological comorbidity.
👉 Full open-access article: doi.org/10.1177/03331024251341237
#tbi #ppth #posttraumaticheadache #behavioraltherapy #cbt #headachemedicine #cephalalgia #neurorehabilitation -
Cephalalgia
@JCephalalgia
🧪 New biomarker insights in migraine!
A cross-sectional study of over 750 adults reveals:
🔹 Serum GFAP levels are modestly but significantly higher (+6.8%) in people with migraine vs. healthy controls.
🔹 Serum NfL levels? No difference found.
🔹 Results were independent of migraine subtype or headache presence at sampling.
These findings open the door for further exploration of GFAP as a potential biomarker in migraine.
📖 Read the full study: doi.org/10.1177/03331024251338178
#migraine #biomarkers #gfap #nfl #neuroinflammation #neurology #cephalalgia #headacheresearch -
Cephalalgia
@JCephalalgia
🧠 Post-Traumatic Headache: Tracking Brain Recovery
New article published in Cephalalgia: doi.org/10.1177/03331024251345160
Why do some patients recover from post-traumatic headache (PTH) after mild traumatic brain injury, while others continue to suffer for months or years?
This longitudinal fMRI study reveals key differences in how the brain responds to pain over time in people with PTH.
✅ Those who improved showed progressive normalization of pain-related brain activity.
❌ Those who did not improve had persistent abnormal activation in regions like the ventral striatum and olfactory cortex.
These patterns may represent biomarkers for persistent PTH, opening the door to earlier identification and more personalized interventions. -
Cephalalgia reposted
Sait Ashina
@SaitAshina
First US population-based survey on CGRP mAb use in migraine now out! Only 5% had ever used them. Top predictors: acute med use, triptan contraindications. Real-world insights to guide personalized care
👉 shorturl.at/uozbx
#migraine #cgrp #headache @JCephalalgia -
Cephalalgia
@JCephalalgia
Cephalalgia Editor's choice - May
We are pleased to announce and congratulate the authors for their paper:
Ku D, Mao L, Nikolova S, Dumkrieger GM, Ross KB, Huentelman M, Anderson T, Porreca F, Navratilova E, Starling A, Wu T, Li J, Chong CD, Schwedt TJ.
Longitudinal analysis of pain-induced brain activations in post-traumatic headache.
Cephalalgia. 2025 May;45(5):3331024251345160. doi: 10.1177/03331024251345160. Epub 2025 May 27. PMID: 40426297.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders. -
Cephalalgia
@JCephalalgia
🧠 RCVS and unusual triggers: a case to reflect on
Reversible cerebral vasoconstriction syndrome (RCVS) is a rare cause of thunderclap headache, often linked to exertion, stress, or vasoactive exposures.
A new case highlights a previously undocumented trigger—underscoring the importance of thorough history-taking in evaluating sudden-onset headache.
🔍 This case raises awareness of potential underrecognized precipitating factors.
Read more in Cephalalgia: doi.org/10.1177/25158163251339404
#neurology #rcvs #headachemedicine #cephalalgia #thunderclapheadache #clinicalcases #vascularneurology -
Cephalalgia
@JCephalalgia
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy
#headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
Cephalalgia
@JCephalalgia
🔬 After the breakthrough of CGRP-targeted treatments, what’s next in migraine research?
📌 Emerging evidence suggests amylin—a peptide in the same family as CGRP—may play a role in migraine pathophysiology.
🧠 This new review explores:
✔️ Amylin’s link with CGRP signaling
✔️ Its ability to trigger migraine in provocation studies
✔️ Potential as a biomarker and therapeutic target
✔️ Early data on sex-specific mechanisms
🧩 Could amylin be the next frontier in migraine treatment—especially for those not responding to CGRP therapies?
👉 Read more and explore the evolving science behind amylin and migraine.
#migraine #headachemedicine #cgrp #amylin #neurology #biomarkers #precisionmedicine #futureofmigrainecare
doi.org/10.1177/03331024251331198 -
Cephalalgia
@JCephalalgia
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports
Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin America, South Asia, the Middle East, and beyond.
We’re calling for papers that explore how migraine is diagnosed, treated, taught, and perceived around the world.
📖 Read the editorial: journals.sagepub.com/doi/10.1177/25158163251339440
#migraine #headache #brain #pain #neurology #neuroscience
@pul_fra @headacheMD @mariofpperes -
Cephalalgia
@JCephalalgia
🚨 New Editorial in Cephalalgia 🚨
"Raising the bar in migraine prevention: Toward freedom and optimal control" by Antonio Russo & Uwe Reuter challenges us to rethink success in migraine care.
🔹 Moving beyond ≥50% MMD reduction
🔹 Emphasizing residual burden and quality of life
🔹 Advocating for ambitious goals: migraine freedom or optimal control
🔹 Highlighting the promise of pragmatic trials (like TACTIC) and multimodal strategies
It’s time for a mindset shift — from symptom reduction to patient-centered outcomes.
👉 Read the full editorial: doi.org/10.1177/03331024251331198 -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🧬 New insights into abdominal migraine in adults
Abdominal migraine is rarely diagnosed in adults, leaving treatment options unclear. This case report suggests that CGRP-targeting therapies can lead to substantial symptom relief.
📉 The patient saw up to a 78% reduction in attack frequency after years of treatment failures.
This case underscores CGRP’s potential role in abdominal migraine pathophysiology and highlights the need for further research.
📖 Read more in Cephalalgia Reports: doi.org/10.1177/25158163251341303
#migraine #abdominalmigraine #cgrp #neurology #headache #cephalalgia -
Cephalalgia
@JCephalalgia
🎉 Congratulations to the exceptional early-career researchers who have completed the 2024 - 2025 Cephalalgia Reviewer Academy! 👏
This inaugural cohort has demonstrated excellence, dedication, and a deep commitment.
👏 A heartfelt thank you to our outstanding mentors - Anna Andreou, Gianluca Coppola, Teshame Monteith, Kuan-Po Peng, Cristina Tassorelli, Marcelo Valença, and Simona Sacco - for sharing their expertise and guiding the next generation of reviewers.
🌍 From diverse backgrounds and across the globe, these eight talented individuals are now ready to contribute to elevate scientific publishing in the headache field.
🔎 We look forward to seeing their continued contributions to Cephalalgia and Cephalalgia Reports - and to welcoming new applicants to the 2025–2026 edition!
doi.org/10.1177/03331024251346916 -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
New edition of the @JCephalalgia reviewer academy now open!
Cephalalgia
@JCephalalgia
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy #headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
Cephalalgia reposted
しゅ
@ac78ad8f866b432
最近産婦人科の先生と話す機会あったけど妊娠中は難儀するよね。
この論文お伝えします
Cephalalgia
@JCephalalgia
OnabotulinumtoxinA treatment for chronic migraine appears to be effective during pregnancy.
There is currently no evidence of pregnancy-related adverse effects associated with the use of OnabotulinumtoxinA for chronic migraine during pregnancy.
However, abrupt discontinuation of OnabotulinumtoxinA treatment in pregnancy has been linked to a high risk of migraine relapse.
journals.sagepub.com/doi/10.1177/03331024251327387
#migraine #headache #brain #pain #neurology #neuroscience
@FayyazA85079186 -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
Migraine is more than pain. This podcast explores a 2025 paper on treating migraine as a human-to-human service, not just a diagnosis.
Link to the podcast: youtu.be/JuQsqipzrYk
#migraine #headache #narrativemedicine #neurology
Link to the paper: journals.sagepub.com/doi/full/10.1177/03331024251343225 -
Cephalalgia
@JCephalalgia
🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀
Are you a passionate professional about headaches?
Boost your CV, gain peer review skills, and connect with experts!
Who can apply?
- Researchers and healthcare providers interested in headache.
- No prior peer review experience needed.
Program Highlights:
- Web course and mentor-guided reviews.
- Earn a certificate and recognition.
Apply by: 23 June 2025🔗 More info and apply: Link in the ihs-headache.org/en/news/would-you-like-to-be-a-review-fo…
Make an impact in headache research! 💡✨ #cephalalgiaacademy #headache #migraine # scientist # research #peerreview #medicalresearch #ihs #neurology -
Cephalalgia reposted
LAB-NEU
@lab_neu2024
Please to share our RCT just published in @JCephalalgia. One step forward to advance migraine care
Cephalalgia
@JCephalalgia
This research explores combining transcranial direct current stimulation (tDCS) with CGRP-targeting monoclonal antibodies to improve migraine treatment.
tDCS as an adjunct: tDCS, applied alongside CGRP monoclonal antibodies, resulted in a significant reduction in migraine days during the 28-day follow-up compared to the sham group.
•
Neurophysiological effects: active tDCS induced a significant decrease in delta power in frontal regions, suggesting an impact on central migraine mechanisms.
•
Reduction in migraine days: participants receiving active tDCS reported fewer migraine days during the 28-day follow-up compared to the sham group.
•
Safety profile: tDCS was well tolerated, with no serious adverse events reported.
journals.sagepub.com/doi/10.1177/03331024251325567
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ @RaffaeleOrnello -
Cephalalgia
@JCephalalgia
OnabotulinumtoxinA treatment for chronic migraine appears to be effective during pregnancy.
There is currently no evidence of pregnancy-related adverse effects associated with the use of OnabotulinumtoxinA for chronic migraine during pregnancy.
However, abrupt discontinuation of OnabotulinumtoxinA treatment in pregnancy has been linked to a high risk of migraine relapse.
journals.sagepub.com/doi/10.1177/03331024251327387
#migraine #headache #brain #pain #neurology #neuroscience
@FayyazA85079186 -
Cephalalgia
@JCephalalgia
Intravenous infusion of substance P induced headache in 15 (71%) healthy adults, compared with only two (10%) following placebo.
•
Substance P administration significantly dilated the superficial temporal artery, although its effects on middle cerebral artery blood flow were less consistent.
•
These results support substance P as a potential mediator of head pain, suggesting that targeting its signaling might offer therapeutic promise for headache disorders.
journals.sagepub.com/doi/10.1177/03331024251336132
#migraine #headache #brain #pain #neurology #neuroscience
@HaidarAlKhazal2 @MessoudAshina -
Cephalalgia
@JCephalalgia
This study proposes the inclusion of formal diagnostic criteria for painful nervus intermedius neuropathy attributed to Bell’s Palsy, which is an under-recognized yet clinically relevant feature of this condition.
journals.sagepub.com/doi/10.1177/03331024251340059
#headache #brain #pain #neurology #neuroscience
@UPensato @RaffaeleOrnello -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Teshamae Monteith, M.D., FAHS, FAAN
@headacheMD
I’m looking forward to learning how migraine is treated across the globe! What unique barriers and areas of collaboration and innovation exists? How do regional health systems manage #migraine differently? Read our editorial and follow this topical collection! @JCephalalgia
International Headache Society
@ihs_official
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports
Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin America, South Asia, the Middle East, and beyond.
We’re calling for papers that explore how migraine is diagnosed, treated, taught, and perceived around the world.
📖 Read the editorial: journals.sagepub.com/doi/10.1177/25158163251339440
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports
Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin America, South Asia, the Middle East, and beyond.
We’re calling for papers that explore how migraine is diagnosed, treated, taught, and perceived around the world.
📖 Read the editorial: journals.sagepub.com/doi/10.1177/25158163251339440
#migraine #headache #brain #pain #neurology #neuroscience
@pul_fra @headacheMD @mariofpperes -
Cephalalgia
@JCephalalgia
Al-Khazali et al. showed that substance P induced headache and arterial dilation in healthy individuals, supporting its role in headache pathogenesis and warranting further research in migraine and other headache disorders.
journals.sagepub.com/doi/10.1177/03331024251336132
#migraine #headache #brain #pain #neurology #neuroscience
@HaidarAlKhazal2 @MessoudAshina -
Cephalalgia
@JCephalalgia
OnabotulinumtoxinA treatment for chronic migraine appears to be effective during pregnancy.
There is currently no evidence of pregnancy-related adverse effects associated with the use of OnabotulinumtoxinA for chronic migraine during pregnancy.
However, abrupt discontinuation of OnabotulinumtoxinA treatment in pregnancy has been linked to a high risk of migraine relapse.
journals.sagepub.com/doi/10.1177/03331024251327387
#migraine #headache #brain #pain #neurology #neuroscience
@FayyazA85079186 -
Cephalalgia
@JCephalalgia
This research explores combining transcranial direct current stimulation (tDCS) with CGRP-targeting monoclonal antibodies to improve migraine treatment.
tDCS as an adjunct: tDCS, applied alongside CGRP monoclonal antibodies, resulted in a significant reduction in migraine days during the 28-day follow-up compared to the sham group.
•
Neurophysiological effects: active tDCS induced a significant decrease in delta power in frontal regions, suggesting an impact on central migraine mechanisms.
•
Reduction in migraine days: participants receiving active tDCS reported fewer migraine days during the 28-day follow-up compared to the sham group.
•
Safety profile: tDCS was well tolerated, with no serious adverse events reported.
journals.sagepub.com/doi/10.1177/03331024251325567
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_ @RaffaeleOrnello -
Cephalalgia
@JCephalalgia
Burning Mouth Syndrome isn’t just “burning.” This paper proposes broader ICHD-4 criteria to include tingling and other dysaesthetic descriptors, ensuring more accurate diagnosis, better research, and improved care for oral pain sufferers.
journals.sagepub.com/doi/10.1177/25158163251339141
#headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
This an editorial linked to the article, Serum GFAP and NfL Levels in Migraine: a Registry for Migraine (REFORM) Study ---which has not published yet.
journals.sagepub.com/doi/10.1177/03331024251338171
#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
New FASTcast!
Is Botox safe for migraine in pregnancy?
126 real-world cases say yes — with no fetal malformations and strong migraine control.
Podcast on the YouTube channel
youtu.be/PRKhxrGPTGM
Paper: doi.org/10.1177/03331024251327387
#migraine #pregnancy #botox #neurology -
Cephalalgia
@JCephalalgia
@JCephalalgia @IHS_official Editor's Choice Article @Simona_Sacco_ Please see our discussion with fantastic @RaffaeleOrnello #evidence-based guidelines for the pharmacological treatment of #migraine Ornello R et al. Cephalalgia. 2025;45(4). doi:10.1177/03331024241305381
@NinaRiggins
www.youtube.com/watch?v=xFezOdMzC9Q -
Cephalalgia
@JCephalalgia
The majority (94%) of participants with persistent post-traumatic headache (PTH) meet the criteria for migraine-like headache.
•
Persistent PTH imposes a level of disability comparable to chronic migraine and higher than that of episodic migraine.
•
Participants with persistent PTH report more frequent use of simple analgesics like paracetamol and ibuprofen, compared to those with migraine.
journals.sagepub.com/doi/10.1177/03331024251331605
#migraine #headache #brain #pain #neurology #neuroscience
@HaidarAlKhazal2 @h_ashina -
Cephalalgia
@JCephalalgia
The evaluation of premonitory spontaneous and nitroglycerin triggered symptoms among patients with cluster headache and migraine potentially impacts headache management including treatment prediction and early intervention.
journals.sagepub.com/doi/10.1177/03331024251331554
#migraine #headache #brain #pain #neurology #neuroscience
@petergoadsby @DraNeurologia -
Cephalalgia
@JCephalalgia
Sphenopalatine neuralgia is a close differential of complex regional pain syndrome of face as both share clinical features and both respond to sphenopalatine ganglion block.
journals.sagepub.com/doi/10.1177/25158163251327173
#headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
This is an editorial linked to the article, Intact White Matter in Adults with Migraine: A REFORM MRI Study --which has not published yet.
journals.sagepub.com/doi/10.1177/03331024251339431
#migraine #headache #brain #pain #neurology #neuroscience
@_RobertaMessina -
Cephalalgia
@JCephalalgia
The case reports suggest chilblains can be associated with treatment with CGRP monoclonal antibodies but not during treatment with a CGRP oral antagonist.
journals.sagepub.com/doi/10.1177/25158163251329568
#migraine #headache #brain #pain #neurology #neuroscience
@SaitAshina -
Cephalalgia
@JCephalalgia
Premonitory symptoms are reported by approximately 80% of cluster headache (CH) patients.
•
Symptoms suggestive of hypothalamic involvement are present in approximately 30% of patients prior to an attack, underscoring the need of neuroimaging research.
•
The use of oxygen treatment is independently associated with the occurrence of premonitory symptoms.
•
The similarity between spontaneous and triggered CH premonitory symptoms and with migraine supports the shared biology of premonitory symptoms in these two entities.
•
Studying potential differences between premonitory symptoms within patients with cluster headache and comorbid migraine would be a useful next step to furthering understanding in this area.
journals.sagepub.com/doi/10.1177/03331024251331554
#migraine #headache #brain #pain #neurology #neuroscience
@petergoadsby @DraNeurologia -
Cephalalgia
@JCephalalgia
Al-Khazali et al. reported that individuals with persistent post-traumatic headache (PTH) exhibit disability and headache profiles comparable to those with chronic migraine, emphasizing the necessity for targeted management strategies akin to chronic migraine care.
journals.sagepub.com/doi/10.1177/03331024251331605
#migraine #headache #brain #pain #neurology #neuroscience
@HaidarAlKhazal2 @h_ashina -
Cephalalgia
@JCephalalgia
📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline
Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process.
✅ Editorial review within 72 hours by two experienced Reviewers
✅ Online publication within 4 weeks of acceptance
✅ Designed to support timely dissemination of high-quality research
The cost for this service is $900 USD, which directly supports the time commitment of our Reviewers. Please note that this fee facilitates expedited handling and does not influence the editorial decision or guarantee acceptance.
To request Fast-Track Review, simply select the ‘Fast Track Review’ option from the article type dropdown menu when submitting your manuscript.
📍 Submit now and advance your research with efficiency and integrity.
journals.sagepub.com/author-instructions/cep -
Cephalalgia
@JCephalalgia
There is a notable high prevalence of gastroesophageal reflux disease (GERD) in burning mouth syndrome (BMS) patients, highlighting a potential comorbid relationship between the two conditions.
•
GERDQ might serve as valuable screening tool assisting healthcare professionals, especially in resource-limited settings.
•
Significantly more common in BMS patients with GERDQ ≥8, altered taste and thickened tongue coating are considered key clinical indicators suggestive for potential GERD symptoms in this population.
.................
journals.sagepub.com/doi/10.1177/03331024251336139
#gerd #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
BIDMC Headache Center
@bidmcheadache
New study: IV infusion of substance P induced headache and arterial dilation in healthy adults. 71% reported #headache vs 10% with placebo. Findings support a role for substance P in headache pathogenesis #migraine #neurology #substancep @JCephalalgia
shorturl.at/6l9vv -
Cephalalgia
@JCephalalgia
🧠✨ New Evidence-Based Guidelines for Migraine Treatment!
The International Headache Society and Italian Society for the Study of Headache have released updated guidelines for the pharmacological management of migraine, covering both acute attacks and preventive strategies.
A major step toward standardizing care and improving outcomes for people with migraine worldwide.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Umberto Pensato
@UPensato
We propose diagnostic criteria for "painful nervus intermedius attributed to Bell's palsy", a widespread #headache condition left out by the ICHD-3. @RaffaeleOrnello @JCephalalgia @ihs_official journals.sagepub.com/doi/10.1177/03331024251340059
-
Cephalalgia
@JCephalalgia
This study demonstrated the effectiveness of atogepant in preventing migraine after a 12-week treatment in real life conditions.
•
Only three out of 106 patients discontinued treatment for adverse events.
•
Moreover, 43% of patients previously resistant to anti-CGRP mAbs benefitted from atogepant after 12 weeks.
•
Atogepant can be considered as a new therapeutic approach for effectively treating migraine patients in clinical practice.
journals.sagepub.com/doi/10.1177/03331024251335927
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
This study demonstrated the effectiveness of atogepant in preventing migraine after 12-week treatment in real life conditions. Only 3 out of 106 patients discontinued treatment for adverse events.
journals.sagepub.com/doi/10.1177/03331024251335927
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
New FASTcast!
Can social media help educate or hurt people with migraine? A new editorial explores both sides.
Link to the podcast on the YouTube channel.
youtu.be/-wC7n-sYyI8
#migraine #headache #cephalalgia #socialmedia #digitalhealth
@JCephalalgia -
Cephalalgia
@JCephalalgia
There is a notable high prevalence of gastroesophageal reflux disease (GERD) in burning mouth syndrome (BMS) patients, highlighting a potential comorbid relationship between the two conditions.
.....
journals.sagepub.com/doi/10.1177/03331024251336139
#gerd #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🚀 Advancing Migraine Care: New Guidelines Released!
The International Headache Society and Italian Society for the Study of Headache present the latest evidence-based guidelines for acute and preventive migraine treatment.
Clear, rigorous, and practical—these guidelines are a major step toward improving migraine management worldwide. 🌍🧠
📖 Discover the full recommendations:
journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience
@faradoost @ihs_official @Simona_Sacco_This media couldn't be displayed. See it on the original post. -
Cephalalgia reposted
⭐️茨城県議選立候補予定者⭐️しのはら克子
@cha_cha_db
【翻訳】
国際頭痛協会とイタリア頭痛研究協会は、急性及び予防片頭痛治療のための最新のエビデンスに基づくガイドラインを提示
明確で、厳格で、実用的です。これらのガイドラインは、世界中の片頭痛管理を改善するための大きな一歩です。
要約版:journals.sagepub.com/doi/10.1177/03...
#頭痛 #片頭痛
Cephalalgia
@JCephalalgia
🚀 Advancing Migraine Care: New Guidelines Released!
The International Headache Society and Italian Society for the Study of Headache present the latest evidence-based guidelines for acute and preventive migraine treatment.
Clear, rigorous, and practical—these guidelines are a major step toward improving migraine management worldwide. 🌍🧠
📖 Discover the full recommendations:
journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🚀 Advancing Migraine Care: New Guidelines Released!
The International Headache Society and Italian Society for the Study of Headache present the latest evidence-based guidelines for acute and preventive migraine treatment.
Clear, rigorous, and practical—these guidelines are a major step toward improving migraine management worldwide. 🌍🧠
📖 Discover the full recommendations:
journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
April's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Evidence-based guidelines for the pharmacological treatment of migraine” which has been selected as the Editor’s Choice for the April issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Martin Syvertsen Mykland
@MyklandMartin
Does insufficient sleep and the ictal phase have similar effects on homeostatic inhibitory effects in migraine? journals.sagepub.com/doi/full/10.1177/03331024251329400 @NTNU @NTNUhelse @NinaRiggins
-
Cephalalgia reposted
Martin Syvertsen Mykland
@MyklandMartin
Thanking @ihs_official @Simona_Sacco_ for highlighting our latest findings in #migraine. We found similar changes in nociceptive habituation after insufficient sleep as is previously observed in the ictal phase of migraine. www.youtube.com/watch?v=H3lUJopGpsk @PetterOmland @NorHeadResearch
-
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Treatment within a multidisciplinary headache team effectively reduces headache frequency, sick leave, and psychological distress in patients with present or recurrent headache-related sick leave
•
Female sex and lower baseline headache frequency were associated with better clinical outcomes
•
Migraine diagnosis and long-term sick leave at baseline predicted persistent sick leave after 12 months.
journals.sagepub.com/doi/10.1177/03331024251332572
#migraine #headache #brain #pain #neurology #neuroscience
@EspnSaxKristoff -
Cephalalgia reposted
thmonk
@thmonk_pf
国際頭痛学会(IHS)は片頭痛の薬物療法に関するエビデンスに基づく急性期治療と予防療法の両方を対象としたガイドラインを発表
厳格なレビューと専門家によるコンセンサスに基づいて作成されたこのガイドラインは、片頭痛治療を標準化し、今後の研究課題を示す
#guideline
#headache
#papers
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
医療者向け🩺
SMART症候学をご存知ですか?
脳外科医でも、知らない方も多いのではないかと思います。
脳腫瘍などに対して、放射線照射をして5-10年以上してから片麻痺性片頭痛のような症状を繰り返すようになる「超遅発性の合併症」です。
具体的には、、、
☑️閃輝暗点や片麻痺、失語、意識障害などが急に出現する。
☑️MRIでは脳梗塞なし。
☑️1-2日経って完全に復活。
☑️片頭痛様の頭痛の訴え。
といった感じです。
照射の5-10年以上経ってからの合併症なので、どちらかというと小児脳腫瘍で問題になりがちです。
Cephalalgia
@JCephalalgia
Stroke-like migraine attacks after radiation therapy (SMART) syndrome remains underrecognized among non-radiologist specialists.
journals.sagepub.com/doi/10.1177/03331024251334355
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
In a cross-sectional study in a large population of frequent flyers risk factors for airplane headache were identified with two multivariate logistic regression models. They align with established risk factors for other headache forms
journals.sagepub.com/doi/10.1177/03331024251329837
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New in Cephalalgia: “Social Media’s Role in Migraine Education: Headache or Not Headache?” Social media offers access, support & awareness—but also spreads misinformation, unverified cures & triggers. Can we harness it for good?
journals.sagepub.com/doi/10.1177/03331024251336152
.....................
Special issue:
📢 Call for Papers: Digital Headache
⏳ Deadline for Submissions: December 31, 2025
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
📌 Manuscripts should be submitted electronically through the journal's online submission system. -
Cephalalgia
@JCephalalgia
MR imaging may detect signs of intracranial hypotension
•
No marked increase of the Bern score was observed in either healthy controls or patients with persistent Post-traumatic headache (PTH).
•
Spontaneous intracranial hypotension (SIH) should be thoroughly investigated in patients with PTH, and MRI findings should be carefully reviewed.
journals.sagepub.com/doi/10.1177/03331024251325556
#headache #brain #pain #neurology #neuroscience
@henrikschytz @HaidarAlKhazal2 @rj_rigmor @drfa_CPH -
Cephalalgia
@JCephalalgia
Stroke-like migraine attacks after radiation therapy (SMART) syndrome remains underrecognized among non-radiologist specialists.
journals.sagepub.com/doi/10.1177/03331024251334355
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Ramiro Esparza
@docramiro
Nueva guía basada en la evidencia para el tratamiento farmacológico de la migraña 2025 por The International Headache Society 🤕
doi.org/10.1177/03331024251321500 y doi.org/10.1177/03331024241305381 -
Cephalalgia
@JCephalalgia
The risk factors for airplane headache (AH) in this large population of air travellers align with generally established risk factors for other headache forms.
•
Significant similarities exist between the risk factors for AH and high altitude headache (HAH).
•
Behavioural modifications, such as ensuring adequate hydration, reducing stress and avoiding sweeteners, should be explored for their potential effectiveness in preventing AH.
•
The effectiveness and safety of folic acid supplementation as a preventive measure against AH should be examined in more detail.
journals.sagepub.com/doi/10.1177/03331024251329837
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
国際頭痛学会より「片頭痛の薬物治療に関するガイドライン」
が新たに発表されました!!👏
過去の推奨と比べて劇的な変化はないと思われますが、CGRP抗体やゲパントなどの新規薬剤のエビデンスがより充実したとのことです。
個人的には、それぞれの推奨がRCTによるのかエキスパートオピニオンなのかしっかり明記してあり、非常に勉強しやすい作りになっていると感じます📝
ゾルミトリプタン vs リザトリプタンなど薬剤のhead to headの比較の章があるのも面白いと思いました。
せっかくの機会なので通読したいと思います。📕
気になったトピックをまた順にご紹介していきますね。
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
しゅ
@ac78ad8f866b432
後でよまねば
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Dra Alicia González Martínez
@DraNeurologia
Excited to share our latest article on spontaneous & nitroglycerin triggered premonitory symptoms in Cluster Headache & Migraine—research from my postdoc with Prof. Goadsby's group. Special thanks to Dr. Wei & Dr. Karsan. journals.sagepub.com/doi/epub/10.1177/03331024251331554 🧠 @JCephalalgia
-
Cephalalgia reposted
Rigmor H. Jensen
@rj_rigmor
Important and detailed controlled study in patients with persistent headache after mild headtraume and here there was no indications of SIH and dural leaks! We have to identify the optimal strategy to identify patients with SIH
-
Cephalalgia
@JCephalalgia
This MR imaging study investigated validated signs intracranial hypotension in people with posttraumatic headache (PTH) compared to healthy controls. Based on this method, people with PTH do not show signs of intracranial hypotension!
journals.sagepub.com/doi/10.1177/03331024251325556
#headache #brain #pain #neurology #neuroscience
@henrikschytz @HaidarAlKhazal2 @rj_rigmor @drfa_CPH -
Cephalalgia
@JCephalalgia
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
Cephalalgia
@JCephalalgia
New in Cephalalgia: “Social Media’s Role in Migraine Education: Headache or Not Headache?” Social media offers access, support & awareness—but also spreads misinformation, unverified cures & triggers. Can we harness it for good?
journals.sagepub.com/doi/10.1177/03331024251336152
.....................
Special issue:
📢 Call for Papers: Digital Headache
⏳ Deadline for Submissions: December 31, 2025
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
📌 Manuscripts should be submitted electronically through the journal's online submission system. -
Cephalalgia reposted
P
@pengyi897806
头痛指南
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Gabriele Sebastianelli
@Gabriele_Seba
What is the role of glial cells and neuroinflammation in #migraine? Will we ever fully understand all the complexities of this dynamic and intriguing condition?
I’m honored to have had the chance to share my thoughts on this topic on @JCephalalgia 🧠🚀
journals.sagepub.com/doi/10.1177/03331024251338171 -
Cephalalgia reposted
Teshamae Monteith, M.D., FAHS, FAAN
@headacheMD
It’s finally here! 🙏🏽🥰❤️🧠 💪🏾🙋♂️
International Headache Society
@ihs_official
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Cherubino Di Lorenzo
@robydilorenzo
New guidelines for the pharmacological management of migraine have finally been published. An immense amount of work for an evidence-based approach!
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 New Migraine Treatment Guidelines Out Now! 🧠💊
The International Headache Society and Italian Society for the Study of Headache have published evidence-based guidelines for the pharmacological treatment of migraine, covering both acute and preventive therapies.
Built on rigorous reviews and expert consensus, these guidelines aim to standardize migraine care and highlight future research needs.
📝 Read more: journals.sagepub.com/doi/10.1177/03331024241305381
Summary version: journals.sagepub.com/doi/10.1177/03331024251321500
#headacheresearch #cephalalgia #neurology #evidencebasedmedicine #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
A multidisciplinary headache team effectively reduces headache frequency, sick leave, and psychological distress in patients with present or recurrent headache-related sick leave.
journals.sagepub.com/doi/10.1177/03331024251332572
#migraine #headache #brain #pain #neurology #neuroscience
@EspnSaxKristoff -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
This important document marks a major advancement in providing evidence-based recommendations to guide best practices in the care of individuals living with migraine. It covers all the pharmacological treatments available and uses a strong methodology.
-
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Pleased to share the release of the new Migraine Guideline!
A joint effort by the @SISCCefalee and @ihs_official
Two versions are available on @JCephalalgia :
• Summary version: doi.org/10.1177/03331024251321500
• Extended version: doi.org/10.1177/03331024241305381 -
Cephalalgia reposted
International Headache Society
@ihs_official
SISC-IHS guideline for pharmacological treatment of #migraine is now published @JCephalalgia @Simona_Sacco_
@Schwedtt @MessoudAshina @SaitAshina @Bohemian_Wu @Faradoost @ninariggins
doi.org/10.1177/03331024241305381 -
Cephalalgia reposted
Sait Ashina
@SaitAshina
Proud to be part of this work with my colleagues! We present new evidence-based guidelines for #migraine treatment, developed by the Italian Society for the Study of Headache and the International Headache Society #headache #neurology #pain
shorturl.at/0OMZL -
Cephalalgia reposted
BIDMC Headache Center
@bidmcheadache
International Headache Society has released the latest evidence-based guidelines for the pharmacological treatment of #migraine, offering clear recommendations for healthcare professionals @ihs_official #headache #neurology #pain #evidencebasedmedicine
shorturl.at/0OMZL -
Cephalalgia reposted
Cherubino Di Lorenzo
@robydilorenzo
Treat the patient, not his/her headache!
Multidisciplinary headache treatment with work-focus in Norway: An observational study - 2025 journals.sagepub.com/doi/full/10.1177/03331024251332572 -
Cephalalgia
@JCephalalgia
Preventive treatment with anti-CGRP mAbs and BTX-A effectively reduces non-perimenstrual headache and non-perimenstrual migraine days but appears to have limited efficacy in perimenstrual headache and migraine days.
•
The perimenstrual window represents the period with the highest risk of headache and migraine attacks during the menstrual cycle.
•
Women using contraceptive treatments seem to have an increased daily likelihood of experiencing headache and migraine attacks.
journals.sagepub.com/doi/10.1177/03331024251332519
#migraine #headache #brain #pain #neurology #neuroscience
@vallhebron, @AdaptiveBrain @ppozorosich @CaronnaEdoardo @alpuente_ruiz -
Cephalalgia
@JCephalalgia
Preventive treatment with anti-CGRP mAbs and BTX-A effectively reduces non-perimenstrual headache and non-perimenstrual migraine days but appears to have limited efficacy in perimenstrual headache and migraine days.
journals.sagepub.com/doi/10.1177/03331024251332519
#migraine #headache #brain #pain #neurology #neuroscience
@vallhebron, @AdaptiveBrain @ppozorosich @CaronnaEdoardo @alpuente_ruiz -
Cephalalgia
@JCephalalgia
Social media can empower—or mislead—people with migraine.
Read this editorial about the risks, rewards, and what we can do better.
journals.sagepub.com/doi/10.1177/03331024251336152
Special issue:
📢 Call for Papers: Digital Headache
⏳ Deadline for Submissions: December 31, 2025
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
📌 Manuscripts should be submitted electronically through the journal's online submission system.
Faraidoon Haghdoost (Big Head Pain)
@faradoost
New editorial in Cephalalgia @JCephalalgia 📢
Social media can empower—or mislead—people with migraine.
Read about the risks, rewards, and what we can do better.
journals.sagepub.com/doi/10.1177/03331024251336152
#migraine #headache #digitalhealth #neurology -
Cephalalgia
@JCephalalgia
📢 ICHD-4: Work in Progress!
The International Headache Society shares updates on the upcoming International Classification of Headache Disorders, 4th edition (ICHD-4).
Key issues under discussion include:
🔹 Overlapping features in primary vs secondary headaches
🔹 Revisions to tension-type headache criteria
🔹 Rethinking chronic vs episodic migraine classification
🔹 Updates on vestibular migraine and medication-overuse headache
🔹 Plans for open community feedback at IHC2025 in São Paulo
Get involved and help shape the future of headache diagnosis!
🧠 Read the full report: journals.sagepub.com/doi/10.1177/03331024251325550
#ichd4 #ihs #cephalalgia #neurology #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
This letter is presented as a thought experiment—grounded in clinical observation and current literature—and aims to promote discussion around the limitations of the current duration-based status migrainosus definition.
journals.sagepub.com/doi/10.1177/03331024251334137
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Letter to the Editor:
Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure: The need for a broader perspective.
Link: journals.sagepub.com/doi/10.1177/03331024251329513
Reply: journals.sagepub.com/doi/10.1177/03331024251329506
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
I used to make voice files for myself to listen on the train, bus, or bike. Now I’m sharing them with you.
This time: What is the evolutionary disadvantage of migraine?
Link to the podcast on the YouTube channel.
youtu.be/DkkyNoW4CJ8
#migraine #headache #neurology -
Cephalalgia reposted
max valeriani
@maxval67
#headaches of #children deserve higher attention! @bambinogesu @unitorvergata @SISCCefalee @sinneurologia
Cephalalgia
@JCephalalgia
This Editorial launches a new Topical Collection of Cephalalgia on Headache in Children and Adolescence. It will include original researches and review articles dealing with the main topics of headache in youth.
journals.sagepub.com/doi/10.1177/03331024251331217
#migraine #headache #brain #pain #neurology #neuroscience
@maxval67
@aynurozge1 -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
【原始時代には最強だった片頭痛?】
面白い論文!
進化論の立場で片頭痛の研究がなされています。
片頭痛は10-20%もの有病率があります。
長い歴史の中で、片頭痛体質が淘汰されずにこれだけ多くの人類に残っているというのは、
昔の世界では片頭痛がむしろ生存に有利だった側面があるということですね。
この論文では「片頭痛の光過敏や音過敏、臭い過敏といった体質が重要だったのではないか?🤔」といっています。
昔の人類にとって「感覚が鋭い体質」って生き残るのに有利だった。
敵の気配、毒の匂い、光の変化…五感が敏感な人ほどサバイバルできた訳です。
で、それが今も“片頭痛の遺伝子”として残ってるかもしれないというんですね。
しかし、現代はどうでしょう?
音も光も情報も多すぎる💥
その感覚過敏が逆に仇となって、脳がオーバーヒート→片頭痛という構図になってるということですね。🤯
逆に、現代の地球では自然選択が強い国ほど片頭痛の有病率が低い結果が出ており、生存競争では不利に働いてそうです、、、
Cephalalgia
@JCephalalgia
🧬🧠 Is Migraine an Evolutionary Mismatch?
A new article in Cephalalgia explores the idea of migraine as a dysevolutionary disorder—a trait once beneficial in ancestral environments but now maladaptive in modern life.
📉 Using global data, the study shows that stronger natural selection correlates with lower migraine prevalence, offering fresh insight into the evolutionary roots of migraine.
📖 Read more: journals.sagepub.com/doi/10.1177/03331024251327361
#migraine #headache #brain #pain #neurology #neuroscience
@MarcoLisicki -
Cephalalgia
@JCephalalgia
Letter to the Editor
Reply to “What is the evolutionary disadvantage of migraine?”
doi.org/10.1177/03331024251327377
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🧬🧠 Is Migraine an Evolutionary Mismatch?
A new article in Cephalalgia explores the idea of migraine as a dysevolutionary disorder—a trait once beneficial in ancestral environments but now maladaptive in modern life.
📉 Using global data, the study shows that stronger natural selection correlates with lower migraine prevalence, offering fresh insight into the evolutionary roots of migraine.
📖 Read more: journals.sagepub.com/doi/10.1177/03331024251327361
#migraine #headache #brain #pain #neurology #neuroscience
@MarcoLisicki -
Cephalalgia
@JCephalalgia
This Editorial launches a new Topical Collection of Cephalalgia on Headache in Children and Adolescence. It will include original researches and review articles dealing with the main topics of headache in youth.
journals.sagepub.com/doi/10.1177/03331024251331217
#migraine #headache #brain #pain #neurology #neuroscience
@maxval67
@aynurozge1 -
Cephalalgia reposted
International Headache Society
@ihs_official
🧠 Ready to present your research on a global stage?
Submit your abstract to IHC 2025 and join the leading global programme in headache medicine.
📅 Deadline: 5 May 2025 – 23:59 (Brasília time)
🔗 Submit now: ihc2025.org -
Cephalalgia reposted
NeuroNews
@NN_publishing
How well do you know @ESOstroke president @Simona_Sacco_? Find out by reading Sacco's recent profile in @NN_publishing, where she discusses her mentors, recent developments in #headache and #stroke care, the GBD project, and more
@univaq @JCephalalgia
neuronewsinternational.com/simona-sacco-profile/ -
Cephalalgia reposted
Fawaz Al-Mufti, MD, FSVIN
@almuftifawaz
Congrats Simona!!
-
Cephalalgia
@JCephalalgia
This paper found that genetic risk for migraine may not be a causal risk factor for Primary-Open Angle Glaucoma (POAG).
journals.sagepub.com/doi/10.1177/25158163251323245
#migraine #headache #brain #pain #neurology #neuroscience
@DimaChaar
@cephreports -
Cephalalgia reposted
International Headache Society
@ihs_official
It was a wonderful reunion of those deeply dedicated to headache medicine—IHS members, the committee chair, and the @JCephalalgia social media editor—at #aanam. Great to see such strong engagement from the #headache community ❤️
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
With amazing @DawnBuse #aanam @AANmember @headacheMD @Bohemian_Wu @ChiaChunChiang @WNGtweets Great #headache session! @JCephalalgia @ihs_official @ahsheadache
-
Cephalalgia
@JCephalalgia
Fremanezumab treatment was effective and safe for patients with refractory migraine and hereditary transthyretin amyloidosis.
Clinical implications
•
Safety: Fremanezumab was well-tolerated, with no significant safety concerns observed in the cases.
•
Potential therapeutic benefit: Given its effectiveness and safety profile, fremanezumab, or other anti-CGRP antibodies, may represent a promising treatment option for patients with refractory migraine and hereditary transthyretin amyloidosis.
journals.sagepub.com/doi/10.1177/25158163251327180
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
A case of refractory cluster headache presented, where there was a clear reduction of attacks after gender-affirming treatment.
This case contributes to a growing body of literature suggesting that hormonal factors may significantly impact the clinical course of primary headache disorders, including cluster headache.
journals.sagepub.com/doi/10.1177/25158163251322801
#migraine #headache #brain #pain #neurology #neuroscience #clusterheadache -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
片頭痛は原発開放隅角緑内障(POAG)の遺伝的なリスクではないことが示されました。
2018年のメタアナリシスで「片頭痛がある人はPOAGのリスクが24%高い」と相関関係が言われていました。
神経炎症など共通点も多いことから、
「片頭痛が原因でPOAGを発症するのではないか?」
と一部心配されていましたが、遺伝的な解析で因果関係が否定された形になるかと思います。
Cephalalgia
@JCephalalgia
This paper found that genetic risk for migraine may not be a causal risk factor for Primary-Open Angle Glaucoma (POAG).
journals.sagepub.com/doi/10.1177/25158163251323245
#migraine #headache #brain #pain #neurology #neuroscience
@DimaChaar
@cephreports -
Cephalalgia
@JCephalalgia
This paper found that genetic risk for migraine may not be a causal risk factor for Primary-Open Angle Glaucoma (POAG).
journals.sagepub.com/doi/10.1177/25158163251323245
#migraine #headache #brain #pain #neurology #neuroscience
@DimaChaar
@cephreports -
Cephalalgia
@JCephalalgia
This letter emphasizes the significance of reassessing the definitions of "not responding" and "partial efficacy," advocating for a more precise categorization that distinguishes effective treatment, partial efficacy, and not responding.
journals.sagepub.com/doi/10.1177/03331024251325526
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Cephalalgia
@JCephalalgia
March's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine” which has been selected as the Editor’s Choice for the March issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep.
....
doi.org/10.1177/03331024251329400
#migraine #headache #brain #pain #neurology #neuroscience
@PetterOmland
@NorHeadResearch -
Cephalalgia reposted
Cherubino Di Lorenzo
@robydilorenzo
Migraine is a more complex mosaic than we can imagine.
@JCephalalgia @MarcoLisicki @jeanschoenen
journals.sagepub.com/doi/10.1177/03331024251327361 -
Cephalalgia
@JCephalalgia
March's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine” which has been selected as the Editor’s Choice for the March issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep.
....
doi.org/10.1177/03331024251329400
#migraine #headache #brain #pain #neurology #neuroscience
@PetterOmland
@NorHeadResearch -
Cephalalgia reposted
Norwegian Centre for Headache Research
@NorHeadResearch
Recent study from @PetterOmland on the impact of insufficient sleep on #migraines. Results show altered pain responses in migraine sufferers compared to controls after reduced sleep. Findings highlight a vulnerability to insufficient sleep between attacks. journals.sagepub.com/doi/10.1177/03331024251329400
-
Cephalalgia
@JCephalalgia
This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep.
journals.sagepub.com/doi/10.1177/03331024251329400
#migraine #headache #brain #pain #neurology #neuroscience
@PetterOmland
@NorHeadResearch -
Cephalalgia
@JCephalalgia
📬✨ Stay Ahead in Headache Research!
Never miss a breakthrough—sign up for Cephalalgia Table of Contents alerts and get the latest in headache and migraine research delivered straight to your inbox.
🔗 Stay informed. Stay inspired.
journals.sagepub.com/home/CEP
#cephalalgia #headacheresearch #neurology #stayupdated #migrainescience -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
The Cephalalgia Award is yet another great reason to submit the best headache research to @JCephalalgia!
Cephalalgia
@JCephalalgia
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
Cephalalgia
@JCephalalgia
Exciting News! 🏆
The 2025 Cephalalgia Award winner has been selected! 🎉
The official announcement will take place at IHC 2025, where the recipient will also present their groundbreaking work.
This prestigious award, presented every two years at the International Headache Congress, honors the best paper published in Cephalalgia over the past two years. The selection process is conducted through blind voting by the journal's editorial team, ensuring the highest standards of excellence and rigor.
💰 Prize: €10,000
🔍 More on past winners: journals.sagepub.com/page/cep/awardwinners
Stay tuned for the big reveal—and if you want your research to be considered for the next award, submit your best work to Cephalalgia!
#cephalalgiaaward #headacheresearch #ihc2025 #scientificexcellence #cephalalgia #migraine #headache -
Cephalalgia
@JCephalalgia
In meta-analysis, the frequency of cervicogenic headache was 3.9% in the general population and 3.1% in headache clinics. This was based on only three eligible studies following ICHD criteria.
•
Females accounted for 80.8% of individuals with cervicogenic headache. No eligible studies reported specific clinical features of cervicogenic headache.
journals.sagepub.com/doi/10.1177/03331024251322446
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Interictal plasma and salivary CGRP levels in vestibular migraine (VM) corresponding to episodic migraine participants do not significantly differ from healthy controls but are elevated in chronic migraine.
•
There is no significant relationship between interictal CGRP levels and clinical characteristics in participants with VM with EM, suggesting that CGRP levels may not serve as effective biomarkers for VM during interictal periods.
journals.sagepub.com/doi/10.1177/03331024251322418
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Almost half of the eligible studies used the screening-tool as evidence of depression, whereas only one study confirmed the diagnosis with a diagnostic interview. This resulted in erroneous estimates of the prevalence of depression among patients with migraine.
•
Correct diagnosis of depression should be conducted as described in national and international guidelines.
•
Guidelines for the use of depression screening tools in patients with migraine are needed.
journals.sagepub.com/doi/10.1177/03331024251317635
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Among adult patients evaluated for headache or facial pain in tertiary care settings, the pooled relative frequency of occipital neuralgia (ON) ranged from 0.6 to 24.4%, underscoring the need for more accurate estimates.
•
The clinical presentation of ON was predominantly unilateral (81%), almost exclusively affecting the greater occipital nerve (98%), with 73% presenting with hypoesthesia. The intensity of pain was mostly severe (54%) with a stabbing quality (59%).
journals.sagepub.com/doi/10.1177/03331024251317595
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Functional connectivity changes were found after three months of treatment with galcanezumab among patients with high-frequency episodic or chronic migraine.
•
In the treatment responders, reduced functional connectivity was observed between the somatosensory, motor, and insular cortices, and several visual regions after treatment.
•
The findings suggest that reduction in nociceptive signals allows the cortex to return to a more normal and less excitable state indicated by decreased synchrony/co-activation between these regions.
journals.sagepub.com/doi/10.1177/03331024241313377
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Meta-analysis of cervicogenic headache revealed a prevalence of 3.9% in the population and 3.1% in clinics, of which of 80.8% were female. The limited data stressed the need for standardization of research and clinical criteria.
journals.sagepub.com/doi/10.1177/03331024251322446
#migraine #headache #brain #pain #neurology #neuroscience
@SaitAshina
@drfa_CPH -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Celebrating an outstanding service! ✨✨✨
Around a year ago, @faradoost and @NinaRiggins, social media edits, joined @JCephalalgia and @cephreports. They have embodied our mission - advancing knowledge by sharing our scientific content. Here’s to many more milestones! 👏🏻👏🏻👏🏻
Cephalalgia
@JCephalalgia
Exciting news!
Faraidoon Haghdoost and Nina Riggins are stepping in as the social media editors for Cephalalgia and Cephalalgia Reports.
Welcome aboard, Faraidoon @faradoost and Nina @NinaRiggins
#headache #socialmedia #neurology -
Cephalalgia
@JCephalalgia
Editor's Choice: An Interview with Drs Andrew Russo and Erik Zorrilla by Dr Nina Riggins.
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice.
Link to the video:
www.youtube.com/watch?v=pJOXHSHa210&ab_channel=Internatio…
Link to the paper:
journals.sagepub.com/doi/10.1177/03331024251314487
#migraine #headache #brain #pain #neurology #neuroscience
@NinaRiggins
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Plasma and salivary CGRP levels in participants with vestibular migraine (VM) were not significantly different from those in healthy controls but significantly elevated in those with chronic migraine (CM).
journals.sagepub.com/doi/10.1177/03331024251322418
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
International Headache Society
@ihs_official
The International Headache Society has developed these guidelines for optimizing the design and conduct of real-world data (RWD) studies, and therefore the strength and reliability of their output.
journals.sagepub.com/doi/10.1177/03331024251318016
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia @ppozorosich -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
A must for general neurologists and those with special interest in headache
Cephalalgia
@JCephalalgia
📢 New Neurology Podcast episode! 🎙️
In the @GreenJournal podcast from the American Academy of Neurology @AANmember Dr. Jessica Ailani interviews Dr. Francesca Puledda (@pul_fra) from @KingsCollegeLon on the @ihs_official practical recommendations for migraine, recently published in @JCephalgia !
Tune in here:
www.neurology.org/media/podcast/global-recommendations-mi…
📄 Read the full articles in Cephalalgia:
Acute:
journals.sagepub.com/doi/10.1177/03331024241252666
Preventive:
journals.sagepub.com/doi/10.1177/03331024241269735
A must-listen for anyone interested in evidence-based migraine management!
Kudos to Francesca and Jessica for this clinical useful podcast! 👏 #migraine #neurology #cephalalgia -
Cephalalgia
@JCephalalgia
A recent review on occipital neuralgia (ON), a severe and paroxysmal pain condition affecting the occipital nerves, analyzed data from 15 clinic-based studies involving 579 patients.
ON shows female predominance and links with migraine and neck trauma.
journals.sagepub.com/doi/10.1177/03331024251317595
#migraine #headache #brain #pain #neurology #neuroscience
@h_ashina -
Cephalalgia
@JCephalalgia
📢 New Neurology Podcast episode! 🎙️
In the @GreenJournal podcast from the American Academy of Neurology @AANmember Dr. Jessica Ailani interviews Dr. Francesca Puledda (@pul_fra) from @KingsCollegeLon on the @ihs_official practical recommendations for migraine, recently published in @JCephalgia !
Tune in here:
www.neurology.org/media/podcast/global-recommendations-mi…
📄 Read the full articles in Cephalalgia:
Acute:
journals.sagepub.com/doi/10.1177/03331024241252666
Preventive:
journals.sagepub.com/doi/10.1177/03331024241269735
A must-listen for anyone interested in evidence-based migraine management!
Kudos to Francesca and Jessica for this clinical useful podcast! 👏 #migraine #neurology #cephalalgia -
Cephalalgia reposted
Teshamae Monteith, M.D., FAHS, FAAN
@headacheMD
Thank you for helping us to set higher standards for migraine care! @JCephalalgia @ihs_official
-
Cephalalgia reposted
International Headache Society
@ihs_official
www.youtube.com/watch?v=-KCPdrBbTRc
Cephalalgia Editor’s Choice Episode 14 – Interview with Dr Dwij Mehta
#headache #orthostatic @Simona_Sacco @JCephalalgia @NinaRiggins -
Cephalalgia
@JCephalalgia
This study reviewed the methodological challenges in using depression screening questionnaires in patients with migraine, in order to investigate whether they are applied and interpreted correctly
journals.sagepub.com/doi/10.1177/03331024251317635
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Reduction in cortical functional connectivity was observed in treatment responders after 3 months of treatment with galcanezumub.
journals.sagepub.com/doi/10.1177/03331024241313377
#migraine #headache #brain #pain #neurology #neuroscience
@SaitAshina
@ramiburstein -
Cephalalgia reposted
International Headache Society
@ihs_official
An independent dose-response association between headache frequency and odds, severity, and impact of fibromyalgia in migraine patients.
journals.sagepub.com/doi/10.1177/03331024251317486
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia -
Cephalalgia reposted
International Headache Society
@ihs_official
Today is Cluster Headache Awareness Day.
Did you know that before the bouts of cluster headache, there is often a brief pre-cluster phase?
Watch this short video by Dr. Jr-Wei Wu @Bohemian_Wu , Chair of the IHS Communication Committee, as he shares new research findings on pre-cluster symptoms and their potential role in the treatment of cluster headache.
To learn more, please go to: doi.org/10.1186/s10194-024-01862-8
#cluster_headache #cefaleia_em_salvas #cefalea_en_racimos #cluster_kopfschmerz #叢發性頭痛 #群発頭痛 #군발두통 -
Cephalalgia
@JCephalalgia
🔴 How to Diagnose Cluster Headache? 🔴
Today is International Cluster Headache Awareness Day, a moment to highlight this debilitating condition and improve recognition.
🎥 Watch this short video by Dr. Faraidoon Haghdoost, One of the Social Media Editors of Cephalalgia, on how to diagnose cluster headache and ensure timely, accurate identification.
📢 Let’s raise awareness and support those affected!
@faradoost
#clusterheadache #neurology #migraine #painmanagement #clusterheadacheawarenessThis media couldn't be displayed. See it on the original post. -
Cephalalgia
@JCephalalgia
Clinical data from 4 ubrogepant and 4 atogepant randomized, double-blind, placebo-controlled trials showed male participants experienced migraine symptom improvement.
journals.sagepub.com/doi/10.1177/03331024251320610
#migraine #headache #brain #pain #neurology #neuroscience
@JCephalalgia -
Cephalalgia reposted
International Headache Society
@ihs_official
Tomorrow, March 21, is International Cluster Headache Awareness Day. Dr. Nina Riggins, Cephalalgia's Social Media Editor, invites everyone to help raise awareness of cluster headache.
#cluster_headache #cefaleia_em_salvas #cefalea_en_racimos #cluster-Kopfschmerz #叢發性頭痛 #群発頭痛 #군발두통 -
Cephalalgia reposted
BIDMC Headache Center
@bidmcheadache
New meta-analysis highlights the limited data on cervicogenic #headache prevalence & frequency. Clinic-based studies suggest a 3.1% relative frequency, with women most affected. More research is needed to refine diagnosis & classification @JCephalalgia
rb.gy/1e6qqt -
Cephalalgia
@JCephalalgia
What is Proper Migraine Management?
Watch this very short video by our Social Media Editor, Dr. Faraidoon Haghdoost @faradoost , on the recent position statement by the International Headache Society.
This statement calls for ambitious goals in migraine prevention, shifting the focus toward migraine freedom and optimal control—not just reducing attacks.
Link to the paper:
journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sait Ashina
@SaitAshina
Our study finds cervicogenic headache affects 3.9% of the population and 3.1% of headache clinic patients, mostly women. Limited data highlight the need for more research on diagnosis and classification. #neurology #headachemedicine #cervicogenicheadache
👉rb.gy/hx3lyc -
Cephalalgia reposted
International Headache Society
@ihs_official
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Chilblains may be a spontaneous, monophasic reaction triggered by galcanezumab. Prescribers should be aware of this potential side effect in the post-marketing phase of this medication.
journals.sagepub.com/doi/10.1177/25158163251322967
#migraine #headache #brain #pain #neurology #neuroscience
@dr_jray1 -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
In line with previous reports, in naïve mice, supradural CGRP promotes migraine-like pain behavior preferentially in females.
•
Naïve female mice show significantly increased number of CGRP-expressing neurons in the ophthalmic region of the trigeminal ganglion (TGV1) compared to males; no difference in CGRP dural innervation fiber density was observed.
•
Induction of CM with repeated NTG or of MOH with sumatriptan increases the sensitivity to migraine-like pain elicited by previously subthreshold doses of supradural CGRP in both female and male mice.
•
Following the induction of CM, mice of both sexes exhibit an increased number of CGRP-expressing neuronal cell bodies in the TGV1; sex differences in CGRP-positive dural sensory innervation were not detected.
•
Mice of both sexes become sensitized to CGRP with increasing migraine frequency consistent with clinical observations of efficacy of CGRP-targeting therapies for migraine prevention in both men and women frequent EM or CM.
•
Sensitization to CGRP-induced migraine-like nociception suggests the possibility of increased efficacy of CGRP targeting therapies in management of acute migraine in men with more frequent migraine.
journals.sagepub.com/doi/10.1177/03331024251317446
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
A mouse model of mild traumatic brain injury (mTBI) produced generalized periorbital and hindpaw cutaneous allodynia as well as thermal hypersensitivity, which suggest central sensitization in promoting multiple PTH-related pain modalities.
•
Following the resolution of mTBI-induced pain, stress triggered cutaneous and thermal allodynia only in previously injured mice, suggesting sustained central sensitization and increased vulnerability to PPTH.
•
Sustained blockade of CGRP signaling with olcegepant prevented mTBI-related APTH as well as stress-induced PPTH more effectively in female than in male mice.
•
CGRP-receptor antagonism after the establishment of central sensitization was minimally effective in blocking PPTH-related pain in either sex.
•
Early and sustained targeted intervention following mTBI with CGRP antagonism may prevent debilitating PTH and its persistence, particularly in females.
journals.sagepub.com/doi/10.1177/03331024251321087
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
This study indicates that patients with MOH report a higher concurrence of psychopathological comorbidities. These can overburden people with migraine, which end up resorting to analgesic overuse, leading to poorer quality of life.
journals.sagepub.com/doi/10.1177/25158163251318713
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
In a mouse model of mild traumatic brain injury, early and continuous blockade of CGRP signaling blocked acute post-traimatic headache (PTH) and prevented PTH persistence, with greater analgesic effects in females than males.
journals.sagepub.com/doi/10.1177/03331024251321087
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Annoucment of the Jes Olesen Awards.
The International Headache Society (IHS) has announced the launch of the annual Jes Olesen Awards. Two awards will be granted each year, recognising outstanding original contributions in each of clinical and basic science research.
Read the paper:
journals.sagepub.com/doi/10.1177/03331024251318563
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Mice of both sexes become sensitized to CGRP with increasing migraine frequency consistent with clinical observations of efficacy of CGRP-targeting therapies for migraine prevention in both men and women frequent EM or CM.
journals.sagepub.com/doi/10.1177/03331024251317446
#migraine #headache #brain #pain #neurology #neuroscience
@daviddodick -
Cephalalgia
@JCephalalgia
Guidelines for the use of depression screening tools in patients with migraine are needed.
journals.sagepub.com/doi/10.1177/03331024251317606
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Patients on long-term mexiletine were titrated to a median last daily dose of 600 mg, which may be a reasonable target dose for rCM patients.
•
The presence of dizziness as an adverse effect during lidocaine infusion was associated with early mexiletine discontinuation.
•
The most reported side effects of mexiletine were nausea, dizziness, and tremors.
journals.sagepub.com/doi/10.1177/25158163241313123
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
A position statement by the International Headache Society calls for ambitious goals in migraine prevention, aiming for migraine freedom and optimal control.
doi.org/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
February's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice” which has been selected as the Editor’s Choice for the February issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
.....
Using three mouse models, this study examined the impact of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) on migraine-relevant behaviors triggered by (1) calcitonin gene-related peptide (CGRP), (2) sodium nitroprusside (SNP), and (3) cortical spreading depolarization (CSD).
....
journals.sagepub.com/doi/full/10.1177/03331024251314487
@AS_Wattz -
Cephalalgia
@JCephalalgia
Raising the Bar for Migraine Prevention!
The International Headache Society calls for higher treatment standards in migraine prevention. With new therapies like CGRP inhibitors, we should aim beyond just reducing attacks—toward migraine freedom and better patient outcomes.
📖 Read the full paper: journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
@ihs_official position stament in @JCephalalgia
Grant Rivers
@GrantSRivers
Finally, changes are ahead for those of us who battle with #migraine & the difficulties associated with them.
The new Position Statement from @ihs_official calls for a reconsideration of the goals of migraine prevention with an emphasis on improving quality of life. -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
In this paper, we highlight the need to move beyond percentage-based success metrics and focus on absolute improvements—aiming for migraine freedom and optimal patient outcomes.
🔗 Read the full paper here: journals.sagepub.com/doi/full/10.1177/03331024251320608
9NEWS report:
www.9news.com.au/national/migraine-new-push-to-help-austr…
The George Institute for Global Health
@georgeinstitute
We welcome new international migraine management guidance to raise the target reduction of migraine days from 50% to 90-100%.
If adopted, the recommendations have the potential to improve the lives of millions of Australians impacted by migraine.
➡️www.georgeinstitute.org/news-and-media/news -
Cephalalgia reposted
LAB-NEU
@lab_neu2024
🚨 Position Statement Alert 🚨
Migraine prevention needs a paradigm shift! This paper from @ihs_official advocates for raising treatment goals beyond the traditional ≥50% reduction in migraine days, emphasizing absolute outcomes like migraine freedom or minimal residual burden.
Cephalalgia
@JCephalalgia
Raising the Bar for Migraine Prevention!
The International Headache Society calls for higher treatment standards in migraine prevention. With new therapies like CGRP inhibitors, we should aim beyond just reducing attacks—toward migraine freedom and better patient outcomes.
📖 Read the full position statement: journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience
.....
@Simona_Sacco_
@MessoudAshina
@faradoost
@headacheMD
@mariofpperes
@ppozorosich
@RaffaeleOrnello
@pul_fra
@schwedtt
@FayyazA85079186
@Cristina4ihs -
Cephalalgia reposted
Sait Ashina
@SaitAshina
New research shows that #galcanezumab may reshape brain function in #migraine. Responders exhibited reduced connectivity in pain-processing regions, suggesting cortical recovery. Check out our study!
#galcanezumab #cgrp #migraine #pain #brain #mri #imaging
shorturl.at/7OvOC -
Cephalalgia reposted
DR. MICHEL VOLCY MD Neurológo Cefaliatra
@Indocen
Fundamental @ihs_official Statement. Migraine prevention freedom, optimal, modest and insufficient control. Higher and better objectives should be final goal. @ACNeurologia @MinSaludCol @invimacolombia @IETSColombia @Medicina_UdeA Prevención migraña: Altos estándares pocos días
International Headache Society
@ihs_official
Raising the Bar for Migraine Prevention!
The International Headache Society calls for higher treatment standards in migraine prevention. With new therapies like CGRP inhibitors, we should aim beyond just reducing attacks—toward migraine freedom and better patient outcomes.
📖 Read the full paper: journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Cherubino Di Lorenzo
@robydilorenzo
Alzare l'asticella, per pretendere il meglio per i nostri pazienti.
Cephalalgia
@JCephalalgia
Raising the Bar for Migraine Prevention!
The International Headache Society calls for higher treatment standards in migraine prevention. With new therapies like CGRP inhibitors, we should aim beyond just reducing attacks—toward migraine freedom and better patient outcomes.
📖 Read the full position statement: journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience
.....
@Simona_Sacco_
@MessoudAshina
@faradoost
@headacheMD
@mariofpperes
@ppozorosich
@RaffaeleOrnello
@pul_fra
@schwedtt
@FayyazA85079186
@Cristina4ihs -
Cephalalgia
@JCephalalgia
Raising the Bar for Migraine Prevention!
The International Headache Society calls for higher treatment standards in migraine prevention. With new therapies like CGRP inhibitors, we should aim beyond just reducing attacks—toward migraine freedom and better patient outcomes.
📖 Read the full position statement: journals.sagepub.com/doi/full/10.1177/03331024251320608
#migraine #headache #brain #pain #neurology #neuroscience
.....
@Simona_Sacco_
@MessoudAshina
@faradoost
@headacheMD
@mariofpperes
@ppozorosich
@RaffaeleOrnello
@pul_fra
@schwedtt
@FayyazA85079186
@Cristina4ihs -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Pleased to share the updated aim and scope of @cephreports. The journal plays a vital role in supporting the @ihs_official mission to address the global burden of headache. We welcome submissions that align with the journal’s scope. For more info, please visit the journal website
Cephalalgia
@JCephalalgia
Cephalalgia Reports: Expanding Science & Bridging Global Gaps
Our latest editorial highlights the evolution of Cephalalgia Reports, reinforcing its mission to address regional disparities in headache research and care. From showcasing local insights to amplifying diverse voices, we’re committed to advancing headache science worldwide.
....
journals.sagepub.com/doi/10.1177/25158163251316840
....
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@mariofpperes
@ramiburstein -
Cephalalgia
@JCephalalgia
Cephalalgia Reports: Expanding Science & Bridging Global Gaps
Our latest editorial highlights the evolution of Cephalalgia Reports, reinforcing its mission to address regional disparities in headache research and care. From showcasing local insights to amplifying diverse voices, we’re committed to advancing headache science worldwide.
....
journals.sagepub.com/doi/10.1177/25158163251316840
....
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@mariofpperes
@ramiburstein -
Cephalalgia
@JCephalalgia
Exciting News: Graphical Abstracts Now in Cephalalgia Reports!
Following the success of graphical abstracts in Cephalalgia, we’re thrilled to announce that Cephalalgia Reports will now feature graphical abstracts to enhance the visibility and accessibility of headache research!
🎨 Why Graphical Abstracts?
✅ Concise, engaging visual summaries
✅ Improves knowledge dissemination
✅ Increases research impact & accessibility
To support this initiative, Esme Ekizoğlu and Rogelio Dominguez-Moreno have been appointed as Graphical Abstract Editors, bringing expertise to help authors craft high-quality visuals.
....
journals.sagepub.com/doi/10.1177/25158163251316843
....
#migraine #headache #brain #pain #neurology #neuroscience
@Simona_Sacco_
@rogelio_dm -
Cephalalgia reposted
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
Cephalalgia
@JCephalalgia
Cephalalgia Editor’s @Simona_Sacco Choice Article! 👏Fantastic Professor Jes Olesen interview with Social Media Editor @JCephalalgia @NinaRiggins
#methodology of drug trials in #migraine Cephalalgia 2024;44(12). doi:10.1177/03331024241298642 @ihs_official
www.youtube.com/watch?v=ZCy6Rl7Dh-s -
Cephalalgia
@JCephalalgia
Cephalalgia Editor’s @Simona_Sacco Choice Article! 👏Fantastic Professor Jes Olesen interview with Social Media Editor @JCephalalgia @NinaRiggins
#methodology of drug trials in #migraine Cephalalgia 2024;44(12). doi:10.1177/03331024241298642 @ihs_official
www.youtube.com/watch?v=ZCy6Rl7Dh-s -
Cephalalgia
@JCephalalgia
Monoclonal antibodies targeting CGRP or the CGRP-receptor may increase BP, but evidence is still limited to one study that indicates a mean increase of 5.2 mmHg in systolic BP during treatment with anit-CGRP(R)-mAbs.
•
The decision to initiate antihypertensive therapy, particularly in (young) patients with mild elevations in BP, should be individualized. Although some may argue against starting treatment in low-risk scenarios, evidence from meta-analyses supports considering antihypertensive therapy, such as candesartan or beta-blockers, which also offer migraine prophylactic benefits.
•
Given the limited current data, additional post-marketing studies are needed to assess the long-term effects of anti-CGRP(R)-mAbs on BP and overall cardiovascular safety.
•
Until more evidence is available, it seems prudent to monitor blood pressure during treatment with anti-CGRP(R)-mAbs.
journals.sagepub.com/doi/10.1177/03331024241297673
#migraine #headache #brain #pain #neurology #neuroscience
@HeadacheLUMC -
Cephalalgia
@JCephalalgia
Approximately 1/3 of patients with NDPH responded to treatment with onabotulinumtoxinA.
Response rates in NDPH were similar to daily chronic migraine.
....
journals.sagepub.com/doi/10.1177/03331024251317448
#migraine #headache #brain #pain #neurology #neuroscience
@sanjay_cheema
@Manjit_Matharu
@SusieLagrata -
Cephalalgia reposted
International Headache Society
@ihs_official
♥️ 2025 Tension-Type Headache (TTH) Awareness Day ♥️
In 2024, @JCephalalgia published a fascinating paper exploring the time features of TTH and other primary headaches. Learn more here: 🔗
journals.sagepub.com/doi/10.1177/03331024241297652
#tth2025 -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
CGRP関連抗体薬による血圧上昇の可能性について言及されています。
血圧を上げないという研究も多く、そんなに神経質に気にしなくても良いかとは思います。
ただ高血圧のリスクを持つ方は導入時にフォローする方が丁寧ですね。
Cephalalgia
@JCephalalgia
Despite the demonstrated effectiveness and tolerability of anti-CGRP-mAbs in migraine prevention, this systematic review highlights the importance of closely monitoring the blood pressure of patients undergoing CGRP-targeted treatment
journals.sagepub.com/doi/10.1177/03331024241297673
@HeadacheLUMC
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sage Journals
@SageJournals
@JCephalalgia honors groundbreaking headache research with the Jes Olesen Awards.
Final reminder: submissions due February 28, 2025. Each award offers a €10,000 prize, with winners presenting at the International Headache Congress.
➡️journals.sagepub.com/page/cep/call-for-papers/jo-health-a… -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Despite the demonstrated effectiveness and tolerability of anti-CGRP-mAbs in migraine prevention, this systematic review highlights the importance of closely monitoring the blood pressure of patients undergoing CGRP-targeted treatment
journals.sagepub.com/doi/10.1177/03331024241297673
@HeadacheLUMC
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
In this retrospective observational study the effectiveness and safety of eptinezumab was confirmed also in people with migraine who had failed erenumab/galcanezumab, hinting at the possibility of a successful switch also in these patients.
journals.sagepub.com/doi/10.1177/25158163251316809
#migraine #headache #brain #pain #neurology #neuroscience
@cephreports -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
血中プロラクチンの上昇は女性の神経を過敏にし、頭痛を誘発するようです。
女性の頭痛は月経周期にともなうホルモンの変動にかなり影響されるため、治療が難しくなることがあります。
一方で、高プロラクチンレベルを伴う慢性頭痛にはドパミンアゴニストなどを適切に用いるなど、ホルモンをコントロールすることで治療できるかも。とのこと。
Cephalalgia
@JCephalalgia
Endometriosis represents a risk factor for migraine, but the mechanisms underlying this comorbidity are unknown.
....
Using a mouse endometriosis model, this study demonstrated that circulating prolactin promotes vulnerability to migraine through sensitization of trigeminal neurons.
....
Prolactin lowering medications may be effective for migraine prevention in women with endometriosis.
journals.sagepub.com/doi/10.1177/03331024241313378
....
@schwedtt
@daviddodick
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Endometriosis is a risk factor for migraine. In a mouse endometriosis model, prolactin promoted vulnerability to migraine by sensitizing trigeminal neurons. Prolactin lowering medications may prevent migraine in women with endometriosis.
journals.sagepub.com/doi/10.1177/03331024241313378
@schwedtt
@daviddodick
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
People genetically predisposed to autism are more likely to experience migraine, including migraine with and without aura.
•
The findings are based on genetic data from over 300,000 individuals
•
Sex does not affect the association
•
Personality trait neuroticism partly explains this relationship
•
The findings highlight the complex genetic and psychological connections between autism and migraine
journals.sagepub.com/doi/10.1177/03331024241312666
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Endometriosis represents a risk factor for migraine, but the mechanisms underlying this comorbidity are unknown.
....
Using a mouse endometriosis model, this study demonstrated that circulating prolactin promotes vulnerability to migraine through sensitization of trigeminal neurons.
....
Prolactin lowering medications may be effective for migraine prevention in women with endometriosis.
journals.sagepub.com/doi/10.1177/03331024241313378
....
@schwedtt
@daviddodick
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Rogelio Dominguez Moreno
@rogelio_dm
VIP!, la endometriosis eleva la prolactina y la prolactina podría aumentar el riesgo de padecer migraña (por eso no es rara esa comorbilidad). Lo cual abre la puerta a la investigación del rol de esta hormona como biomarcador o de terapias dirigidas a esta hormona.
#modeloenrata -
Cephalalgia
@JCephalalgia
January's Editor's Choice
@Simona_Sacco_
We are pleased to announce and congratulate the authors on their paper, “Defining the Typical Characteristics of Orthostatic Headache in Patients with Spontaneous Intracranial Hypotension,” which has been selected as the Editor’s Choice for the January issue of Cephalalgia.
This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.
......
Time to baseline headache severity on lying down is the most important factor when assessing for an orthostatic headache. In patients with chronic headaches, retrospective history of orthostatic headache at onset should be sought as this quality can be lost with time. Rhinorrhoea can be present in almost 14% of patients with spontaneous intracranial hypotension.
.........
journals.sagepub.com/doi/10.1177/03331024241308154
@Manjit_Matharu
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
People genetically predisposed to autism are more likely to experience migraine, including migraine with and without aura.
Sex does not affect, and personality trait neuroticism partly explains this relationship.
journals.sagepub.com/doi/10.1177/03331024241312666
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
"🏆 Announcing the Jes Olesen Awards! 🌍✨
Cephalalgia proudly introduces these prestigious awards, recognizing groundbreaking research in headache medicine. With a €10,000 prize for each category, we’re seeking the best original papers in both basic and clinical sciences. Don’t miss this opportunity to showcase your work on a global stage and advance the understanding of headache disorders!
📅 Submission opens 1 October 2024 – 28 February 2025 💡 Categories: Basic Science & Clinical Science 🏅
Winners Will:
Present at the International Headache Congress
Gain Global Recognition on Cephalalgia & IHS Platforms
Submit your breakthrough research and be recognized as a leader in the field!" -
Cephalalgia reposted
LAB-NEU
@lab_neu2024
Congratulations to @RaffaeleOrnello from @univaq! @JCephalalgia
Cephalalgia
@JCephalalgia
🎉✨ Celebrating Our Exceptional Peer Reviewers for Cephalalgia
On behalf of the entire Cephalalgia journal team, we extend our deepest gratitude and heartfelt congratulations to our exceptional peer reviewers for their invaluable contributions:
Gregory Dussor (U.S.A.)
David Garcia-Azorin (Spain)
Roberta Messina (Italy)
Raffaele Ornello (Italy)
Aynur Özge (Turkey)
Lanfranco Pellesi (Denmark)
Their dedication, expertise, and insightful feedback have been instrumental in ensuring the high quality and rigor of Cephalalgia.
✨ Exceptional reviewers were selected based on:
Number of reviews completed
Ratio of reviews accepted versus invitations sent
Timeliness in completing reviews
Quality of review reports
📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!
#cephalalgia #peerreview #academicexcellence #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sage Journals
@SageJournals
Gain global recognition with the Jes Olesen Awards on Cephalalgia & IHS platforms. We seek the best original papers in basic and clinical sciences.
Showcase your work and advance headache disorder understanding! Submit by 28 February 2025.
journals.sagepub.com/page/cep/call-for-papers/jo-health-a… @JCephalalgia -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Less than 1 month left to apply for the prestigious Jes Olesen award 🥇
Cephalalgia
@JCephalalgia
Cephalalgia is pleased to announce the establishment of the Jes Olesen Awards, recognising outstanding contributions in headache medicine across both clinical and basic sciences.
The awards will be granted annually to the best original research papers submitted under a dedicated call.
Each year there will be two awards, one for a basic science paper, and one for a clinical paper.
Recipients will present their work at the bi-ennial International Headache Congress.
Award value: Eur 10,000 per award
Submission closes 28 February 2025.
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
📢 Call for Papers: Digital Headache
🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders.
Introduction
The development of new digital technologies and their increasing use is impacting headache and migraine care and research. This special issue of Cephalalgia will explore the emerging field of "Digital Headache," encompassing the various ways in which advancements in technology and digital device use may contribute or impact the headache field.
Scope
We invite submissions on a wide range of topics related to Digital Headache, including but not limited to:
✔ Artificial intelligence
✔ Chatbots
✔ Telemedicine
✔ Digital education
✔ Digital technology in research
✔ Impact of digital devices on headache
✔ Public health impact of digital technology
Submission Guidelines
📌 All submissions must adhere to the general submission guidelines of Cephalalgia.
📌 Manuscripts should be submitted electronically through the journal's online submission system.
📌 Please clearly indicate in the cover letter that the manuscript is intended for the "Digital Headache" special issue.
⏳ Deadline for Submissions: December 31, 2025
⚠ Disclaimer: This Call for Papers is for informational purposes only. The final decision on manuscript acceptance rests with the Editor-in-Chief of Cephalalgia.
@Simona_Sacco_
#digitalheadache #cephalalgia #headacheresearch #aiinmedicine #telemedicine #medicalresearch #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Cephalalgia is pleased to announce the establishment of the Jes Olesen Awards, recognising outstanding contributions in headache medicine across both clinical and basic sciences.
The awards will be granted annually to the best original research papers submitted under a dedicated call.
Each year there will be two awards, one for a basic science paper, and one for a clinical paper.
Recipients will present their work at the bi-ennial International Headache Congress.
Award value: Eur 10,000 per award
Submission closes 28 February 2025.
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Time to baseline headache severity on lying down is the most important factor when assessing for an orthostatic headache. In patients with chronic headaches, retrospective history of orthostatic headache at onset should be sought as this quality can be lost with time. Rhinorrhoea can be present in almost 14% of patients with spontaneous intracranial hypotension.
journals.sagepub.com/doi/10.1177/03331024241308154
#migraine #headache #brain #pain #neurology #neuroscience
@Manjit_Matharu -
Cephalalgia
@JCephalalgia
Study reveals significant sex differences in photophobia after cortical spreading depression in rats, shedding light on gender-specific pain mechanisms.
journals.sagepub.com/doi/10.1177/03331024241310550
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Congratulations to @Raffaelli_B and welcome in the Editorial Board!@JCephalalgia @cephreports
Cephalalgia
@JCephalalgia
🎉✨ Announcing the Top Peer Reviewer Award Winner for Cephalalgia!
We are thrilled to recognize Bianca Raffaelli as the recipient of the Top Peer Reviewer Award! Her exceptional contributions, insightful feedback, and unwavering dedication have been instrumental in upholding the high quality and rigor of Cephalalgia.
Additionally, we’re delighted to announce that Bianca has been appointed as an Associate Editor for the journal—a well-deserved recognition of her expertise and commitment to advancing headache research.
📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!
Please join us in congratulating Bianca on these remarkable achievements!
#cephalalgia #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New study by @ChrStaehr et al. uses a genotype-first strategy to study FHM-associated genes. Variants in CACNA1A and ATP1A2 are linked to migraine. Intriguingly, homozygous SCN1A variants increase migraine risk but reduce epilepsy risk!
journals.sagepub.com/doi/10.1177/03331024241306103
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Sucharita Ray
@Atirahcus
Congratulations Bianca! And thank you @JCephalalgia and @Simona_Sacco_ for recognizing the work of peer reviewers and acknowledging their work!
Love to learn from the best! -
Cephalalgia
@JCephalalgia
🎉✨ Announcing the Top Peer Reviewer Award Winner for Cephalalgia!
We are thrilled to recognize Bianca Raffaelli as the recipient of the Top Peer Reviewer Award! Her exceptional contributions, insightful feedback, and unwavering dedication have been instrumental in upholding the high quality and rigor of Cephalalgia.
Additionally, we’re delighted to announce that Bianca has been appointed as an Associate Editor for the journal—a well-deserved recognition of her expertise and commitment to advancing headache research.
📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!
Please join us in congratulating Bianca on these remarkable achievements!
#cephalalgia #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🎉✨ Celebrating Our Exceptional Peer Reviewers for Cephalalgia
On behalf of the entire Cephalalgia journal team, we extend our deepest gratitude and heartfelt congratulations to our exceptional peer reviewers for their invaluable contributions:
Gregory Dussor (U.S.A.)
David Garcia-Azorin (Spain)
Roberta Messina (Italy)
Raffaele Ornello (Italy)
Aynur Özge (Turkey)
Lanfranco Pellesi (Denmark)
Their dedication, expertise, and insightful feedback have been instrumental in ensuring the high quality and rigor of Cephalalgia.
✨ Exceptional reviewers were selected based on:
Number of reviews completed
Ratio of reviews accepted versus invitations sent
Timeliness in completing reviews
Quality of review reports
📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!
#cephalalgia #peerreview #academicexcellence #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
New study by @ChrStaehr et al. uses a genotype-first strategy to study FHM-associated genes. Variants in CACNA1A and ATP1A2 are linked to migraine. Intriguingly, homozygous SCN1A variants increase migraine risk but reduce epilepsy risk!
journals.sagepub.com/doi/10.1177/03331024241306103
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Christian Staehr
@ChrStaehr
🧠 Our new study in @JCephalalgia (journals.sagepub.com/doi/full/10.1177/03331024241306103) explores genetic variants in FHM1-3 genes using @uk_biobank data.
A genotype-first approach revealed that these 🧬variants ⬆️#migraine risk—and surprisingly, a link to ⬇️ #epilepsy was discovered.
Here’s what we found🧵 -
Cephalalgia
@JCephalalgia
Time to baseline headache severity on lying down is the most important factor when assessing for an orthostatic headache. In patients with chronic headaches, retrospective history of orthostatic headache at onset should be sought as this quality can be lost with time. Rhinorrhoea can be present in almost 14% of patients with spontaneous intracranial hypotension.
journals.sagepub.com/doi/10.1177/03331024241308154
#migraine #headache #brain #pain #neurology #neuroscience
@Manjit_Matharu -
Cephalalgia
@JCephalalgia
Female rats exhibited a more intense and prolonged photophobic response to potassium chloride (KCl) injections compared to males.
•
KCl injections caused significant light-aversion in females, while males showed no significant change in light-aversion across treatment groups.
•
No sex differences were observed in pupil-to-iris ratios following KCl or aCSF injections.
•
Females demonstrated greater eye closure and periorbital allodynia post-KCl injection compared to males, indicating stronger pain-related responses in females.
journals.sagepub.com/doi/10.1177/03331024241310550
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Peter Kranz
@PeterGKranz
So what exactly makes a headache orthostatic anyway?
📄 New paper alert 📄
journals.sagepub.com/doi/full/10.1177/03331024241308154 -
Cephalalgia reposted
Keren Leah
@KerenLeah
This is a visual representation of the abstract ⬇️ 🧠💧#sih #csfleak
-
Cephalalgia reposted
Keren Leah
@KerenLeah
🧠🆕️🔓 A specialist interest group shares the first data-driven definition of the typical #orthostaticheadache characteristics observed in Spontaneous Intracranial Hypotension ⬇️
💧@csfleakuk #spinalcsfleak #headache #neurox #neurotwitter #medtwitter
journals.sagepub.com/doi/full/10.1177/03331024241308154 -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
The deadline for submitting your work for this prestigious award is fast approaching! Don’t miss the chance to bring your work into the spotlight and enter the arena of excellence! @JCephalalgia @ihs_official
Cephalalgia
@JCephalalgia
"🏆 Announcing the Jes Olesen Awards! 🌍✨
Cephalalgia proudly introduces these prestigious awards, recognizing groundbreaking research in headache medicine. With a €10,000 prize for each category, we’re seeking the best original papers in both basic and clinical sciences. Don’t miss this opportunity to showcase your work on a global stage and advance the understanding of headache disorders!
Submission opens 1 October 2024 – 28 February 2025 💡 Categories: Basic Science & Clinical Science 🏅
Winners Will:
Present at the International Headache Congress 🌍
Gain Global Recognition on Cephalalgia & IHS Platforms 📢
Submit your breakthrough research and be recognized as a leader in the field!" -
Cephalalgia
@JCephalalgia
One of the primary focuses of the Cephalalgia and Cephalalgia Reports social media editors has been to ensure that all papers published in the journals are highlighted across the IHS and the journals' social media channels.
journals.sagepub.com/doi/10.1177/03331024241310519
#migraine #headache #brain #pain #neurology #neuroscience
@NinaRiggins
@faradoost
@Simona_Sacco_
@cephreports -
Cephalalgia
@JCephalalgia
"🏆 Announcing the Jes Olesen Awards! 🌍✨
Cephalalgia proudly introduces these prestigious awards, recognizing groundbreaking research in headache medicine. With a €10,000 prize for each category, we’re seeking the best original papers in both basic and clinical sciences. Don’t miss this opportunity to showcase your work on a global stage and advance the understanding of headache disorders!
Submission opens 1 October 2024 – 28 February 2025 💡 Categories: Basic Science & Clinical Science 🏅
Winners Will:
Present at the International Headache Congress 🌍
Gain Global Recognition on Cephalalgia & IHS Platforms 📢
Submit your breakthrough research and be recognized as a leader in the field!" -
Cephalalgia
@JCephalalgia
🎉✨ Exciting News! Welcoming Our New Associate Editors
We’re thrilled to introduce our newest Associate Editors for Cephalalgia and Cephalalgia Reports:
Anna P. Andreou
Rolf Fronczek
Bronwyn Jenkins
Francesca Puledda
Marta Vila Pueyo
Their expertise and dedication will help shape the future of headache research publishing. Join us in giving them a warm welcome to the team!
#cephalalgia #cephalalgiareports #headache #neurology #migraine
@ap_andreou
@pul_fra
@mavipuey
@Simona_Sacco_ -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Welcome on board to the two new Graphical Abstract editors of @cephreports!
Cephalalgia
@JCephalalgia
🎉✨ Welcome to Our New Graphical Abstract Editors!
We are thrilled to introduce Rogelio Dominguez-Moreno and Esme Ekizoğlu as the new Graphical Abstract Editors for Cephalalgia Reports! Their expertise will enhance the visual representation of cutting-edge headache research, making it more accessible and engaging for our readers.
Join us in giving them a warm welcome!
#graphicalabstracts #headache #neurology #medicalpublishing
@rogelio_dm @Simona_Sacco_ -
Cephalalgia
@JCephalalgia
🎉✨ Welcome to Our New Graphical Abstract Editors!
We are thrilled to introduce Rogelio Dominguez-Moreno and Esme Ekizoğlu as the new Graphical Abstract Editors for Cephalalgia Reports! Their expertise will enhance the visual representation of cutting-edge headache research, making it more accessible and engaging for our readers.
Join us in giving them a warm welcome!
#graphicalabstracts #headache #neurology #medicalpublishing
@rogelio_dm @Simona_Sacco_ -
Cephalalgia
@JCephalalgia
Complex regional pain syndrome (CRPS) can present as a syndrome of headache with facial pain.
CRPS can develop without any known mechanically related trauma.
These cases should be reviewed and classified according to the Budapest Criteria as early diagnosis and treatment may improve symptoms and quality of life.
journals.sagepub.com/doi/10.1177/25158163241307325
#headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Simona Sacco
@Simona_Sacco_
Kudos to the two brilliant social media editors of @JCephalalgia and @cephreports 👏🏻 Your work is invaluable in bringing headache science to the world! 🌟 @NinaRiggins @faradoost @ihs_official
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
“Building community and visibility” Published!🙏🧠 @JCephalalgia @ihs_official @Simona_Sacco_ @faradoost @WNGtweets @ahsheadache @AANmember @miles4migraine 🧠 journals.sagepub.com/doi/10.1177/03331024241310519
-
Cephalalgia reposted
Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate
@NinaRiggins
“Building community and visibility” Published!🙏🧠 @JCephalalgia @ihs_official @Simona_Sacco_ @faradoost @WNGtweets @ahsheadache @AANmember @miles4migraine 🧠 journals.sagepub.com/doi/10.1177/03331024241310519
-
Cephalalgia
@JCephalalgia
This study demonstrated that serum uric acid levels in patients with tension type headache were lower than in controls.
Uric acid is a substance that exhibits antioxidant properties by removing superoxide, a reactive oxygen species, from the cell, inhibiting the reaction between superoxide and nitric oxide, and reducing the production of peroxynitrite. Lower uric acid levels may indicate a role in tension type headache (TTH) pathophysiology by affecting oxidative stress mechanisms, inflammation and neuroprotection.
Modifying uric acid levels may lead to new therapeutic approaches in the treatment of TTH.
journals.sagepub.com/doi/10.1177/25158163241308795
#headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
正月は頭痛発作が起こりがちです。
なぜなら正月は体内時計のリズムが大きく乱れるからです。
体内時計と片頭痛には大きな関連があり、脳の視床下部の関与が考えられています。
明日から仕事の方も多いと思います。
寝正月→仕事の生活リズムの変化はまた身体に負担がかかります。
正月休みが終わるのは名残惜しいですが、今日は諦めて早く寝ましょう。
Cephalalgia
@JCephalalgia
"This comprehensive review underscores the significance of chronobiology in phenotyping primary headache disorders and unraveling their pathophysiological underpinnings.
Insights from chronobiological studies pave the way for enhanced efficacy and precision in headache management, marking a significant advancement in patient care.
journals.sagepub.com/doi/10.1177/03331024241297652
@draneurologia
@faradoost
@dr_jray1
@ppozorosich
@CaronnaEdoardo
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Epicrania fugax triggered by head/neck movement or change in position may be due to subdural hepatoma, posterior fossa lesions or cervical vertebral lesions.
journals.sagepub.com/doi/10.1177/25158163241307328
#headache #neurology #pain -
Cephalalgia reposted
Umberto Pensato
@UPensato
· 1/10 🤯 Is Migraine a Disease?
Its high prevalence, especially in women of reproductive age, and its preserved genetic background suggest otherwise.
Could Migraine have a Darwinian, Evolutionary Meaning? Let’s dive in! 🧵👇 @JCephalalgia
journals.sagepub.com/doi/10.1177/03331024231209303 -
Cephalalgia
@JCephalalgia
December's Editor's Choice
@Simona_Sacco_
The methodology of drug trials in migraine has been described in multiple publications and is fragmented.
This paper synthesized this information and is an easy inroad to understanding the principles of drug trials.
journals.sagepub.com/doi/10.1177/03331024241298642
#migraine #headache #brain #pain #neurology #neuroscience
@d036218 -
Cephalalgia
@JCephalalgia
🏆 🏆 Cephalalgia is excited to announce the Jes Olesen Awards for the Advancement of Headache Medicine! 🏆 🏆
Submit your original research in one of two categories: Basic Science 🧬 or Clinical Science 🩺, and stand a chance to win a €10,000 prize per award.
The submission period runs from 1 October 2024 to 28 February 2025 📅.
This is a great opportunity to have your work recognized and presented at the International Headache Congress in São Paulo! 🌍
Eligibility: Original research papers only, and one submission per author.
📑 Visit the links for details!
journals.sagepub.com/home/CEP
journals.sagepub.com/pb-assets/PDF/JO_Award_CFP-172723543… -
Cephalalgia
@JCephalalgia
Cephalalgia is introducing graphical abstracts to its publications. A graphical abstract is a visual summary, in a single representation, of the findings of a study.
It must represent concisely and accurately the scientific content of the article. The aim of the graphical abstract is to summarise the main results of the study.
See the photo to get familiar with the template.
journals.sagepub.com/doi/10.1177/03331024241300883
#migraine #headache #brain #pain #neurology #neuroscience
@dgarciaazorin
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
This is the protocol for a placebo-controlled crossover trial to explore how sildenafil (Viagra®) triggers migraine in men with migraine. While prior studies have focused on women, this study aims to uncover potential sex differences in mechanisms.
journals.sagepub.com/doi/10.1177/25158163241307329
#migraine #headache #brain #pain #neurology #neuroscience
@Lanfpelledoc -
Cephalalgia
@JCephalalgia
"🏆 Announcing the Jes Olesen Awards! 🌍✨
Cephalalgia proudly introduces these prestigious awards, recognizing groundbreaking research in headache medicine. With a €10,000 prize for each category, we’re seeking the best original papers in both basic and clinical sciences. Don’t miss this opportunity to showcase your work on a global stage and advance the understanding of headache disorders!
📅 Submission opens 1 October 2024 – 28 February 2025
Categories: Basic Science & Clinical Science 🏅
Winners Will:
Present at the International Headache Congress 🌍
Gain Global Recognition on Cephalalgia & IHS Platforms 📢
Submit your breakthrough research and be recognized as a leader in the field!" -
Cephalalgia
@JCephalalgia
Cephalalgia is introducing graphical abstracts to its publications. A graphical abstract is a visual summary, in a single representation, of the findings of a study.
It must represent concisely and accurately the scientific content of the article. The aim of the graphical abstract is to summarise the main results of the study.
journals.sagepub.com/doi/10.1177/03331024241300883
#migraine #headache #brain #pain #neurology #neuroscience
@dgarciaazorin
@Simona_Sacco_ -
Cephalalgia
@JCephalalgia
The methodology of drug trials in migraine has been described in multiple publications and is fragmented.
This paper synthesized this information and It is an easy inroad to understanding the principles of drug trials.
journals.sagepub.com/doi/10.1177/03331024241298642
#migraine #headache #brain #pain #neurology #neuroscience
@d036218 -
Cephalalgia
@JCephalalgia
The machine-learning based tool holds promise in the prediction of treatment outcomes for patients with migraine undergoing anti-CGRP/R mAbs.
journals.sagepub.com/doi/10.1177/03331024241262751
#migraine #headache #brain #pain #neurology #neuroscience
@dgarciaazorin
@MRomozzi -
Cephalalgia
@JCephalalgia
Data from five large clinical trials demonstrated that atogepant was associated with consistent and modest dose- and duration-dependent weight loss when used as a preventive treatment in people with episodic or chronic migraine.
•
Given the high rate of comorbid obesity in people with migraine, the impact of atogepant on weight is an important factor to inform clinical decision making.
journals.sagepub.com/doi/10.1177/03331024241299753
#migraine #headache #brain #pain #neurology #neuroscience #weight
@petergoadsby
@daviddodick -
Cephalalgia
@JCephalalgia
These results demonstrate the value of preventive treatment with atogepant for reducing migraine-attributed impacts on multiple aspects of daily life, health, and well-being across the spectrum of people with migraine
journals.sagepub.com/doi/10.1177/03331024241300305
#migraine #headache #brain #pain #neurology #neuroscience
@ppozorosich
@Cristina4ihs
@CGottschalkMD -
Cephalalgia
@JCephalalgia
@JCephalalgia @Simona_Sacco_ Editor's Choice Article #ai & #headache. Please see a fantastic Video Interview @ErlingTronvik with Social Media Editor @NinaRiggins @IHS_Official
www.youtube.com/watch?v=dNmnuGNK16M -
Cephalalgia
@JCephalalgia
The number needed to treat for atogepant 60 mg once daily vs placebo was comparable with CGRP mAbs.
Atogepant demonstrated a numerically lower number needed to treat compared with CGRP mAbs in the primary analysis.
doi.org/10.1177/03331024241299377
#migraine #headache #brain #pain #neurology #neuroscience
@ppozorosich -
Cephalalgia
@JCephalalgia
This study reports several different aura manifestations, highlighting atypical features, aura relapse rates, and treatment approaches for aura. These findings could contribute to a deeper understanding of aura and its management.
-
Cephalalgia
@JCephalalgia
This study reports several different aura manifestations, highlighting atypical features, aura relapse rates, and treatment approaches for aura. These findings could contribute to a deeper understanding of aura and its management.
journals.sagepub.com/doi/10.1177/03331024241299453
#migraine #headache #neurology -
Cephalalgia
@JCephalalgia
📢✨ Exciting News!
The Abstracts of the 20th Biennial Migraine Trust International Symposium (MTIS), held in London, UK, from 5th to 8th September 2024, are now available! Dive into the latest advancements and groundbreaking research in migraine and headache disorders.
🗂️ Explore the abstracts and stay updated on cutting-edge developments in the field.
journals.sagepub.com/doi/full/10.1177/03331024241280496
#mtis2024 #migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
These results demonstrate the value of preventive treatment with atogepant for reducing migraine-attributed impacts on multiple aspects of daily life, health, and well-being across the spectrum of people with migraine
journals.sagepub.com/doi/10.1177/03331024241300305
#migraine #headache #brain #pain #neurology #neuroscience
@ppozorosich
@Cristina4ihs
@CGottschalkMD -
Cephalalgia
@JCephalalgia
Incremental burden was observed across migraine subgroups (1–3 MHDs, 4-7 MHDs, 8-14 MHDs, and ≥15 MHDs) irrespective of the use of prescription medication compared to the matched controls without migraine.
journals.sagepub.com/doi/10.1177/03331024241276415
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
🏆 🏆 Cephalalgia is excited to announce the Jes Olesen Awards for the Advancement of Headache Medicine! 🏆 🏆
Submit your original research in one of two categories: Basic Science 🧬 or Clinical Science 🩺, and stand a chance to win a €10,000 prize per award.
The submission period runs from 1 October 2024 to 28 February 2025 📅.
This is a great opportunity to have your work recognized and presented at the International Headache Congress in São Paulo! 🌍
Eligibility: Original research papers only, and one submission per author.
📑 Visit the links for details!
journals.sagepub.com/home/CEP
journals.sagepub.com/pb-assets/PDF/JO_Award_CFP-172723543… -
Cephalalgia
@JCephalalgia
The number needed to treat for atogepant 60 mg once daily vs placebo was comparable with CGRP mAbs.
Atogepant demonstrated a numerically lower number needed to treat compared with CGRP mAbs in the primary analysis.
journals.sagepub.com/doi/10.1177/03331024241299377
#migraine #headache #brain #pain #neurology #neuroscience
@ppozorosich -
Cephalalgia
@JCephalalgia
www.ihc2025.org
@JCephalalgia @IHS_official @Simona_Sacco_ @cephreports
Registration is now open for the 10th IHS International Headache Academy (iHEAD) to be held in São Paulo, Brazil, from 9 – 10 September 2025. @ninariggins @Faradoost -
Cephalalgia reposted
ひふみ|頭痛と脳神経外科
@dr_hifumi
身体の芯が冷えると、頭痛が起きそうな感覚ありませんか?
「冷え」が不調に関連するメカニズムが明らかになっていくかも、、、と思いました。
皮膚の寒冷受容体TRPM8が、片頭痛にも関連してるかも?という報告↓
Cephalalgia
@JCephalalgia
The cold receptor TRPM8 is a migraine susceptibility gene, but its role in migraine pathogenesis is unclear. This study found that the neurotrophin artemin, and its receptor GFRa3, sensitize TRPM8 to produce both migraine-like and cold pain in mice.
journals.sagepub.com/doi/10.1177/03331024241297679
#migraine #headache #brain #pain #neurology #neuroscience
@davemc1968 -
Cephalalgia
@JCephalalgia
Females with medication-overuse headache had repressed levels of Anti-Müllerian Hormone, a well-established biomarker for fertility, likely through disruption of granulosa cell proliferation.
journals.sagepub.com/doi/10.1177/03331024241290530
#migraine #headache #brain #pain #neurology #neuroscience
@rj_rigmor
@hmru_cph -
Cephalalgia
@JCephalalgia
The cold receptor TRPM8 is a migraine susceptibility gene, but its role in migraine pathogenesis is unclear. This study found that the neurotrophin artemin, and its receptor GFRa3, sensitize TRPM8 to produce both migraine-like and cold pain in mice.
journals.sagepub.com/doi/10.1177/03331024241297679
#migraine #headache #brain #pain #neurology #neuroscience
@davemc1968 -
Cephalalgia
@JCephalalgia
November's Editor's Choice
@Simona_Sacco_
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society
This study aimed to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache, which varied greatly across the world.
journals.sagepub.com/doi/10.1177/03331024241297688
#migraine #headache #brain #pain #neurology #neuroscience
@pul_fra
@dgarciaazorin
@MarcioNattan
@Alkaragholi_MM
@obegassededhaem
@arne_may -
Cephalalgia reposted
Faraidoon Haghdoost (Big Head Pain)
@faradoost
🕒✨ Time and Headache: What’s the Connection?
Our latest review in Cephalalgia dives into the intriguing relationship between timing processes and primary headache disorders.
📖 Read more: journals.sagepub.com/doi/10.1177/03331024241297652
#migraine #neurology
Cephalalgia
@JCephalalgia
"This comprehensive review underscores the significance of chronobiology in phenotyping primary headache disorders and unraveling their pathophysiological underpinnings.
Insights from chronobiological studies pave the way for enhanced efficacy and precision in headache management, marking a significant advancement in patient care.
journals.sagepub.com/doi/10.1177/03331024241297652
@draneurologia
@faradoost
@dr_jray1
@ppozorosich
@CaronnaEdoardo
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia reposted
Rigmor H. Jensen
@rj_rigmor
Simple analgisics are not so simple please be aware of the negative effect on sexhormones and fertility
Cephalalgia
@JCephalalgia
Females with medication-overuse headache had repressed levels of Anti-Müllerian Hormone, a well-established biomarker for fertility, likely through disruption of granulosa cell proliferation.
journals.sagepub.com/doi/10.1177/03331024241290530
#migraine #headache #brain #pain #neurology #neuroscience
@rj_rigmor
@hmru_cph -
Cephalalgia
@JCephalalgia
"🏆 Announcing the Jes Olesen Awards! 🌍✨
Cephalalgia proudly introduces these prestigious awards, recognizing groundbreaking research in headache medicine. With a €10,000 prize for each category, we’re seeking the best original papers in both basic and clinical sciences. Don’t miss this opportunity to showcase your work on a global stage and advance the understanding of headache disorders!
📅 Submission opens 1 October 2024 – 28 February 2025 💡 Categories: Basic Science & Clinical Science
Winners Will:
Present at the International Headache Congress 🌍
Gain Global Recognition on Cephalalgia & IHS Platforms 📢
Submit your breakthrough research and be recognized as a leader in the field!" -
Cephalalgia
@JCephalalgia
Females with medication-overuse headache had repressed levels of Anti-Müllerian Hormone, a well-established biomarker for fertility, likely through disruption of granulosa cell proliferation.
journals.sagepub.com/doi/10.1177/03331024241290530
#migraine #headache #brain #pain #neurology #neuroscience
@rj_rigmor
@hmru_cph -
Cephalalgia reposted
Jr Wei Wu, MD, FAAN
@Bohemian_Wu
Just finished today’s headache clinic with 50 patients. I also have several cluster headache patients with comorbid migraine, we will try to observe whether headache becomes worse or not when starting verapamil 💪
Cephalalgia
@JCephalalgia
Going forward, physicians should consider the importance of informing patients of the risk of headache worsening as part of routine practice when starting verapamil.
journals.sagepub.com/doi/10.1177/25158163241295990
#migraine #headache #brain #pain #neurology #neuroscience
@petergoadsby
@cephreports -
Cephalalgia
@JCephalalgia
Going forward, physicians should consider the importance of informing patients of the risk of headache worsening as part of routine practice when starting verapamil.
journals.sagepub.com/doi/10.1177/25158163241295990
#migraine #headache #brain #pain #neurology #neuroscience
@petergoadsby
@cephreports -
Cephalalgia
@JCephalalgia
"This comprehensive review underscores the significance of chronobiology in phenotyping primary headache disorders and unraveling their pathophysiological underpinnings.
Insights from chronobiological studies pave the way for enhanced efficacy and precision in headache management, marking a significant advancement in patient care.
journals.sagepub.com/doi/10.1177/03331024241297652
@draneurologia
@faradoost
@dr_jray1
@ppozorosich
@CaronnaEdoardo
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
"This comprehensive review underscores the significance of chronobiology in phenotyping primary headache disorders and unraveling their pathophysiological underpinnings.
Insights from chronobiological studies pave the way for enhanced efficacy and precision in headache management, marking a significant advancement in patient care.
journals.sagepub.com/doi/10.1177/03331024241297652
@draneurologia
@faradoost
@dr_jray1
@ppozorosich
@CaronnaEdoardo
#migraine #headache #brain #pain #neurology #neuroscience -
Cephalalgia
@JCephalalgia
Exciting news!
Faraidoon Haghdoost and Nina Riggins are stepping in as the social media editors for Cephalalgia and Cephalalgia Reports.
Welcome aboard, Faraidoon @faradoost and Nina @NinaRiggins
#headache #socialmedia #neurology

















































































































































































































































































































































































































































































































































































































































































































































































































































